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ABSTRACT
The thesis research was designed to study the characteristics of two
important physiological processes in smooth muscle: ca2+ transport
mediated by the plasmalemmal Ca -ATPase and muscarinic receptor-G
protein interactions. In . resting smooth muscle, several ca
extrusion or sequestration processes offset the passive inward leak of
Ca . Although biochemical
Ca pump plays a key role in this process, the precise role of this
evidence suggests that the plasmalemmal
enzyme could not be proven until a reliable estimate of the inward
Ca 1 eak was measured. Recent studies using dispersed smooth muscle
cell s from the toad stomach provided estimate the basa 1
transmembrane Ca fl ux rate; thus, we exami ned the transport capac ity
of the plasmalemmal Ca pump in this tissue. Gastric smooth muscle
tissue was disrupted homogenizat i.on and nitrogen cavitation.
Membranes enriched 20. fold for plasma membrane markers were obtained
us i n g . d iff e re n t i a 1 centri fugat i on and purification flotation on
discontinuous sucrose gradients.
The membrane vesicles exhibited an ATP-dependent Ca uptake that
was insensitive to azide or oxalate but sensitive to stimulation by
calmodulin or inhibition by orthovanadate and the calmodulin antagonists
trifluoperazine (TFP) or calmidazolium (CMZ). 45ca accumulated in the
presence of ATP was rapidly released by Ca2+ ionophore but not by
2.-
agents that stimulate Ca release from the sarcoplasmic reticulum
(caffeine, inositol trisphosphate, GTP). However , both CMZ and TFP
evoked a Ca release that was comparable to that observed in the
presence of Ca ionophore, suggesting that these compounds have
profound effects on membrane Ca2+ permeabi 1 i ty.
ca transport exhibited a high affinity for ca2+ (KD 0.
pM) and a high transport capacity, producing a :; l2, OOO-fold gradient
for Ca and a transmembrane flux rate at least 3-fold greater than
that observed in resting smooth muscle cells.
As a first step toward understanding the biochemical basis for the
divers ity muscari n i cho 1 i nergi c actions smooth muscle
examined the distribution of muscarinic receptor subtypes and coupling
to guanine nucleotide-binding (G) proteins in airway and gastric smooth
musc 1 e. Receptor subtypes were classified in membranes prepared from
bovine trachea and toad stomach based on the relative abilities of the
selective antagoni sts pi renzepi ne l ) , AF- 116 and 4-DAMP
HJQNBdisplace the binding. of nonselective antagoni st
(quinuclidinyl benzi late). Based on the binding profiles for these
antagonists, it was concluded that both smooth muscle types contain a
mixture of M
2 and M subtypes. In trachea the majority of receptors
(86%) were M
2' whereas in stomach the maj ori ty of receptors (88%) were
vi i
The displacement of ( HJQNB binding by the agonist oxotremorine
indicated a mixed population of high affinity (KD = 4 nM) and low
affinity (K 2-4 pM) binding sites. The addition of GTPyS
abolished all high affinity agonist binding, suggesting that coupling of
the receptors to G proteins may confer high affinity. Reaction of
membranes with pertussis toxin in the presence of ( PJNAD caused the
pJ-labelling of a 41 kD protein in both gastric and tracheal
smooth musc 1 e. Pretreatment of the membranes with pertussis toxin and
NAD completely abolished high affinity agonist binding in gastric smooth
muscle, but produced little if any decrease in high affinity agonist
activation 1 eads
We conclude that although muscarinic receptor
the elevation of intracellular ca2+ and
binding trachea.
contraction of both airway and gastric smooth muscle , the dissimilar
distributions of receptor subtypes and distinct patterns of coupling to
G proteins may ; nd.i cate that each smooth muscJ e type uses different
receptor-G protein interactions to regulate intracellular signalling
pa thways .
vi i i
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CHAPTER I.
INTRODUCTION TO SMOOTH MUSCLE CA
2+ HOMEOSTASIS
The level of cellular calcium (Ca) is considered to be the primary
determinant regulating the contractile state in smooth muscle. A 1 though
the detailed mechanisms by which Ca regulates smooth muscle contraction
are not fully understood , it is generally considered tha-t a rise 
intracellular ca2+ activates the regulatory protein calmodulin,
resulting stimulation myos.i n ight chain kinase with
concomi tant increase actomyos i n ATPase activity and tens i on
deve 1 opment. The messenger role 2+ requl res its ma i nta i nence
within the cytoplasm at a low (submicromolar) -concentration, and the
cell has evolved mechanisms to maintain intracellular ca2+ at a level
that is approximately 10, 000 fold lower than the extracellular fluid.
(Carafol i , 1986) . The resul tant arge el ectrochemi cal gradi ent for
2+ 
ensures that even minor changes in the Ca2+ permeability of the
plasma membrane in response to physiological stimuli could result 
significant changes in its intracellular concentration.
The major goal of studies of Ca2+ handling by..smooth muscle has2+ to elucidate the mechanisms by which the Ca concentratlonbeen
withfn smooth muscle cells are maintained at rest and in response to
relaxing or contractile stimuli. A large variety of preparations have
been employed in such studies including intact smooth muscle strips,
subcellular membrane fractions p repa red from smooth mu s c 1 e
suspensions of enzymatically dispersed smooth muscle cells.
efforts focused source
Initia 1
determi ni ng the. cellular
(extracellular vs. intracellular) that was involved in the contractile
response of intact tissues. These studies indicated that two different
2+ 
reserVOlrs 0 could serve as ac lvator a : an extracellular
pool of ca
2+ and a pool of Ca2+ that is tightly bound or sequestered
within the cell (Hurwitz and Suria, 1971). The role of extracellular2+ . Ca ln contractlon was initially demonstrated in studies in smooth
muscle strips in which contraction was measured , as function of2+ extracellular Ca concet1tration (Edman and Schild, 1962; Hurwitz et
Such studies showed that Caa 1., 1962; Brad i ng and Sheddon, 1980).
removal from the external medium led to the gradual loss of contractile
respons i veness of the , smooth muscle strips (Hiroaka et al., 1968),
although there was considerable tjssue to tissue variability in the rate
of dec 1 i ne res pons i venes s . In addition, there was considerable
variability as to the relative importance of extracellular Ca for
different contractile agents: responses to electrical stimuli and KCl
depolari zation were much more dependent on extracell ular Ca than
were responses to pharmacological stimul i. Such results led to the
observation initially made by Edman and Schild (1962) that ca2+ may
also be released from an intracellular store by pharmacological agents.
The role of these intracellular Ca2+ stores in the r gulation of
smooth muscle contractility have been studied primarily in vascular
smooth muscle, in which responses to norepinephrine were shown to
persist in ca free solutions (Hudgins and Weiss, 1968; Devine et al,
1972) . Simi lar results were later demonstrated with smooth muscle from
the trachea using histamine and acetylcholine (Kirkpatrick, 1975) and
from the taenia coli (Brading and Sneddon, 1980).
Further evidence for the role played by extracellular and cellular
Ca stores was sought by following the unidirectional and net
movements of 45Ca between the smooth muscle tissue and its external
environment. 45ca fluxes at rest and in response to contractile
agents ( KCl depolarization norep i neph ri ne, acetyl cho 1 i ne) were
extensively investigated , but the outcome of such experiments did not
lead to a unified concept. In initial studies of 45ca efflux from
smooth muscle, Schatzmann (1961) was unable to correlate changes in
ca washout with net changes in Ca content of the guinea pig taenia
coli. Moreover, studies of 45ca efflux from intact tissue by . Bozler
(1963) led to the conclusion that the observed efflux was too large to
be accounted for .by an ATP-dependent pump, since the energy
required by this pump would be considerably gretaer than the entire
metabolism of the tissue. In addition , van Breeman and Daniel (1966)
demonstrated that K
+ -
induced depolari zation of rat uterus which
contracts smooth muscle presumably by promotlng a entry, caused a
dec rease in Ca uptake and a net reducti on in Ca content of the
ti ssue. These results were not confirmed by Schatzmann (1964), however,
who found that K depolarization of guinea pig taenia coli caused an
increase in 45Ca efflux with no net change in Ca content.
Reports on agonist-induced Ca2+ flux were equally contradictory.
Schatzmann (1961) noted a slight stimulation of 45ca efflux with
acetylcholine (ACh) in taenia coli whereas van Breeman and Daniel (1966)
found no effect of thi s agoni st on Ca effl ux from the uterus.
Potter et al. (1970) found both an increase ln a uptake and efflux
induced by ACh in toad stomach smooth muscle. Similarly, some studies
showed an epi nephri ne- i nduced increase' in Ca effl ux from the aorta
(Hudgins, 1969), while others showed an epinephrine- induced decrease in
ca efflux from the same tissue (Seidel and Bohr, 1971). Thus, there
was little correlation between contractility and flux studies. The
principal . reason underlying these apparent discrepancies is that the
transport of Ca across the smooth muscle cell membrane represents
only a small fraction of the total exchange that occurs between the
external - medium and the vario s extracellular binding sites within the
smooth muscle tissue. Thus, the complex geometry of the extracellular
space within the tis.sue (and resultant diffusion delays) -and the
prevalence of 45ca binding sit.es within the extracellular matrix posed
considerable diff-iculties in the analysis and interpretation of the
results (van Breemn and McNaughton , 1979).
Several methods were subsequently developed to c i rcumvent the
problems of extracellular 45Ca binding and exchange, including the
. 3+ addition of La (Lanthanum) or Ca EGTA (ethyleneglycol-bis
(B-aminoethylether)-N, tetracetic acid), in order to displace or
deplete the extracellular-bound Ca (van Breeman et al., 1973; van
Breeman and Castels, 1974). The principle behind the " 3+ method" is
that this tri va 1 ent cation displaces the labelled ca2+ from
further transmembrane Ca exchange.extracellular sites and blocks
Using this method Deth and van Breeman (1974) were able to show that the
rapid initial phase of aortic contractions induced by norepinephrine and
angiotensin II were dependent on a common intracellular store while the
slow phase of the contractions were dependent on ca2+ influx.
addition, they were able to observe relaxation of the tissue even though
2+ La blocked Ca efflux across the plasma membrane, a finding which
suggested that intracellular sequestration was able to bring about
cellular relaxation. Finally, expos i ng ti ssues metabo 1 i c
inhibitors to deplete cellular ATP and monitoring uptake using the
II La method"
, Casteel and van Breeman (1975) obtained an estimate of
2+ .the passive inward leak of ln resting smooth muscle (- 0.
pmol/cm surface area-sec) and demonstrated that ci extrusion
from smooth muscle was markedl sensitive to depletion of cellular ATP
but insensitive to changes in the transmembrane Na+ gradient.
A 1 though these approaches provided some insights into
handling in smooth muscle, technical problems (secondary changes in ion
contents and in the permeability and stability of the p asma membrane,
etc. ) have compromi sed the i r usefulness. The use isolated
subce 11 ul ar membranes from smooth muscl e represented an a ternati ve
method to assess t e comp ex lnteractlons between Ca ions and smooth
muscle membranes and circumvented some of the intrinsic difficulties
associated with intact preparations. Studies using such preparations
were able to demonstrate ATP-dependent accumulation by these membrane
fractions wh i c h was initially presumed refl ect uptake the
sarcoplasmic reticulum (e.
g. 
Carsten, 1969). It was later recogni zed
that these crude mi crosoma 1 fracti ons cons i sted primari 1 of plasma
membrane vesicles. The presence of an active, ATP-dependent a
transport system localized in the plasma membrane was first demonstrated
in vascular (Fitzpatrick, 1972) and in visceral smooth muscle (Hurwitz
et al., 1973) using membrane vesicles prepared by homogenization and
differential centrifugation. These vesicles accumulated Ca2+ in 
ATP-dependent, azide- i nsens i ti ve manner that2+ (Ca Mg )-dependent ATPase activity. was associated withWith more extens i ze
purification of the membrane fractions it was possible to demonstrate
two types of Ca pumps within smooth muscle. Janis et al. (1977)
confi rmed the presence pumps the plasma 1 emma 1 and
sarcoplasmic reticulum fractions of myometrium that exhibited similar
affinities for ca2+ and similar. maximum velocities (Vmax
)' 
The
presence of a second Ca transport ATPase was also suggested by
phosphorylation experiments with smooth muscle microsomes. If membranes
were phosphorylated in the absence of the most promi nent
Ca -dependent phosphoi ntermed i ate corresponded to a protei n of MW -
100, 000 , similar to that reported for the skeletal muscle sarcoplasmic2+ 
retl cul um Ca pump. In the presence of La , the most promi nant
phosphointermediate corresponded to a protein of MW - 138 000 similar
to that observed for the erythrocyte plasmalemmal Ca ATPase.
The use of subcellular fractions also allowed for the direct
. 2+
demonstration of a Na ICa exchange mechanism in smooth muscle. 
addition to an active ca2+ transport system, it was postulated that
smooth muscles also may be able to control intracellular ca
2+ levels
by an Na /ca
circumstances, lowers
of the Na + grad i ent.
exchange system that, under physiological
cytoso 1 i c util i zing the potent i a energy
Earlier attempts demonstrate this transporter
contracti 1 ity changes
remov i ng 
2+ flux)
and observi ng changesin intact smooth muscle (by
had been compromi sed
technical problems such as the possible competition between Na and
2+ for membrane binding sites (Daniel et al. , 1982). Using isolated
membrane fracti ons, however, Grover et a 1. (1981) were able f()r the
first time to obtain direct evidence for the existence of a Na /Ca
exchange mechanism in smooth muscle plasma membranes isolated from rat
di rected Na gra ent
Such studies demonstrated that an
net
myometri um (Grover et a 1., 1981).
abolition the Na + gradient with monens in,
uptake and that
a Na -selective
outwa rd 1 y caused
i onophore, abolished the effect of the Na gradient on Ca uptake.
Similar results have subsequently been reported for guinea pig ureter
(Aickin et a1., 1984) rat mesenteric artery (Matlib, 1985), tracheal
smooth muscle (Slaughter, et al., 1987) and arterial smooth muscle cells
(Smith et al 1987).
The results from these types of studies have led to a better
understanding of the regulation of intracellular a 10ns 10 smooth
mu s c 1 e cell s It is now clear that contractile agents can increase
i ntrace 11 ul ar Ca , either by stimulating the release of Ca from
i nterna stores in the sarcoplasmic reticulum or by stimulating the
entry of Ca from the extracellular medium via voltage-sensitive or
receptor-operated channe 1 s . A 1 though the sarcoplasmic reti cul um
represents only a small percentage of total ell volume (2-5% or roughly
pL; see Eggermont et al., 1988), it may nevertheless play 
important role in regulating cytosolic Ca For example , assuming an
average resting intracellular ca
2+ level of 100-200 nM (Williams and
Fay, 1986; Yamaguchi, 1986) and assuming that the sarcoplasmic reticulum
2+ pump generates a 10, 000 fold gradient for ca the total
2+ .1n the sarcoplasmic reticulum would approach 1-2 mM, similar to
measured estimates of total cellular ca2+ in isolated smooth muscle
cells (Scheid and Fay, 1984). This concentration of ca2+ within the
sarcoplasmic reticulum represents approximately 1. fmol of ca
(assuming a volume of - 0. 5 pL).
Ca from the sarcoplasmic reticulum into an average cell volume of 10
pL could raise cytosolic ca2+ to - 10 pM, a value 10-fold higher
than- that required for smooth muscle contraction (Williams and Fay,
Therefore, a release of 10% of the
1986; Yamaguchi , 1986). Thus, the sarcoplasmic reticulum represents a
potentially important storage and release Slt or a 
Due to the constant inward leak of ca2+ down its electrochemical
gradient, inhibition alone of ca
2+ influx or 
release is not sufficient
to allow relaxation to occur. Thus, an outward extrusion or inward
sequestration mechani sm must be operati ve 
cytoplasmic Ca-
2+ 
conce-trations observed at rest.
ma i nta i n the low
The studies using
subcellular membrane fractions indicated that three cellular transport2+ 
systems act to lower cytoplasmic Ca : the Ca pump located in the
sarcoplasmic reticulum, the ca
2+ pump on the plasma membrane and a2+ Na Ca ant1porter on the plasma membrane. Although the precise2+ 
contributions. of these Ca -transport1ng systems are not completely
understood, there is abundant evidence that each system can contri bute
the regulation intracellular ca
membrane Na /ca
smooth musc 1 e. For
exampl e, the plasma exchanger has been
characteri zed large. capacity, low affinity (K 1-10 pM)
system that presumably functions to remove excess cytosolic Ca that
occurs following acti vation (Kwan, 1986), whereas both the plasmal emma 
and sarcoplasmic reticulum pumps serve as lower capacity but higher
affinity (K = 200-500 nM) transporters.
The Ca pumps of the sarcoplasmic reticulum and plasma membrane
differ in their molecular mass, immunological properties, stoichiomefry
between ATP hydrolyzed and calcium transported, and sensitivity to a
number of inhibitors and activators. The sarcoplasmic reticulum ca
pump has an affinity (K for ca2+ below 0. pM, is inhibited by
vanadate (50 pM) and transports Ca 
2+ wi th a 
stoi chi ometry of
2 ca :1 ATP (Carafoli, 1988). Its activity appears to be modulated
by a proteolipid, phospholamban which can be phosphorylated by cAMP and
calmodulin-dependent protein kinases (Meissner 19B7). The plasma
membrane 
l+ pump has a K
m for ca
2+ in 
the 0. 1 to 0. 5 pM range,
is inhibited by low~r concentrations of vanadate. (0.1 - pM)and
2+ transports Ca Wl t stoi chi ometry of Ca : ATP. An important
feature- of lasmalemmal ca2+ pump is its regu.lation 
calmodulin. The stimulatory effect calmodulin was originally
observed by Bond and Clough (1972) who found that a protein in human
erythrocytes activated the Ca -ATPase activity of the plasma
membrane. Jarret and Penniston (1977) later demonstrated that purified
calmodu 1 in mimi cked the effects thi s soluble protei n the
erythrocyte membrane.
The plasmalemmal 2+ smoot musc e Ca pump 1 s a 1 so ta rget for
calmodulin and this interaction has been exploited to purify the ATPase
on calmodulin affinity columns (Wuytack et al., 1981). The purified
Quantitative analysis of
the effects of calmodulin were measured using purified Ca pumps
reconstituted -into liposomes. The most clear-cut effects of calmodulin
on the overall ATPase reaction and ca
2+ transport are an increase in
enzyme is a single polypeptid& of MW 138, 000.
the apparent affinity for ca2+ activation and increase in the
maximal rate of the reaction (Garrahan 1986). In intact membrane
systems, calmodulin interactions with the plasmalemmal Ca pump are
often assessed by measuri ng the effects of ca lmodul in antagoni sts 
ATP-dependent Ca
2+ transport or on ca2+ + Mg2+ stimulated ATPase
acti vi ty.
The direct involvement of calmodulin in the activation of the
plasmalemmal Ca -ATPase suggests the existence of a self-regulatory
mechanism for intracellular ca
2+ homeostasis in smooth muscle.
Calmodulin is fully activated when the cytosolic Ca levels reach or
exceed micromo-lar co.ncentrations (Cheung 1982), thereby activating2+ Ca extus10n by the pump. As Ca returns to the submicromolar
steady-state leve 1 the ac.t i.ve calmodul i n- pump comp 1 ex
dissociates, thereby decreasing enzymatic activity to the basal level
(Popescu and Ignat , 1983).
Ca pump may also be regulated by cAMP-dependent phosphorylation in
In addition to calmodulin regulation, the
certain smooth muscle types (Kwan, 1986 ) and by protein kinase C
(Furukawa et al., 1989).
The exact role of the smooth muscle sarcoplasmic reticulum Ca
pump is unclear, in part due to the scarcity of sarcoplasmic reticulum
in smooth muscle and its variable distribution among the different
smooth muscle types. It is generally considered that this enzyme plays
role in the rapid removal of increased cytosolic Ca that occurs
after activation by contractile agents (Eggermont et al., 19B8). On the
other hand, the plasmalemmal Ca pump, because of its high affinity
for ca
2+ and high translocation velocity, is generally considered to
the primary regulator of steady-state cytosolic ca2+ levels.
its precise contribution ' to cellular ca2+ homeostasis hasHowever,
been difficult to assess due to several limitations. For one, the
magnitude of the basal transmembrane leak rate for Ca that must be
opposed by the plasmal emma 1 Ca pump has not, until recently, been
precisely determined due to the complexities of intact tissue
preparations (diffusion delays, extensive extrac llular ca2+ binding,
etc.
). 
Thus it has been difficult to determine whether the plasma
membrane Ca pump has sufficient transport capacity to offset this
eak. This diffi culty was ci rcumvented us i ng suspensions
enzymatically dhpersed gastric smooth muscle cells such that it was
possible to obtain reliable estimates of basal and agonist-stimulated
unidirectional transmembrane Ca. fl uxes (Schei.d and.- Fay, 1984a, b.).
Another limitation associated with defining the contribution of the
2+ pump to ca2+ homeostasis involves difficulty in translating
biochemical estimates of enzymatic activities to estimates of transport
memb-rane fractions,
For example, estimates of maximal transport rates in
expressed as moles of Ca transported per mg
function in vivo
protein, are highly dependent on the purity of the membrane preparation
and on the initial velocity of ca2+ transport. The contention from
biochemical studies that the plasmalemmal Ca pump plays a dominant
role in maintaining low resting levels of cellular Ca had thus not
been directly proven.
The major goal for the first portion of my thesis research was to
evaluate the hypothesis that the smooth muscle plasmalemmal ca
ATPase plays an essential role in cellular Ca homeostasis. The
specific aims were designed to document the functional role of the
plasma membrane Ca pump by assessing the transport capacity of the
toad gastric smooth muscle enzyme under conditions which are thought to
prevail in resting cells.
To this end, we 
1 ) developed , plasma membrane preparation f rom toad gastric
smooth musc 1 e. The purity of the preparati on was assessed 
determi ni ng the acti vi ty of several , marker enzymes for the
plasma membrane, mitochondria , or sarcoplasmic reticulum.
defined the characteri st i and kinetic properties
ATP-dep-endent uptake and compared them with those
measur-ed in membrane fract.:ons prepared from pig antral smooth
muscle, a preparation ' that has been extensively studied. The
studies with porcine mu s c 1 e a 11 owed assess the
eff ti veness of our membrane 'preparati ve procedures and
compare our observed Ca transport characteri stics to those
observed , previously in this tissue by other investigators.
More specifically, we measured the sensitivity to vanadate
oxalate and azide, and assessed the calmodulin sensitivity of
Ca transport in order to determi ne whether the observed
ATP-dependent Ca uptake was due to the operation of a
plasma 1 emma 1 ATPase. Finally, in order to determine if the
membranes were contaminated by sarcoplasmic reti cul um the
effects of agents known to stimulate sarcoplasmic reticulum Ca
release efflux from preloaded vesicles were exami ned.on 
determi ned the plasmalemma pump was capable
generating a transmembrane calcium gradient similar to that
observed in intact smooth muscle cells. 2+ 
converted the measured velocity of the Ca pump at 
1 eve 1 s observed in resting smooth muscle cells (100-200 nM
Ca ) to a - fl ux rate per surface area and compared thi s rate
to the value of the passive transmembrane flux rate observed in
intact smooth muscle cells.
Chapter I I.
Assessment of the Transport Capacity of the Plasma1emma12+ Ca Pump 1n Smooth Muscle
ABSTRACT
In resting smooth muscle
offset the inward Ca2+ leak.
variety of Ca2+ extrusion - processes
Biochemical stud i es suggest that the
plasma 1 emma 1 ci+ pump domi nates thi s process; however thi s
contention could not be proven without a reliable estimate of the inward
2+ leak that must be opposed by active transport. Recent stud i es
using dispersed cells from the toad stomach provided such an estimate;
thus , we examined the capacity of the plasmalemma1 ca2+ pump in this
tissue. Membranes were prepared using nitrogen cavitation, high salt
extraction and flotation on discontinuous sucrose gradients. These
membrane vesicles were enriched 16 - 24 fold for plasma membrane markers
and exhibited an ATP-dependent' uptake of 45Ca that was insensitive to
azide oxalate but sensiti ve orthovanadate inhibition and
calmodulin stimulation. 45 Ca accumulated in the presence of ATP was
rapidly released by Ca 10nop ore ut not by caffeine,
Uptake exhibited a high affinity for Ca ' (K
3 '
pM) and
high transport capacity, producing :; 12000 fold gradient for Ca
and a transmembrane flux rate greater than that observed in resti ng
GTP.
smooth muscle cells. Thus, this enzyme is capable of maintaining steady
state Ca
2+ levels in smooth muscle.
The results from these studies were accepted for publication:
A. Lucchesi, R.A. Cooney, C. Mangsen-Baker , T.W. Honeyman and C.
Scheid. Analysis of the transport capacity of plasmalemmal Ca2+ pump
in gastric smooth muscle. Am. J. Ph siol. 255:C226-C236, 1988.
I NTRODUCTI ON
It has long been recogni zed that the plasma membrane of smooth
muscle plays a key role in maintaining the low levels of intracellular
Ca that prevail under resti ng conditions. Thi s semi permeant barri er
regulates Ca2+ entry through voltage- and/or receptor-gated ca
chann' e1s and cl+ extrusion via various transport processes. Thus far
at east two 2+ Ca ex rUS10n processes have been identified in the
smooth muscle plasmalemma: an ATP-independent exchange process in which
the extrusion of cellular Ca2+ is coupled to the entry 
extracellular Na + (Na /Ca exchange) and an ATP-dependent Ca
pump which actively extrudes cellular Ca2+ (see Daniel et al., 1983
for revi ew) .
Of these processes , the plasmalemmal Ca pump has been considered
2+ the primary regulator of cellular a omeos aS1S 1n smooth muscle
based on the high affinity of the enzyme and its high translocation
capacity (Wibo et al. , 1981; Wuytack et al. , 1981; Raeymakers et al.,
1983; Grover, 1985; Sharma and Bhalla , 1986). Demonstrati ng the preci 
2+ 
contribution of this enzyme to steady state Ca omeostas1s
.l V1VO
has been difficult however because uncerta i nty regardi ng the
2+ '
magnitude of the basal transmembrane Ca flux that must be opposed by
the Ca2+ pump. Estimates of thi s transmembrane 1 eak rate for ca
cannot readily be obtained in intact smooth muscle because of technical
problems associated with diffusion delays in the extracellular matrix
and recentextracellular binding. studies us i ngHowever
suspensions of enzymatically dispersed smooth muscle cells from the toad
1984) . Thi s passive leak
rate in resting cells (Scheid and Fay,
averages 0. 1 pmoles/cm .sec in these
that the plasmalemmal Ca pump - 
stomach measured thi s fl ux
cells; thus, one would predict
the presence 0 preval 1ng Ca levels of 100 - 200 nM (see Williams
and Fay, 1986 and Yamaguchi, 1986) - must be capable of producing an
opposing outward ci+ flux equal to or greater than this leak rate if
indeed the enzyme plays a dominant role - in smooth muscle ca
homeostas is.
The present studies were designed to document the functional role of
the plasma membrane Ca pump smooth musc 1 e by assessing the
transport capacity of the toad smooth muscle enzyme under conditions
that are thought to prevail in resting smooth muscle cells. To thi s
end, plasma membrane fractions were prepared from toad gastric smooth
musc 1 e and a number of the k i neti c properties of ATP-dependent uptake
were defi ned. These characteri sti cs were compared to those of membrane
fractions prepared from pig antral smooth muscle , a preparation that has
been extensively characterized by other investigators (Wuytack et al.
1981) and that served as a benchmark for the present studies. other
characteristics, including vanadate sensitivity, calmodulin regulation
and insensitivity to azide and oxalate, were used to confirm that the
observed ATP-dependent uptake was due to the presence of a p1asmalemmal
Ca ATPase.
in membrane
The transport capacity of the plasmalemmal Ca2+ pump
vesicles, expressed as moles/sec.cm cell membrane , was
5 fold higher than the passive transmembrane flux rate observed in
isolated smooth muscle cells. Thus , the low levels of cytosolic Ca
that prevail in resting smooth muscle could be maintained solely by the
operation of the ' plasmalemmal Ca pump. preliminary report of
these findings has -appeared (Lucchesi et al. , 1987).
METHODS
Pre arati on of Membrane Fracti ons. Preparation of plasma1emmal vesicles
from toad stomach muscle was carried out as indicated in Figure All
procedures were carried out at 4 C. For each preparation stomachs
from 25 toads (Bufo mari nus) were excised, trimmed of mucosa and
connective tissue and minced with scissors in ice -cold homogenization
buffer consisting of 50 mM MOPS ((N-Morpholino)propanesulfonic acid), pH
1, 150 mM NaCl , 5 mM EDTA, 1 mM dithiothreitol (DTT), 17 mg/L of PMSF
(phenylmethyl su fonyl fluoride) , and mg/L soybean tryps i 
inhibitor. The minced tissue was then homogenized in a Waring blender
(2 x 30 sec at low speed) in 20 volumes of the above buffer. Further
disruption was achieved using an U1traturrax Tissuemizer (an initial 25
sec burst using the SDT-182EN probe followed by a 25 sec burst using
the smaller SDT-100 EN probe). The crude homogenate was then fi ltered
and disrupted twice by nitrogen cavitation. Ce 11 ular debri s was removed
by two low speed centrifugations , a 20 min spin at 5 000 x g in a GSA
rotor followed by a 10 min centrifugation at 10, 000 x g in a GSA rotor.
The supernatant from this spin was centrifuged at 3D, OOO x g for 90 min
in a SS34 rotor. The resultant crude microsomal pellets were then
suspended in homogenization buffer containing 0. 6 M NaCl and centrifuged
at 30, 000 x g for 60 mi n in a SS34 rotor. The treatment with a buffer
of high salt concentration served to remove contaminating myofilaments.
PELLET 
STOMACH HUSCULARIS
Crude mince
Waring blender
Ultraturrax Tissuem1zer
HOHOGENA 
n N min
SUPERNATANT
10, 000 x g, 10 mln
SUPERNATANT
30, 000 xg 90 min
SUptRNATAHT
PELLET
PELLET
Salt Extraction
30, 000 xg 60 min
PELLET
OOO rpm, 70 min
-UPPER6 40,000 rpm, 90 mln
LOWER
1.0
SUPERHATANT
FRACTION I
FRACTION II
frozen in liquid N2
stored at -aoo
Figure 1. Flow chart for preparation of membrane vesicles from toad
stomach musc 1 e.
Membrane fractions were further enriched by a sucrose flotation method
modified from Jones (1986). The salt-extracted microsomal pellets were
resuspended in a buffer containing 150 mM NaCl , 50 mM MOPS (pH 7. 1), 25
pyrophosphate, and 1.0 M sucrose. Ten aliquots this
solution were transferred po 1 yca rbona te centrifuge tubes. This
suspension was overl ayed with seven buffer containing 0. 6 M
suc rose 50 mM MOPS (pH 7. 1), 300 mM NaCl and 25 mM Na pyrophosphate.
The tubes were filled to volume with a buffer containing 0. 3 M sucrose
and 50 mM MOPS (pH 7. 1) . The samples were centrifuged using a Beckman
Ti 60 rotor for 70 min at 370, 000 x g. Two trans 1 ucent , membrane-ri ch
bands were obtained: an upper band at the 0. 3/0. 6 M sucrose interface
and a lower band at the 0. 6/1. 0 M sucrose interface. The bands were
carefully extracted with a Pasteur pipet in ' order to avoid removing
media (containing soluble contractile proteins) immediately surrounding
the fracti ons. The collected fractions were then diluted 5-fold with
ice cold buffer containing 100 mM NaCl and harvested by centrifugation
for 90 min at 161, 000 x g in a Ti 60 rotor. The sedimented membranes
were resuspended by sonication in storage buffer (250 mM sucrose , 40 mM
MOPS (pH 7. 1), 1 mM DTT , and 10 pg/ml leupeptin), rapidly frozen in
liquid nitrogen and stored at -80 C. Aliquots of the various
fractions were assayed for protein content according to the method of
Lowry (1951).
For the preparation of membranes from pig antral smooth muscle, pig
stomachs (usually l or 2 for each batch of membranes) were obtained from
1 oca 1 slaughterhouse transferred ice to the aboratory and
processed described for the toad stomach. One additi ona 
centrifugation step was utilized in processing pig tissue: an additional
10 min, 5000 x g centrifugation between the nitrogen cavitation steps.
Other steps the reparati ve procedure were identical to those
described for the toad.
Membrane Characteri zati on
Cho 1 i ner i c Rece tor Bindin The presence muscarinic
cholinergic receptors was quantitated by assaying for specific binding
of ( H)-quinuclidinyl benzilate (QNB). Reactions were carried out 
a total volume of 1. 0 ml at 31 C in a buffer containing: 40 mM MOPS,
pH 7. 1, 10 mM M9C1 2' 2 mM EDTA , 50 mM NaCl , 3 nM ( H)-QNB (specific
activity 35. 2 Ci/mmol). Binding was initiated by the addition of 50-100
protei n. After 60 mi n incubation peri od the reaction was
terminated by rapid filtration through Whatman GF/F filters using a
Hoeffer fi ltration apparatus. The fi Hers were washed 5 times with 3
mls of ice cold buffer containing 50 mM MOPS (pH 7. 1), 25 mM NaCl, and 5
M9C1
(Liquiscint,
The filters were then dissolved counti ng fluid
National Diagnostic Reagents) and counted in a iquid
scinti llation counter. Specific binding of ( HJ-QNB was calculated as
the difference in binding observed in the presence and absence of 100
atropi ne specific antagoni st for muscarinic c h 0 1 i n e rg i c
receptors. Nonspecific binding was l% in these studies.
b. Marker Enz me Assa The activity of the plasma membrane marker
nucleotidase was measured in a medium containing 50 mM glycine-NaOH,
pH 9. 1, 5 mM AMP and 10 mM MgC1 Reactions were initiated by the
addition of 50-60 pg of protein and nucleotidase activity was detected
by measuri ng the amount of i norgani c phosphate that was rel eased duri 
30 minute incubation at 3l Inorganic phosphate was quantitated
by the malachite green assay of Itaya and Ui (1966).
Assays for .NADPH cytochrome f. reductase , a putative marker for the
endQplasmic reticulum (Matlib et a1. 1979), and NADH cytochrome 
reductase, a marker for mitochondrial membranes (Matlib et al. , 1979),
were carri ed out spectrophotometri ca lly accordi ng to Sottocasa et a 
(1967) in a buffer. containing 50 mM potassium phosphate , pH 7. 1 mM
KCN , 47 nmoles cytochrome f. and either 0. 15 mM NADPH or 0. 1 mM NADH.
Reactions were initiated by the addition of 60-90 pg protein and the
progress of the reaction was monitored as an increase in the absorbance
at 550 nm.
oubain-sensitive ni tropheny1 phosphatasestimulated
(PNPPase) acti vity was determi ned accordi ng to the procedure of Kostka
and Kwan (1986). The standard assay medium contained 50 mM imidazole
pH 7. 8, 5 mM MgC1 2' and 5 mM PNPP. The reaction was initiated by the
addition of 50-70 pg of protein at C (toad) or C (pig) and was
terminated after 30 min of incubation by the addition of ml of
ice-cold 1N NaOH. Samples were then centrifuged to remove precipitated
protei ns. Enzyme activity was quantitated spectrophotometrically by
monitoring the absorbance ni tropheno 400 us i ng
extinction coefficient of l8, 000/M-cm for the enzyme (Kostka and Kwan
1986) . K -act1vate PNPPase activity was defined as the difference
between acti viti es observed in the presence and absence of 10 mM KC1.
For those assays in whi ch K
+ -
acti vated PNPPase acti vity was employed
to assess the sidedness of the vesicles , the amount of imadazole in the
react ion 250 ma i n ta i n isotonicmi xtu re increasedwas
conditions. Enzyme acti vi ty was then determi ned for contro 1 membranes
and for membranes that had been rendered permeant by a 30 mi n exposure
at 4 C to 70 pg/ml of saponin. The difference in activity between
permeant vesicles (total activity) and in control membranes (right side
out membranes) is assumed to reflect the activity associated with
inside-out vesicles.
Measurement Membrane Vesicles.Trans ort
uptake by membrane vesicles was determined by a Millipore filtration
techn i que. This involved incubating theplasma 1 emma 1 ves i c 1 es
fOllowing standard reaction mixture: 20 mM HEPES (N-2- hydroxyethy1-
piperazine- 2-ethane sulfonic ,acid), pH 7. 1, 5 mM NaN
3' 100 mM KC1
3mM MgC12' 10pM . 2+ and -1 pCi/ml 45ca. When indicated
ATP (5 mM) was added along with a regenerating system consisting of 5 mM
creatine phosphate and U/ml reat i ne phosphok i nase. Under these
conditions, the levels of MgCl and CaC1 were increased to 8. 066 mM
and , to maintain the 2+ levels of free Mg and Ca at 3 
and 10 pM, respectively. In experiments in which calmodulin was added
to the reaction mixture , the calmodulin was added as a C/+ calmodulin
comp 1 ex at a final concentration of 2 pg/ml. Uptake experiments were
carri ed out at room temperature such that the data obta i ned for
vesicular ptake in toad vesicles could be compared to the transmembrane
fluxes observed previously in suspensions of toad smooth muscle cells
(Scheid and Fay, 1984a). Experiments were initiated by adding 30-
pg of membrane protein to the reaction mi xture. At various time s
after membrane addition, duplicate aliquots were removed and
filtered through 1. 2 pm Mil1ipore filters. Fi lters were washed with 5
ml of ice-cold buffer containing 1 mM LaCl and 150 mM NaCl , dissolved
in counting fluid and counted using a liquid scintillation counter.
ATP-dependent Ca 2+ uptake was defi ned as the . uptake in the presence of
ATP mi nus the uptake in the absence of ATP.
In some experiments the 1 eve 1 ion i zed Ca 1n reactlon
mixture was varied using EGTA buffers. In these instances, total Ca
was maintained at 100 pM, and the amount of EGTA required to achieve
2+ 
the desired concentrations 0 10nlZe an a final (Mg J of 1.
was calculated using Fabiato s stability constants for EGTA , ATP
and creatine phosphate (Fabiato , 1981). A 11 other consti tuents of the
reaction buffer remained the same.
For assessing 45Ca release from membrane vesicles
loaded wi th 45Ca for 60 mi n at room temperature in the
vesicles were
standard uptake
buffer (see above) containing 5 mM ATP. Efflux was initiated by a
10-fold dilution of preloaded vesicles with buffer containing 100 mM
KC1, 20 mM HEPES , pH 7. , and either 1.0 mM EGTA or 0. 1 mM EDTA.
some experiments, caffeine (20 mM), D-myoinosito1 1 , 4 , 5-trisphosphate
(IP pM) , GTP (10 pM ), (lOpM) GTP ( 1 0 pM ) were
included the eff 1 ux buffer. At various time s after dilution,
duplicate 1 ml a1iquots of the reaction mixture were removed , filtered
and counted as descri bed above.
Electron Microsco The relative purity of membranes at various steps
the preparative procedure was assessed by electron microscopic
examination of thin sections of pelleted material. Puri f i ed membranes
(both upper and lower fractions) and material obtained at the initial
000 x g spin were fixed in 2% glutaraldehyde , postfixed in 1% osmium
tetroxide and embedded in epon. Sections were stained with uranyl
acetate and lead citrate and examined on a JEOL 100 ZX microscope.
Si nce the membrane vesicles used for transport studies were
s ubj ected to a single sonication pri or to thei r use, whereas the
vesicles used monitor intravesicular vo 1 ume ( from -1 nu 1 n
trapping studies, see below) were subjected to a second sonication
before use, we examined the vesicle size of both populations. This
involved measurement of over 500 vesicle profiles in at least six
electron micrographs for each group to obtain an .estimate of the average
vesicle diameter This initial estimate was then corrected for errors
produced by sectioning vesicles above or below their midpoint; thus , the
value for the true vesicle diameter was calculated as D = d(4lrr)
(see Weibel , 1979).
Electro horesis. The relative purity of various membrane fractions was
a 1 so assessed us i ng ge 1sodi um dodecy1 sulphate po 1 yac ryl ami de
e 1 ectrophores is. polyacrylamide andlinear 6-16% gradient 
Laemmli buffer system (pH 6. , see Laemmli , 1980) were used for these
studies. Gels were stained with Coomassie brilliant blue.
Intravesicular Volume Measurements. To assess intravesicular volumes
75 mg of membrane vesicles (toad lower fraction) were disrupted by
sonication (2 x 10 sec burst at 65 Watts with a Sonifer Cell Disrupter)
in the presence of ( H)-inulin (1.0 pCi/ml). The amount of labelled
inulin trapped within the vesicles was then determined by filtering the
vesicles through 1. pm filters , washing the filters with ice cold
isotonic saline containing 10 mM inulin and counting the filters. Tota 1
counts associated with werefi lters corrected for nonspecificthe
binding of ( HJ-inulin (ie. for label bound to filters in the absence
of added membranes).
Materials. these studies were of the highestemp 1 oyedReagents
purity available. Those used for uptake buffers were dissolved in
ultrapure water (18 MQ resistivity) prepared by filtering distilled,
deionized water through a Gelman-Water I filtration apparatus.
Ca1midazolium, calmodulin (bovine brain), GTP PNPP (ditris salt)
and ATP were purchased from Sigma Chemical Co. Ionomycin was obtained
from 5-trisphosphate was(IPCalbiochem, D-myoi nos ito and
purchased from both Sigma Chemical Co. and Calbiochem. Caffeine was
obta i ned CaC1 andHJ- inulinAldrichfrom Chemi ca 1 Co.
H)-QNB were obtained from New England Nuclear Co.
Stati sti cs. Statistical analysis to determine the significance levels
of differences employed either a simple Student' s t-test (for comparing
single experimental condition with its control) or a Dunnett' s test
(for multiple comparisons with a single control, see Wi ner 1962) .
Differences were considered significant if the probability of chance
occurrence was 05.
RESUL TS
The last step in the preparative procedure described above provides
two membrane vesicle fractions , an upper fraction in which vesicle
diameters (Mean t SE for 130averaged 157 t 0. 008 in the pig
measurements) lower f ract i on the vesicle diametersand a i n wh i c h
averaged 0. 158 i 0. 004 and 0. 23 i 0. 012 pm in the toad and pig,
respectively (Mean t SE for 513 and 120 measurements , respectively).
The total yield of protein in these two fractions averaged -12. 0 mg
per 70 g tissue in both species. Some of thi s protei n is contri buted 
residual filamentous material associated with the vesicles; however, as
can be seen in the electron micrograph of toad lower fraction (Figure 
and in comparable micrographs of pig. vesicles (not shown) , the bulk of
the material in these bands is comprised of closed membrane vesicles
that are homogeneous in s i ze and shape. In contrast, the pellet from
the 30, 000 x g spin from either toad or pig contains substantial amounts
materi a shown) .(notmitochondria, and fi lamentouscollagen
Further evidence for the effecti veness of our current puri fi cation
Figure 2. Plasmalemmal vesicles from toad stomach muscle. Vesicles in
this electron micrograph were collected from the sucrose gradient at the
interface between the layers of 0. 6 and 1. 0 M sucrose. X 66 000. Bar =
o . 1 pm 
procedures can be seen in Fi gure For this figure samples were
removed after vari ous steps in the puri fi cation procedure and subj ected
to ge 1 e 1 ectrophores is. As is evident in this gel, both actin and
myosin are progressively removed during purification (compare Lane 3
with Lanes and 8) , a 1 though there still detectab 1 e act in
contamination remaining in the purified membrane fractions.
The distribution of membrane marker enzymes in crude and purified
membrane fractions is shown in Table 1. Specific binding of QNB was
205
116
Figure 3. SDS-po1yacrylamide gel electrophoresis of the fractions
obtained during the isolation of pig antral plasma membrane vesicles.
80pg of sample or 7 pg of purified actin or calmodulin were appliedto a linear 6%-16% polyacrylamide gel. Lane 1. M markers- carbonic
anhydrase (29 kD), egg albumin (45 kD), bovine albumin (66 kD),
phosphorylase b (97. kD), f3-galactosidase (116 kD), and myosin (205kD). Lane 2. Buffer. Lane 3. Crude homogenate. Lane 4. Pellet from
5000 x g spin. Lane 5. purified skeletal muscle actin and bovine brain
calmodulin. Lane 6. pellet from 30 000 x spin. Lane 7. upper
membrane fraction isolated from the 0. 3/0. 6 M sucrose interface. Lane8. lower membrane fraction isolated from the 0. 6/1. sucroseinterface. Lane 9. Mr markers- a Lactalbumin (14. kD), soybean
trypsin inhibitor (20 kD), glyceraldehyde-3-phosphate dehydrogenase (36
kD), egg albumin (45 kD), and bovine albumin (66 kD).
assessed in membrane fracti ons from both speci es. In the toad, the
relative enrichment for specific QNB binding was -13 fold in the lower
fraction fo 1 d fraction. pig, theupper thetheand -17
enri chment for specific thi s muscarinic antagoni st wasbinding
Table 
R
elative Enrichment of Various 
a
rker Enzymes in Toad and Pig Gastric smooth Muscle M
em
branes.
QNB
N
ucleotidase
N
A
D
PH
N
A
D
H
Toad
Binding
cyt f.
c
y
t
 
c
reductase
reductase
C
r
ude Membranes
0 fold (9)
5 fold (7)
8 fold (2)
2 fold (2)
P
u
rified Membranes
U
p
p
e
r
 fraction
17.0 fold (13)
16 fold (6)
1.4 fold (2)
8 fold (2)
Low
er fract i 
13.0 fold (11)
18 fold (6)
4 fold (2)
2 fold (2)
Pig
QNB
stim
ulated
N
A
D
PH
N
A
D
H
Bind i ng
PN
PPase
cyt f.
c
y
t
 
c
reductase
reductase
C
r
ude Microsomes
4. (8)'
3 (2)
P
u
ri fied M
em
branes
U
p
p
e
r
 fraction
21 (7)
6 (2)
5 (2)
L
o
w
e
r
 fraction
24 (8),
1.5 (2)
5 (2)
Sp
ecific QNB binding in crude homogenate of the toad = 35.9t4.8 fmoles/mg protein (mean
M
.
 for 9 separate experiments) in the pig specific
QNB binding averaged 14lt16.
fm
oles/m
g (meantS.
M
. from
 5 experim
ents.
N
u
cleotidase activity in the crude homogenate averaged 83t2.
7 pmol/min-mg (Mean
M
.
 for 4 experiments).
K
-
s
timulated PNPPase activity in the crude homogenate was 0.
016 pmol/hr-mg in this
experim
ent. 
N
A
D
P
H
 
c
y
t
 f. reductase activity a
ve
raged 6.7 nm
ol/m
in m
g
 in the
' crude homogenate of the
toad and 4.
2 nmol/min-mg in the crude homogenate of the pig (2 experiments for each).
N
A
D
H
 
c
y
t
 f. reductase activity av
eraged 23 nm
ol/m
in m
g
 in the crude homogenate of the toad
a
nd 20 nmol/min-mg in the crude homogenate of the pig (2 experiments for each).
somewhat higher than .in the toad, but the relative enrichment for each
fraction was similar, averaging 21 fold in the upper fraction and 24
f old i n th e 1 owe r . The other plasma membrane marker employed for toad
plasma membranes was 5 nucleotidase. The acti vity of thi s enzyme was
purified to a similar extent in both fractions in the toad , with an
average enri chment of 16 to 18-fold. the pig, nucleotidase
activity did not appear to be a suitable marker for plasma membranes
because a large fraction of the activity in the crude homogenate was
apparently soluble (readily lost after high salt extraction). Thus, in
the pig the activity of K stimulated , ouabain-sensitive PNPPase was
used as an alternative plasma membrane marker. PNPPase activity in pig
antral smooth muscle membranes was enriched to a slightly lower extent
than QNB binding, averaging 10-fold in the upper fraction and 15-fold in
the lower fraction.
The activity of NADPH cytochrome f reductase , a putative marker for
. sarcoplasmic was enri ched only slightly in the membranereti cul um,
fractions speci es the crude homogenatec ompa redfrom both
(-1 . 6 -f old fractions .-1. fold the toad) .the pig and
Similarly, NADH cytochrome f reductase acti vity, a mitochondrial enzyme
marker , was slightly enriched in the purified membrane fractions showing
an enrichment of - 5-fo1d over homogenate in the pig and .- 2-fo1d in
the toad. Note , however, that for both of these enzymes the relative
activities were similar in both the crude microsomes and in the purified
membrane fractions the membrane markers thewhereas for p 1 a sma
activities were considerably higher in purified membranes than in crude
mi c rosomes .
The gastric smooth muscle p1asmalemmal vesicles exhibited a time-
and ATP-dependent uptake of 45Ca as evidenced by the data presented in
Figure 4. In this experiment, addition of 5 mM ATP produced a marked
ionomycin
E 5
, 7
Time (minJ
Figure 4. Effect of ionomycin on ATP-dependent uptake by membrane
vesicles from toad stomach muscle. Results from a single experiment 
which calcium uptake was carried out in the standard reaction mixture in
the presence (Xi s) or absence (circles) of 5 mM ATP. At indicated
times, duplicate ml aliquots were removed and filtered to halt
exchange. Ionomycin (10 pM) was added to both groups at t = 5 min(arrow). Note that exposure to ionomycin rapidly released the label
accumulated in the presence of ATP but had little effect 
ATP-independent 45Ca accumulation.
increase in Ca uptake by vesicles derived from toad stomach muscle.
Pooled data from 7 such experiments indicated that this stimulation
averaged fold membranes from toad fraction ( uptakeupper
increased from 1. 1: 0. to 12. 1: 1. nmoles/mg protein within 2
mi n, Mean 1: SE from 7 experiments .: 0. and fold 
membranes lower fraction (an increase from 1. 1: 0.f rom toad
1: 0. nmoles/mg membrane protein within 2 min , Mean 1: SE from 
experiments
, p 
.: 0. 01) Ca transport in pig vesicles showed a
comparable time- and ATP-dependent uptake of 45Ca (data not shown).
ATP-dependent accumulation of Ca by these vesicles appeared to
reflect vesicular uptake rather than binding since the label was rapidly
lost on addition of the 10nop ore lonomYCln (Figure 4). Exposure
to ionomycin caused a rapid loss of label accumulated in the presence
ATP but had no effect on label accumulated in the absence of ATP.
In order to further characterize ATP-dependent transport in these
ves i c 1 es and d i s cern the ( ego mitoc hond ri a sarcoplasmicsource
reticulum or plasma membrane) of the Ca 
. '
pumps we examined
ATP-dependent Ca, uptake in the presence of various inhibitors. 
one series of experiments we assessed the efficacy of orthovanadate as
inhibitor of ATP-dependent inhibitor isuptake since this
reportedly extremely effective at inhibiting the plasma 1 emma 1
pump (apparent K. of 0. 1 - 0. 6 pM , see Sharma et a 1. , , 987 and Wi 
1The reduced uptake in the lower membrane fraction may be due to
greater contamination by actomyosin in earlier preparations; in more
recent experiments in which more care was used in extracting the lower
band , the uptake/mg protein was identical in the two membrane fractions.
et a 1 . , 1981 but less effective at inhibiting the sarcop 1 asmi 
reticulum see(apparent Sharma et a 1 . ,pump
1987) . These studies indicated that the Ca2+ uptake in both toad and
pig ves i c es' was orthovanadatemembrane extremely sens it i ve
inhibition with half maxima inhibition obta i ned vanadate
concentrations less than 0. 1 pM (Figure 5). Azide , an inhibitor of
mitochondria Ca' transport Grover et a 1 . ,(Daniel et a 1 . , 1983 ;
1983; Sottocasa, 1967), had no effect on this transport.
X- 
k. 1 uM
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Vanadate lJJM)
ure 5. Effect of vanadate on ATP-dependent 45Ca uptake. The
initial 45Ca uptake rate (that observed during the first 30 seconds of
uptake) was measured in the presence of various concentrations of
vanadate. The plot of the reciprocal of the velocity versus the
corresponding vanadate concentration yielded an apparent K of 
-( .
pM.
ATP-dependent uptake averaged nmo 1 es/mg -mi n the
presence of azi de (15 mM) and 1. 97 nmo 1 es/mg -mi n in the absence of
azide (Means from 3 paired experiments using membranes derived from the
toad; comparabl e S i mi 1 a r 1 y ,
oxalate, an anion that has been used to trap Ca and
uptake of 45ca in purified vesicles from the sarcoplasmic
resu 1 ts were obta i ned for the pig) .
addition of
enhance the
reticulum (Grover et a1. , 1980; Wibo et a1. , 1981; Raeymakers et a1.,
1983; Grover et a 1., 1985), had no effect on uptake by any of the
membrane fractions tested (eg. toad upper or lower fractions, pig upper
or lower fractions; data not shown).
The studies using various inhibitors and activators of ca2+ uptake
2+ 
suggested that the observed a accumu atlon was attributable to
sequestration in p1asma1emmal vesicles. This conclusion was further
supported by studies of 45Ca release from pre label led vesicles. A
variety of agents that have been reported to release Ca from the
sarcoplasmic reticulum fai led to stimulate 45 release from these
vesicles. Exposure of the vesicles to caffeine (20 mM), to IP (10
pM), to GTP (10 pM) or to IP plus GTP (10 pM each, not shown)
had no effect on 45ca release (Figure 6). On the other hand, label
add i t i on of the Ca i onopho rerapi d 1 y released after the
re 1 ease from these vesicles was
was
i onomyc in (Figure 6). Basa 1
relatively slow, K averaged 6. 0 f 0. x 10-3 min -1 in the toad
and 0. 020 :! 0. 003 min -1 in pig membrane vesicles within 5 to 10 min
after dilution (Mean f SE for 8 and 10 experiments respectively).
Thus, the results from efflux studies indicated that the membrane
vesicles were tightly sealed and primarily of plasmalemmal origin.
1cr .
Time (min)
ure 6. 45Ca efflux from plasma1emmal vesicles. In this
experiment, membranes were pre1abelled for 60 min with 45Ca in the
presence of 10 pM free Ca2+ and 5 mM ATP. Efflux was initiated diluting the vesicles 10 fold with C 2+-free/EGTA buffer. At various
times after dilution, control aliquots (circles) were removed and
filtered. At the arrows, drugs were added to other aliquots of diluted
membranes. Note that label was lost rather slowly from the untreated
vesicles, a finding that suggests that the vesicles are tightly sealed.
Exposure to 10 pM IP3 (Xi s), 10 pM GTP (triangles), or 20 
caffei ne (squares) had no apparent effect on 45Ca eff1 ux. Exposure to
1 pM ionomycin (inverted. triangles) led to a rapid release of labelled
Ca, however.
Additional studies examined the kinetic characteristics 
ATP-dependent Ca transport to assess the affinity and translocation
capacity of this process and to examine its sensitivity to exogenous
calmodulin. These studies indicated that the rate of ATP-dependent
Ca uptake in both pig and toad membranes was dependent on pCa. The
apparent Km for Ca was 0.. pM in toad membranes and 0. pM in
pig membranes, while the apparent V for this transport was 14.
max
nmo1es/min-mg in the toad and 13. nmoles/min-mg in the pig (Figure
7) .
Toad
Pig
VIs
Figure 7. 2+ dependence of ATP-dependent uptake in smooth muscleplasmalemma. The initial velocity of ATP-dependent 45Ca uptake (that
observed during the fi rst 30 seconds of uptake) was monitored at varyi ng
pCa s in the presence of exogenous calmodulin. A plot of the initial
velocity (V) vs VIS (where S = (Ca2+) in pmoles) is shown for
plasmalemmal vesicles from toad (circles) and pig (Xi s) gastric smooth
muscle. The apparent Km for Ca2+ was 0. pM in toad vesicles and
pM in pig vesicles. The apparent Vmax for ATP-dependent Ca2+
transport was 14. nmo 1 es/mi n -mg in the toad and 13. nmo 1 es/mi n -mg
in the pig.
Addition of exogenous calmodulin at a given free (ca produced a
small but consistent stimulation of ATP-dependent Ca2+ uptake in both
the toad (upper panel, Figure 8) and the pig (not shown) with no effect
ATP- i ndependent , 2+ ac.c.umu 1 at ion. Thi s stimulation averaged
-1. fold in the toad and fold in the pig 
(p 
05 in both
cases, paired analysis of data from 13 and 25 experiments , respectively)
and involved a stimulatory effect on both the K and V
max
of the
transport system.. No attempts were made to dep ete the membranes of
endogenous calmodulin for these studies , however; thus , these results
presumably underestimate the ability of calmodulin to stimulate cl+
uptake by these preparations.
The regulation of ATP-dependent Ca transport by calmodulin was
further explored using the specific calmodulin antagonist , calmidazo1ium
(Gietzen et a1., 1981; Van Belle , 1981). Exposure of the vesicles to
calmidazolium led to an inhibition of the calmodulin-stimulated 45
uptake (Figure 8, lower panel) with no effect on ATP-independent uptake
( data not shown) . Thi s inhibitory effect ca lmidazo 1 i urn was
concentrati on-dependent with statistically significant inhibition
obtained at a concentration of 5 pM in the toad and 1. 0 pM in the
pig (data not shown).
In order to determine whether the plasmalemmal ci+ pump in toad
membrane vesicles has a sufficient transport capacity to offset the
measured transmembrane leak rate or Ca 1n resting smooth muscle
ce 11 s we exami ned ATP-dependent Ca uptake under conditions that
approximate those in resting smooth muscle cells (free Ca 200 nM
see Wi 11iams and Fay, 1986 and Yamaguchi , 1986). The observed uptake
rate ( expressed nmo 1 es/mi n -mg) was then converted
transmembrane f1 rate (expressed pmoles/sec-cm cell membrane)
as follows (see also Table 2). The estimate of average vesicle diameter
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ure 8. Calmodulin dependence of ATP-dependent 45Ca uptake in toad
p1asmalemmal vesicles. Upper panel: Stimulation of ATP-dependent45Ca uptake on addition of exogenous calmodulin. Results from a
representati ve experiment in whi ch ATP-dependent 45Ca uptake was
monitored as a function of time in our standard uptake buffer (7 pM
free Ca in the presence (Xi s) and absence (circles) of added
calmodulin (2 pg/ml). Lower panel: Concentration-dependent
inhibition of ATP-dependent 45Ca uptake by the specific calmodulin
antagonist calmidazolium (CMZ). Asterisks indicate a statistically
significant effect of ca1midazolium (* = p 05, ** = P 01).
Table 2. Calculation of intravesicular volumes and surface areas
Average Vesicle Radius
Average Vesicle Volume
Average Vesicle Surface Area
Intravesicular Volume per Mg
Number of Ves i c 1 es per Mg
Tota 1 Surface Area per Mg
085 pm
57 x 10-15 cm
10 x 10-10 cm
47 x 10-3 cm
5 . 72 x 10 11 /mg
520 cm2/mg
in toad lower fraction obtained from morphometric analysis was used to
calculate the average volume/vesicle (V = 2. 57 X 10-15 cm ) and the
average surface area/vesicle (S. A. = 9. 1 X 10 10 cm From our
estimate of the trapped i ntraves i cul ar vol ume/mg membrane protei n (Total
vo 1 ume = 1. 47 i 0. 08 p 1 /mg ; Mean i for 4 determinations), we
calculated the total number of vesicles of volume y. per mg of membrane
protein and the total membrane surface area/mg membrane protein (S. A. =
520 cm /mg membrane protei n) . Using this value we could convert the
:..'
observed ATP-dependeni; uptake at pCa 6 (2. 16 x 10 moles/30
sec .mg; Mean from 8 experiments) fl ux rate (1 . X 10
moles/sec. cm ; see Tab 1 e 3) . The latter underestimates the
transmembrane fl ux rate produced ATP-dependent Ca transport
however in that it assumes all vesicles contribute to the observed
uptake. Pres umab 1 y, only inside-out vesicles are capab 1 
ATP-dependent Ca
2+ accumulation, and estimates of vesicle orientation
2Note that vesicular diameter averaged 0. 169 i 0. 004 pm (Mean i
SE for 513 measurements) for vesicles sonicated twice prior to fixation
the conditions used in 3H-inulin trapping studies - and 0. 158 t
005 (Mean t SE for 507 measurements) for vesicles sonicated once.
Thus, the second soni cation had no appreciabl e effect on i ntravesi cu1ar
volumes , surface areas , etc., nor did it appear to increase the number
of broken vesicles evident in electron micrographs.
Table 3. Membrane Transport in Vesicles and Isolated Cells From Toad
Stomach Musc 1 e.
Pre arati on
F1 ux
x10-13 mol/cm2.sec
Trans ort
xlO- 23 mol NB/rece tor
Isolated Cells
Membrane Vesicles
Membrane Ves i c 1 est
1.0
1.39
10.
Uncorrected for vesicle sidedness
tCorrected. for vesicle sidedness assuming
ves i c les contri bute to uptake and. that 40% of
out
that only inside-out
the vesicles are inside-
(based on K stimulated , ouabain-sensitive PNPPase activity before and
after vesicle thatpermeabi 1 i zati on) - i ndi cate only 40% the
vesicles were inside-out. Thus, the actual transmembrane flux rate
produced by ATP-dependent Ca transport under these conditions is
47 X 10
-13 moles Ca/sec 2 cell membrane.
2f-
We also compared the Ca transport of membrane vesicles to the
Ca flux intact cells by a measurement that did not rely 
estimates This involved normalizing theof vesicular surface a rea.
transport data from both cells and vesicles relative to the distribution
plasma ' membrane c h 0 1 i n e rg i cprotei n, the muscarinicanother
receptor. Density cholinergic receptors bothmuscari ni c
preparati ons was determi ned from studi es of 3H-QNB bi ndi ng. In intact
cells, receptor density averaged -123, 000
experiments) or 3. 92 x 109 receptors/cm
ites/ce 11 ( Data from 4
cell membrane (membrane
surface area per cell calculated for cells assuming that the cells are
oblate spheroids with average dimensions of 100 pm X 10 pm). Thus,
the flux per muscarinic receptor in cells with
-23
flux of 0. 1 pmoles/cm -sec was 2. 55 x 10 moles
transmembrane Ca
Ca/receptor-sec. In membrane vesicles from toad lower fraction, the
density of muscarinic receptors averaged 1. 806 x 10 receptors/mg
(Mean from 4 determinations). Si nce ATP-dependent uptake (corrected for
by these vesicles averages 1. X 10 -10
, the Ca transport per QNB binding site
22 
moles a recep or-sec, a va ue near 
vesicle ori entat ion)
mo 1 es/sec -mg at pCa 
vesicles 1.0 
fold higher than that for intact cells.
DISCUSSION
The present studies were designed to assess the transport capacity
of the plasmalemmal ca pump in membrane fractions from toad stomach
musc 1 e. To this end, we developed simple , relatively rapid procedures
to obta in high yields intact, tightly-sealed membrane vesicles.
Membranes were prepared from both toad stomach muscle and from pig
antral smooth . muscle to validate ' our preparative procedures and allow
for a direct comparison of our data with published reports on mammalian
smooth muscles. These procedures yielded two purifi ed membrane
fractions for each species that were functionally identical with respect
to the di stri buti on of vari ous marker enzymes and with respect to the
characteristics of ATP-dependent Ca transport. The explanation for
the different mobilities of these fractions on the discontinuous sucrose
gradients is not entirely clear. The difference could simply reflect
variation in vesicle size since the average diameter of vesicles in the
lower fraction (at least for pig smooth muscle membranes) was 30%
larger than that of vesicles in the upper fraction. Alternatively, the
fractions may differ in their permeability to sucrose , in the extent of
contamination by nonmembrane proteins or in the relative enrichment for
different regions of the plasma membrane (eg. regi ons ri ch in dense
bodies or caveo1ae). At present we cannot distinguish among these
possibilities.
Both of the membrane fractions appeared to consist primarily 
ves i c 1 es deri ved from the plasma membrane. These fractions were
enriched 13-24 fold for plasma membrane marker enzymes; and although
there was residual contami nat ion by nonp 1 asma 1 emma 1 membranessome
( based acti vitythe marker for mi tochondria andenzymes
sarcoplasmic reticulum), essentially all of the observed ATP-dependent
Ca uptake could be attributed to plasmalemmal vesicles. Azide , an
inhibitor of mitochondrial ca2+ transport had no effect on 45
uptake. Nor was uptake stimulated by oxalate , a Ca2t- trapping anion
that potentiates uptake by. sarcoplasmic reticulum . Moreover , release
of 45Ca from prelabelled vesicles was not affected by caffeine, IP
or GTP agents that purportedly release Ca from the sarcoplasmic
reticulum (Endo et al. , 1977; Obara and Yabu , 1982; Carsten and Miller
1985; Seumatsu et al., 1985; Wolf et al., 1987).
Other characteri sti cs of ATP-dependent Ca transport by these
fractions were also consistent with the involvement of a plasmalemmal
ci+ transport ATPase. For uptake inhibited lowone, was
concentrati ons orthovanadate. The for vanadateapparent
inhibition was less than 0. 1 pM, a value similar to that required for
3The use of oxalate sensitivity as a criterion for the presence of
sarcoplasmic reticulum membranes is controversial , see reference 
inhibition of p1asmalemmal Ca .. pumps and considerably lower than that
required for inhibition of sarcoplasmic reticulum Ca pumps (Wibo et
a1., 1981; Raeymakers et al. , 1983; Sharma et al. , 198.7).
ATP-dependent Ca2+ uptake by these fractions was
In addition,
regulated
calmodulin. Addition of exogenous calmodulin produced a significant
stimulation andATP-dependent uptake these vesicles
exposure antagoni stthe membranes the specific c a 1 mod u 1 
calmidazolium inhibited ATP-dependent Ca uptake.
The accumulation of 45Ca observed in these vesicles appears to
reflect uptake by tightly sealed vesicles. Accumulated label was lost
only slowly from these vesicles under control conditions (half time for
tracer loss averaged 385 min) but was rapidly lost after exposure to a
2+ ionophore (:;80% of accumulated label lost within min).
Moreover , the total intravesicular Ca2+ accumulated was appreciable as
shown the fo 11 owi ng calculation. For ves i c 1 es exposed 250
C 2+ ATP-dependent uptake averaged nmo 1 es/mg duri ng the
firs t mi nute (Mean from - 8 experiments). Since the tota 1
intravesicular volume for such vesicles averaged 1. 47 pl per mg, the
transmembrane gradient produced by thi s transport would approach 12 000
fold assuming all vesicles contribute to the observed uptake or 30 000
fold if uptake data are corrected for sidedness (-40% of the vesicles
appear to be inside-out and only those vesicles can utilize ATP to
transport Ca ). Note , however, that an appreciable fraction of the
transported Ca
2+ may be 
bound within the vesicles, such that the final
intravesicular (ca or the transmembrane Ca2r gradient cannot be
determined precisely.
The ATP-dependent Ca transport systems observed in the present
studies on toad and pig smooth muscle had an affinity similar to that
reported previously for plasmalemma1 Ca pumps (Matl ib et al. , 1979;
Grover et al., 1980; Wibo et al. , 1981; Grover et al. , 1983; Raeymakers
et a 1., 1983;). The apparent V for uptake, expressed as, an uptake
max
rate per mg membrane protein, also resembled that in a number of other
preparations (Mat1ib et al., 1979; Grover et a1., 1980; Grover et al.
1983;) but was considerably lower than that reported for reconstituted
transport (Wuytack, more highly1981 ) and for purifi edsystems
preparations (Sharma and Bha lla, 1986; Sha rma et a 1 ., 1987) , si nce
estimates of V largely reflect the extent of enrichment or purity
max
of the di fferent preparations. Our goal in these studies was not simply
to purify plasma membranes from smooth muscle but rather to obtain a
membrane fraction in which essentially all of the observed uptake could
plasma 1 emma 1attributed ATP-dependent accumulation
vesicles. Once this was achieved we could reliably convert uptake rate
to transport capacity or to transmembrane cit- flux by expressing the
data membrane. Un 1 i ve 1 oc ity , theuptake rate per
calculated not affected by thecapac itytransport presence
nonmembrane proteins since both the estimates of velocity and membrane
surface area are normalized per mg protein such that the influence of
nonmembrane protein contaminants cancels out.
Calculation of the transport capacity of the plasmalemmal
pump in toad, membrane fractions and comparison with the known rate of
2+ flux in intact smooth muscle cells indicates that this transport
system key role in determining the freecapable of playing a
cytosollC Ca levels in smooth muscle. At prevailing intracellular
2+ Ca concen ra lons , the calculated transport capacity of the enzyme,
after correction for the percentage of inside-out vesicles, is 3.47 X
-13
mo 1 es/cm . sec more than the basa 1fold higher than
-13 moles/cm
.sec) observedtransmembrane fl ux ( 1.0rate
isolated smooth muscle cells (Scheid and Fay, 1984) . In fact thi 
calculation may underestimate the actual transport capacity in vesicles
slightly, since some vesicles may be capable of trapping inulin but may
be eaky to Ca 
Ca uptake, but would contribute to surface area measurement and, as
This population of vesicles would not contribute to
result surface wou 1 dthe actua 1 ratetransport per area
mi nimi zed.
The transport capacity of the plasmalemmal Ca pump can be also
2+ be compared to the transmembrane Ca ux ln intact cells using an
independent approach of vesicularre 1 y estimatesthat does not
volumes and membrane surface areas but which instead relates the ca
transport in both cells and vesicles to the distribution of muscarinic
receptors in the two preparations. For isolated smooth muscle cells
the fl ux per muscari ni c
Ca /receptor.sec.
-23
mo 1 e sreceptor averages
For vesicles thi s flux is considerably higher
10. -23 mo 1 e s Ca /receptor.sec correction for vesicleafter
ori entati on. Thus two independent assessments i ndi cate that the
transport capacity of the p1asmalemma1 Ca2+ pump is at least 3 fold
higher than that required to offset the inward leak of Ca measured
in smooth muscle cells at rest.
In summary, the present report provides an estimate of the transport
capacity of the plasmalemmal Ca pump at prevailing intracellular
ci+ concentrations and indicates that the transport system is capable
of playing a dominant role in maintaining cytosolic Ca2+ levels in
resting smooth muscle. Moreover, since the prevailing cytosolic Ca
levels in resting smooth muscle are close to the K of this enzyme
(Williams and Fay, 1986, Yamaguchi, 1986) and since the transport
2+ 
capacity of the enzyme appears to exceed the paSSlVe Ca ea rate
operation of the plasmalemma1 Ca
2+ pump should be 
capable of buffering
small changes in cellular Ca2+ resulting from increased ci+ entry.
The data a 1 so indicate this reserve somewhatthat transport
limited, however, and thus predict the observed increases in cytosolic
ci+ that occur during exposure to contractile stimuli (Williams and
Fay, 1986, Yamaguchi , 1986).
Chapter I I I.
EFFECTS OF THE ANTI -CALMODULIN DRUGS CALMIDAZOLIUM
AND TRIFLUOPERAZINE ON 45CA TRANSPORT
IN PLASMALEMMAL VESICLES FROM GASTRIC SMOOTH MUSCLE
ABSTRACT
The anti calmodulin drugs calmidazolium ( CMZ) and trif 1 uoperazi ne
(TFP) were shown to have a number of effects on Ca transport by
p 1 a sma 1 emma 1 vesicles from gastri c smooth musc 1 e. Although these
compounds produced the expected dose-dependent
ATP-dependent Ca transport system
inhibition the
plasma 1 emma 1
Ca re 1 ease comparable to that observed in the presence
ionophore ionomycin. This increased transmembrane Ca
they a 1 so evoked a
of the ca
flux was 
large that the apparent ecrease ln it accounted for much of
uptake produced by these agents.
ATP-dependent Ca uptake could only be reliably assessed for brief
30 seconds) drug exposures. The explanation for the observed effects
of CMZ and TFP on membrane Ca2+ permeability is unclear. The increased
transmembrane Ca flux may reflect nonspecific effects on membrane
Thus , di rect effects of CMZ and TFP on
permeabil ity ref 1 ect specific interaction themay
anticalmodulin drugs with a Ca re 1 ease channel or with the 
transport ATPase. In any case, these results suggest the need for
caution in the design and interpretation of studies using both CMZ and
TFP as anticalmodulin agents.
This work has been accepted for publication:A. Lucchesi and C. R. Scheid. Effects of the anti-calmodulin drugs
calmidazolium and trifluoperazine on 45Ca transport in plasmalemmal
vesicles from gastric smooth muscle. Cell Calcium. 9:87-94, 1988.
INTRODUCTION
Calmodulin (CaM) plays a pivotal role in regulating a variety of
2+ dependent cell enzymes including phosphodiesterase, adenylate
cyclase , the plasmalemmal Ca transport ATPase and myosin light chain
kinase (Cheung, the1980 ; and Dedman 1980) .Means Because
importance of this regulator , investigators have utilized a variety of
anti ca lmodu 1 in identify ca lmodu 1 in-dependentdrugs processes
vari ous ti ssues. Phenothiazines such as trifluoperazine have been used
most extensively in such studies , but recent evidence suggests that
these drugs exert ca lmodul in- independent effects whi ch compromi se thei r
useful ness intact systems. i t wa s found that theFor example,
phenothiazines inhibit neurotransmitter binding at concentrations less
than those requi red for antagoni sm of ca lmodul in-dependent processes
(Blackmore et al. , 1981; Gietzen et al., 1981). These prob 1 ems 1 ed to a
search for better calmodulin antagonists , one of the most promising of
which is ca1midazolium (CMZ, formerly known as R 24571). This drug is
considerably more potent than other available anticalmodu1in drugs , does
not affect receptor binding and exhibits high specificity for
calmodulin-regulated enzymes including the plasmalemmal ca2+ transport
ATPase (Gietzen et a1., of thesevan Belle, 1981 ) .1981 ; Because
apparent advantages ca lmidazo 1 i um was employed in recent studies of the
calmodulin Ca transport gastric smooth mu s c 1 edependence
plasmalemmal membranes (Lucchesi et al. , 1988). These studies indicated
that while this drug is an effective inhibitor of calmodulin-stimulated
Ca + transport, it a 1 so exerts large effects on membrane permeabi ity
to ca
2+ that seriously compromise its usefulness.
METHODS
Isolation of purified plasmalemma. Plasma1emmal vesicles were prepared
from the stomach muscle of the pig and the toad Bufo marinus as
described previously (Lucchesi et a1. , 1988). Briefly, this involved
homogen i zat ion Ultraturraxgastric musc 1 e withthe smooth
Tissuemizer, further disruption of the tissue by nitrogen cavitation
and centrifugation of the homogenate at low speed to remove cellular
debri s. The crude microsomal pellet was then treated with high salt to
so 1 ubil i ze contracti 1 e protei ns , and purifi ed membranes were co 11 ected
gradient 1986) .discontinuous sucrose ( Jonesflotation
Membranes were rapidly frozen in liquid nitrogen and stored at -80
prior to their use in these studies.
Assays for the activity of various marker enzymes indicated that the
membrane vesicles were largely derived from the plasma membrane. The
purified membrane fractions from both pig and toad were enriched 15-18
fold for the plasma membrane markers 5 nucleotidase and K -stimu1ated
PNPPase, and H-QNBfold for13 -24 the specific binding
(quinuc1idinyl benzilate), a muscarinic cholinergic antagonist; whereas
these membranes were enriched less than 1. 5 fold for the sarcoplasmic
reti cul um marker addition, theNADPH cytochrome f reductase.
ATP-dependent Ca2t transportcharacteri sti cs these membrane
fractions were those of plasma 1 emma 1 Ca pump
Ca uptake was unaffected by
consistent with
(Lucchesi et al., 1988). ATP-dependent
azide, a mitochondrial
2+ trapping anion
, 2+Ca transport inhibitor, or by oxalate , an
that reported 1 potent i ates uptake the
sarcoplasmic reticulum (see Daniel et al. , 1983, for review). Moreover
Ca uptake was stimulated (1. 4 - 2. fold) by exogenous calmodulin
and inhibited by low concentrations of orthovanadate (apparent K. "
o . 1 pM).
Assa take. Stud i es of ATP-dependent uptake were
carried out as described previously (Lucchesi et al., 1988). Briefly,
this involved incubating membrane vesicles ( 30-35 membrane
protein/ml reaction mixture) at room temperature in a standard uptake
buffer containing HEPES 1 00 KC1 MgC 1
NaN free and pCi Iml Ca. For buffersCa ,
containing mM ATP the amounts MgC 1 and increasedCa were
066mM and 17pM respectively, and a regenerating system consisting
of creati ne phosphate and 8 U/m1 creatine phosphok i nase was
included. In experiments in whi ch exogenous ca 1modul in was added to the
addedmlxture OV1ne raln ca mo u 1n w s as react ion
calmodulin complex at a final concentrati on pg/ml 120 nM).
For uptake studies, ATP- i ndependent and ATP-dependent uptake were
monitored separately and uptake was initiated by the addition
membranes to the reaction mixture. Uptake was ha lted at predetermi ned
intervals by filtering duplicate 1 ml aliquots of the reaction mixture
through 1. 2 pm Millipore filters. Fi lters were washed with 5 ml of
ice-cold buffer containing 1 mM LaC1 3 and 150 mM NaCl , dissolved 
counting fluid and counted in liquid scintillation counter.
ATP-dependent Ca uptake was defi ned as the uptake in the presence of
ATP mi nus the uptake in the absence of ATP. Separate studies were
carri ed out to veri fy that the effects of CMZ on ATP-dependent or
ATP-independent 45Ca uptake could not be explained by effects of the
solvent DMSO employed for CMZ stock solutions. In all cases the final
concentration of DMSO in the assay buffer was 0. 5% (v/v).
Assa s of Ca Release. To examine the acute effects of calmidazolium
on 45Ca transport vesicles were allowed to accumulate 45Ca in the
presence of ATP for severa 1 mi nutes and were then exposed to either 10
ca 1 mi dazo 1 i C/+ pM) .the i onophore i onomyc in
Vesicles were filtered at various times after drug addition and the
effects these accumulatedagents 1 abe 1 was determi ned.
Alternatively, we examined the effects of cMZ or TFP on 45Ca efflux
from prelabeled vesicles. In these experiments, vesicles were allowed
to accumulate 45Ca in the presence of ATP for 60 min , and efflux was
initiated by diluting the vesicles 10-20 fold with unlabelled buffer
containing 100 mM KC1 , 20 mM HEPES, pH 7. , and 0. 1 mM EGTA. In some
experiments aliquots loaded vesicles diluted bufferwere
containing calmidazolium (1-10 pM), TFP (10 or 100 pM) or in buffer
containing the Ca2+ ionophore ionomycin (l or 10 pM). In other
experiments, vesicles were diluted with control buffer and a1iquots of
diluted vesicles were exposed to drugs during the course of efflux.
either case, duplicate 1 ml aliquots were removed at various times after
dilution, and filtered as described above for uptake studies.
Stati sti cs. Statistical analysis employed either a simple St.udent'
t-test for comparing a single experimental condition with its control or
a Dunnett' s test for multiple comparisons with a single control (Winer
1962) . Differences were considered significant if the probability of
chance occurrence was 05.
Materials. Stomach muscle from the domestic pig was obtained from a
oca 1 slaughterhouse. Toads (Bufo mari nus) were imported from the
Dominican Republic and maintained in the university animal facilities
until sacrifice.
Reagents employed for the transport studies were of the hig,hest
purity available (Aristar grade) and were dissolved in ultrapure water
(18 MQ resistivity) prepared by filtering distilled, deionized water
th rough Gelman-Water fi ltration apparatus. Ca1midazolium,
tri f1 uoperazi ne and ca lmodul in (bovi ne brai n) were purchased from Sigma
Chemi ca 1 Ionomycin was obta i ned from Cal bi ochem. CaC1 wasCo.
obtained from New England Nuclear Co.
RESUL TS
Effects of CMZ on Ca release. The effect of CMZ on Ca release
as initially demonstrated by experiments like that presented in Figure
9, in whi ch we exami ned the acute effects of CMZ on ATP-dependent 45
uptake in membrane vesicles derived from pig antral smooth muscle.
These experiments demonstrated that exposure of the vesicles to 10 pM
CMZ during the course of an uptake experiment caused a marked, rapid
release of 45ca accumulated in the presence of ATP. This release of
Ca resembled that observed in vesicles exposed to 10 pM ionomycin
ci+ ionophore. Brief exposure to CMZ caused only a slight release
of 45Ca accumulated in the absence of ATP (data not shown). However,
12.
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Figure 9. Results from a typical study of the acute effects of CMZ and
ionomycin on 45Ca uptake in the presence (closed circles) and absence
(open circles) of ATP. Exposure of pig plasmalemmal vesicles to 10 JlM
CMZ (squares) or JlM ionomycin (Xi s) (at arrow) led to a marked loss
of label.
Ca accumulati on.
prolonged exposure to CMZ produced a marked reduction in ATP- independent
In some of our initial studies in which vesicles
ATP- independent uptake was reduced by
were preincubated with CMZ for 10-12 min prior to initiation of uptake
the pi g
35% in vesicles derived from
(10 pM CMZ reduced uptake from 1. 06 I 0. 20 nmoles/mg-min
in controls to 0. 64 I 0. 15 nmoles/ mg-min, Mean I SEM for 7 paired
experiments;
-( 0. 01 for paired analysis), and by 36% in the toad
(controls reduced from 1. 54 I 0. 36 to 0. 88 I 0. 26 nmo1es/mg-min in
for paired analysis).
the presence of 10 JlM CMZ, Mean I SEM for experiments; p -( 0.
These results could not be explained by an effect
: !
of the solvent DMSO employed for calmidazolium. The 1 eve 1 s of DMSO
employed in these studies (0. 2%) had no effect on either ATP-dependent
or ATP- i ndependent Ca uptake (data not shown).
The effect of CMZ on 45Ca release was further confirmed in studies
of 45Ca efflux from prelabeled vesicles as shown in Figure 10.
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Figure 10. Results from representative 45Ca efflux study.
Prelabeled toad vesicles were diluted 10-fold with control buffer. Atpredetermined times , aliquots were removed and either filtered without
further treatment (controls , filled circles) or exposed to the followingdrugs: 1. pM CMZ (Xi s), 2. pM CMZ (squares), 5. pM CMZ(triangles), 10 pM CMZ (stars), or 10 pM ionomycin (open circles).
Note that the effect of CMZ on efflux increased with increasing CMZ
concentrati ons and that 10 pM CMZ produced a greater enhancement of
45Ca release than did exposure to Ca2+ ionophore.
Exposure of toad plasma1emmal vesicles to varying concentrations of CMZ
increased the rate loss from
concentration dependent manner such that at the highest dose tested (10
prelabeled yes i c 1 es
pM), the efflux rate was comparable to that observed in the presence
of 10 pM ionomycin, a 10nop ore.
produced similar increases in 45 efflux
Exposure to 100 pM TFP
from pre loaded ves i c 1 es
while 10 pM TFP had no effect (see Table 4 below). Experiments using
plasmalemmal vesicles derived from pig antral smooth muscle produced
similar results (Table 4).
Table 4. Effect of CMZ, TFP and Ionomyci n on the rate of 45Ca
efflux from smooth muscle plasmalemma.
Condition
Contro 
CMZ (O. lpM)
CMZ (1. 0 pM)
CMZ (2. 5 pM)
CMZ (5. 0 pM)
CMZ (10 pM)
Ionomyci nt
TFP (10 pM)
TFP (100 pM)
Efflux rate (min-1)
Pig Toad
017 to. 003 (11)
035 (2)
040 to. 011 (5)
N. D.
113 (2)
318 t 0. 050
491 t 0. 132
008 t 0. 004
235 t - 062
0061 to. 0005 (6)
N. D. 
052 t 0. 018
078 t 0. 018
284 t 0. 088
457 t 0. 264
694 t 0. 103
N. D.
N. D.
( 3)
( 3)*
( 3)*
( 7 ) ***
(6)**
( 7 ) ***(5)** 
(4 )
( 5)**
tBoth pM and 10 pM ionomycin produced similar effects 
45Ca release; thus data using either concentration ' were pooled forthis table. Data presented are Means t SEM for the number of
experiments in parentheses. Levels of significance , determined by a
Dunnett' s test, are indicated by asterisks: * = p " 0. 05; ** = p "
01); *** = p" 0. 001. N. = not determined.
Pooled data from several efflux experiments are presented in Table
Note that 10 pM CMZ caused a 240-fold increase in the efflux rate
constant for the toad and a 20-fold increase in the rate constant for
the pig. As mentioned above , the effects were concentration-dependent
with statistically significant increases observed at concentrations
greater than 1. M in both species.
a 1 so produced a significant increase
High doses of TFP (100 pM)
in the rate of Ca efflux
whereas 10 pM TFP had no effect.
Effects of CMZ and TFP on ATP- endent Ca u take.
CMZ produced a concentration-dependent i nhi biti on of ATP-dependent
uptake in both toad and pig plasmalemma1 ves i c es. Since CMZ also
produced a mar lncrease 1n a efflux , it was possible that this
apparent inhibition of Ca
2+ 
uptake was due to increased ca
2+ efflux
rather than reduced ATP-dependent uptake Thus, we reexami ned the
uptake data after correcting for backflux of label (see Scheid and Fay,
1980 for details). Thi s correction is somewhat impreci se for non-steady
state cond it ions (Keynes , 1954) such that we focused on the effects of
bri ef exposure (30 second s) to the drug and found that CMZ sti 11
produced clear concentration- dependent inhibition uptake
membranes derived from either pig or toad gastric smooth muscle (Fig. 11
and 12). For longer exposure times , however, the corrections were so
1 a rge that the apparent inhibition uptake, even high
concentrations of CMZ (10 pM), could be completely accounted for by
the increased backflux (efflux) of label.
The data presented in Fi gure 11 illustrate the effects of CMZ 
ATP-dependent Ca uptake in toad plasma 1 emma ves i c 1 es In this
species , a brief (30 second) exposure to CMZ produced a dose- dependent
inhibition with significant reductions ln ATP-dependent Ca uptake
observed at concentrati ons :; 5 pM. These studies were carried out 
the absence of exogenous calmodu1i (caM).
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Figure 11. Effect of varying concentrations of CMZ on ATP-dependent
45Ca uptake in toad plasmalemma. Bars indicate the percent inhibition
of uptake at 30 sec. All data were corrected for backflux of Ca
using the correction factor (kt/l- kt) where k = rate constant
determined from efflux experiments (Keynes, 1954). Data presented arethe Mean 1: SEM for the number of experiments in parentheses.
Significant differences are indicated. by asterisks 
(* = p 
05, ** = P
01).
In membrane vesicles derived from pig antral smooth muscle , brief
exposures (30 seconds) to CMZ a 1 so produced a concentration- dependent
inhibition of uptake, and these effects were more pronounced in the
presence than in the absence of exogenous CaM. In these studi es , the
addition of exogenous CaM caused a 1. fold increase in ATP-dependent
uptake measured at 30 seconds, from 1. 63 1: 0. 20 nmol Ca /mg protein
in the absence of added CaM to 2. 80 ! 0. 22 nmol Ca /mg protein in
the presence of exogenous calmodulin (p .( 0. , Figure 12A). ( Note
however that membrane ves i c 1 es were not depleted of endogenous CaM
prior to these studies such that the uptake observed in the "controls
does necessari lynot ref 1 ect CaM- i ndependent ATP-dependent
uptake) .
:J 2.
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Figure 12. Effects of various concentrations of CMZ and TFP 
ATP-dependent 45Ca uptake in plasmalemmal vesicles derived from pig
antral smooth muscle. A. CMZ Open bars indicate uptake in the absence
of exogenous CaM. Hatched bars represent uptake in the presence of
bovi ne brain CaM (2 pg/ml). The effects of 10 pM CMZ were not
determined in the presence of CaM. B. TFP Open bars indicate uptake
in the absence of CaM. Hatched bars indicate uptake measured in the
presence of exogenous CaM. All data were obtained 30 sec after theinitiation of uptake and were corrected for backf1ux. Data presented
are the Mean :! SEM for the number of experiments indicated above thebars. Significant differences are indicated by asterisks (* = p .( 0. 05,
** = P .( 0. 01).
When increasing amounts of cMZ were added to the uptake medium, a
significant inhibition of ATP-dependent uptake was observed at 10 pM
CMZ in the absence of exogenous calmodulin. In the presence of added
CaM, significant inhibition was obtained for concentrations pM.
The inhibitory effects of CMZ in. the presence of exogenous CaM were
largely attributable to an attenuation of the CaM-induced stimulation of
ATP-dependeht Ca uptake. However, at a concentration of 5 pM , CMZ
completely abolished the effects of CaM and reduced ATP-dependent uptake
to levels below those observed in controls in the absence of exogenous
The differing sensitivities of ATP-dependentCaM (0. -c p :; 0. 05).
Ca uptake to CMZ in the presence vs the absence of exogenous CaM may
indicate that the drug has differing efficacies for transport stimulated
by endogenous CaM (which is presumably tightly associated with the
membrane vesicles and the Ca2+ ATPase) vs that stimulated by exogenous
CaM , and/or it may indicate that at higher concentrations, the drug can
produce additional CaM-independent effects on ca
2+ transport.
Studies were also carried out to assess the effects of TFP 
ATP-dependent Ca uptake. These studi es i ndi cated that exposure of
pig vesicles (i n exogenousthe absencep 1 as ma 1 emma 1 TFP
calmodulin) produced a concentration-dependent inhibition of uptake,
with 10 pM TFP inhibiting uptake by 18. :! 5. 7% (Mean :! SEM for 6
experiments, p -c 0; 05) and 100 pM inhibiting uptake by 63. :! 14.
(Mean :! SEM for 6 experi ments, p -c 0. 01). In contrast to the results
with CMZ, the addition of 2 pg/m1 of CaM completely reversed the
effects of TFP at both concentrations tested (Figure 12B).
DISCUSSION
The results from the present studies indicate the need for extreme
caution the both calmidazolium and trif 1 uoperazi neuse
anti calmodu1 in agents. The levels of calmidazolium (10 pM) _ and of
trif 1 uoperazi ne (100 that caused profound effectspM)
release by gastric smooth muscle plasma1emmal vesicles have been used
routinely in many studies, often with no controls to assess for effects
on membrane 2+ Ca permea 1 1 ty. At these 1 eve 1 s ,these agents
however, we observed a number of actions of these agents that complicate
the i nte rp reta t i on of expe ri menta 1 data. For one, cons i stent wi th other
findings (Gietzen et al., 1981; Van Belle , 1981; Gietzen , 1983) we found
that prolonged exposure (10 min) to relatively low concentrations of CMZ
(10 pM) produced significant inhibition ATP- ; ndependent 45
uptake. Secondly, exposure of plasmalemma1 vesicles to CMZ or TFP (at
10 and 100 pM respectively) cause a marked increase in membrane
permeability to Ca2+ (a finding which may also explain the inhibition
of ATP-independent 45Ca uptake). The increase in membrane ci+
permeability was 1 a rge could reliably detect that one not
inhibitory effect on ATP-dependent transport unless exposure times were
brief (30 less). With longer exposures to CMZ 1 min) thesec or
increased backflux of label was sufficient to account for essentially
all of the observed reduction in 45Ca accumulation even at the highest
concentration tested (10 pM). Thus it woul seem that CMZ and TFP
may not suitab 1 stud i es ca lmodu 1 i n-regu 1 atedfor
transport, except in isolated cells or membrane vesicles in which brief
exposure times ( 30 sec) are feasible.
Stud i es the interactions between ca lmodu 1 i n and the
anticalmodulin agents CMZ and TFP on ATP-dependent 45Ca uptake also
produced surprising results. We found that the additionsome
exogenous CaM increased the efficacy of CMZ for inhibiting ATP-dependent
uptake, whereas similar additions CaM abo 1 i shed inhibitorythe
effects of TFP on this process. The latter results were expected based
on the evidence that TFP can compete with CaM at its effector site on
various enzymes (Vincenzi, 1981). The interaction between CMZ and CaM
suggests a different type of competition at the caM/enzyme complex
however. CMZ attenuated the stimulatory effects of CaM on the transport
system (reduc i ng uptake to 1 eve 1 s seen in the absence of exogenous CaM),
whereas CaM abo 1 i shed the i nhi bitory effects of TFP on ATP-dependent
between
These findings suggest a different mode of interaction
CMZ and TFP wi th CaM and the Ca transport ATPase: CMZ
to interact with the CaM/ca2+ ATPase complex in the cell
transport.
appears
membrane whereas TFP appears to compete di rectly with CaM for its
binding site on the ca
2+ ATPase.
The prec i se manner by whi ch CMZ and TFP evoked the observed changes
2+ 
in ATP-dependent Ca transport an 1n mem rane permeability is not
entirely clear. These compounds may elicit changes in the. membrane
transport permeability mediated ThisCaM.that are not
possibility was not ruled out by the present studies since the membranes
were not depleted of endogenous calmodulin. However, there are numerous
examp 1 es CaM - i nd ependent actions these compounds the
literature. Previ ous studi es have shown that CMZ can produce di rect
CaM- i ndependent i nhi bi ti on vari ety of enzymes i nc 1 ud i ng myos i n
light chain kinase (Mazzei et al., 1984; Zimmer et al. 1984),
calmodulin-depleted Ca2+ transport ATPase (Van Belle 1981; Vincenzi
et al., 1982), phospho-diesterase (Gietzen, 1983), proteolysis-activated
Ca transport ATPase (Adunyah et al., 1982; Gietzen et al., 1982) and
the sarcoplasmic reticulum Ca-ATPase (Anderson et al. , 1984; Tuana and
MacLennan , 1984). Thus, the effects of CMZ and TFP on membrane Ca
transport and permeabil ity may refl ect a ca lmodu1 i n- i ndependent acti 
of these compounds.
The manner by whi ch these compounds produced the observed increase
in membrane Ca2+ permeability is also unclear. The increased
transmembrane Ca
2t flux may reflect a nonspecific effect on membrane
i ntegri ty. However, these compounds do not produce similar effects in
the permeabi 1 i ty sarcop asmi c vesicles ( Tuana andreti cul um
MacLennan, 1984). Moreover , the clear dose-dependency of the changes 
2+ efflux 
make this explanation less likely. Alternatively, the
increased permeability may reflect direct interaction with
release channel in the membrane vesicles and/or with the Ca2+ ATPase.
Recent studies in isolated sarcoplasmic reticulum have suggested that
the Ca
2+ transport 
system can function as a ci+ channel (McWhi rter
et al., 1987), thus it is possible that the drugs shift the transport
system to this mode of operation.
In summary, while we were able to define conditions in which we
could detect a direct , calmodulin-dependent effect of CMZ and TFP 45 ATP-dependent Ca uptake , the profound effects of these compounds on
2+ 
membrane a permea 1 1ty made these conditions very restrictive.
isolated
Thus , although these compounds might be quite useful bi ochemi ca 
studi es enzymes and/or in systems in whi ch short drug
exposures are feasible, they may not be useful in other systems.
Chapter IV
Discussion of Ca Transport Studies
The primary goal of this portion of my thesis was to determine the
relative contribution of the plasmalemmal Ca pump to Ca homeostasis
smooth muscle. suggested the Introduction east two
transport systems contri bute extrusion thi s ti ssue:
Na + /ci+ exchange and the plasmalemmal pump. Bi ochemi ca 
evidence suggests that the former is a low affinity, high capacity
system which might be more important in non steady-state conditions (eg.
when cellular Ca is high as during activation), whereas the
plasma1emmal ATPase is a high affinity, low capacity system. These
findings led to a general agreement that the plasmalemmal Ca pump
was the primary determinant of resting ca2+ levels , but it has been
difficult demonstrate that characteri sti cs Ca 2t-thethe
transport estab 1 i shed i n vi t ro conditi ons canunderproces ses
directly applied For examp 1 e i t wa sin vi vo situation.the
difficult determi nedgi venwhether transport rateto assess
membrane vesicles was of sufficient magnitude to offset completely the
passive leak rate measured in vivo Part of the difficulty lies in the
fact that estimates of this leak rate were unavailable. However , thi 
prob 1 em reso 1 ved preparation: enzymati ca llyeast onewas
dispersed toad gastric smooth muscle cells. In order to assess the
2..transport capacity of the plasma1emmal Ca pump in this tissue , it
was necessary to correlate the velocity of the pump at physiological
2+ 
concentrations with the observed estimate of the inward Ca
leak rate in intact smooth muscle cells.
The study of the transport capaclty 0 , t e Ca pump requi red the
deve 1 opment bi ochemi ca eva 1 uate itstoo 1 the necessary
translocation velocity in toad gastric smooth muscle. This included the
development of suitable methods for the preparation of plasma membrane
fratcions as well as methods for assessing membrane purity. Then, to
ensure that the observed Ca transport in these membranes could be
attributable to ci+ pump of plasmalemmal origin the
characteri stics of the measured Ca transport had to be carefully
eva 1 uated .
The methodology that was developed for preparing plasma membrane
fractions from smooth muscle involved several refinements of existing
published techniques. These refinements included a modification of the
homogeni zati on procedure to include a nitrogen cavitation step to
disrupt the tissue more fu 11 y. This procedure i nvo 1 ves the sudden
decompress i on of the homogenate after it has been equil i brated with
nitrogen at 1250 ps i . The rapid change in pressure causes a thorough
disruption of the tissue fragments and cells and is especially effective
for smooth muscle tissue because of its high content of connective
ti ssue. A second refinement was the use of high salt to solubilize the
actomyos i n that heavi ly contami nates the crude microsomal fraction.
This procedure not only increases the purity of the membrane fraction
(see Figures 2 and 3) but also serves to remove the (ca
Mg )-dependent ATPase activity associated with the myofilaments. The
last procedural modification was the use of sucrose flotation gradients,
in which the vesicle were suspended in 1 Molar sucrose and allowed to
equilibrate to their buoyant density during centrifugation.
In this procedure, only tightly sealed vesicle with entrapped buffer of
low ionic strength would be able to float; any leaky vesicles would
become equilibrated with 1 Molar sucrose and would be unable to reach
the inherent buoyant density (determined by their phospholipid content)
duri ng the short centrifugati on step. Thus, this separation technique
enriches for membrane vesicles that are tightly sealed.
In order to use the isolated membrane fractions for the study of the
transport capacity of the p1asma1emma1 Ca pump, it was necessary to
first demonstrate that the majority of the vesicles were largely derived
from the plasma membrane. Thi s i nvo1 ved the mea urement of the acti vi ty
of various membrane markers: 5' nucleotidase activity and cholinergic
receptor binding for plasma membranes NADH cytochrome reductase
activity for mitochondria and NADPH-cytochrome c reductase activity for
sarcoplasmic reticulum. The resu lts from these experiments i ndi cated
that the membrane preparati on was enriched 13-24 fold for plasma
membrane markers and enriched only a minimal extent for mitochondrial
and sarcoplasmic reticulum markers.
These results suggested that most of the membranes were in fact
derived from the plasmalemma. Using these preparations from both toad
and porc i ne gastri c musc 1 e , we were then ab 1 e to demonstrate that the
smooth muscle membranes could accumulate 45Ca in an ATP-dependent
(Figure 4). It could be concluded that this ATP-dependent 45ma n n e r
uptake refl ected the presence of an acti ve transport system rather than
ATP-dependent binding because exposure to the Ca2+ ionophore ionomycin
caused an instantaneous release of the accumulated 45Ca.
It was then necessary to determi ne whether thi s ATP-dependent uptake
was due to the presence of a plasma 1 emma 1 pump. Accordi ng 
Penniston (1983), two fundamental criteria can be used to define the2+ presence of a plasma membrane Ca pump: 1) the observed Ca uptake
should for a pump of plasmalemmalexhi bi t characteri st i expected
origin and 2) the ATP-dependent uptake should possess a high affinity
for The first criterion was evaluated by examining the45 
sensitivity of Ca uptake to agents that modulate Ca transport by
intracellular organelles. i nd i cated that ATP-dependentOur results
mi tochondria unaffected azideuptake transportwas
inhibitor , or oxalate , a Ca precipitating anion that enhances uptake
by skeletal muscle sarcoplasmic reticulum (Hasselbach , 1978), It should
be noted, however that the assumption that oxalate stimulation of
uptake relects transport into smooth muscle sarcoplasmic reticulum has
been brought into question given the results of several recent studies
(Kwan, 1985). In some tissues (e. g. rat mesentary) oxalate produced no
stimulation of uptake in microsomal fractions enriched in sarcoplasmic
reticulum (Kwan et al., 1981), while in other tissues (e. g. dog aorta)
oxalate stimulated 45ca accumulation by a fraction enriched in plasma
membranes (Kwan et a 1 . , 1984).
More rigorous evidence that sarcoplasmic reticulum contamination did
not contribute to the observed 45Ca fluxes in our vesicle preparation
was obtained from the 45Ca efflux experiments (see Figure 6). These
results indicated that Ca release from preloaded vesicles was not
affected by agents that stimulate sarcoplasmic reticulum ca2+ release
including caffeine , IP and GTP (Endo et al., 1977; Obara and Yabu
1982; Carsten et al., 1985; Suematsu et al., 1985; Wolf et al., 1987).
Other studies demonstrated that the ATP-dependent Ca uptake in
both pig and toad stomach membranes exhibited properties expected for a
plasmalemmal Ca pump. Vanadate at low concentrations has been shown2+ 2+ to inhibit plasma membrane a Mg - epen ent ATPase actlv1ty2+ 2+ and Ca uptake by blocking a step 1n t Ca -pump reactlon cyc e
i n wh i c h the phosphorylated form of the pump protei n undergoes a
Ca acrossconformat i ona change required for the translocation of
the membrane (Schatzmann
inhibited 45Ca uptake in
a 1 . , 1986) . study, vanadateour
concentrat ion-dependent manner wi 
appparent K .: 0. 1 pM , similar to the values for vanadate inhibition
. 2+of the p1asma1emmal Ca pump in guinea pig ileum (Sharma et al.
1987) and in porcine stomach muscle (Raeymakers, 1983).
The second criterion for establishing the existence of 
Ca affinity - was fulfi lled 
2+ uptake had an apparent Km for
plasma 1 emma pump hi gh
demonstrat i ng that ATP-dependent
2+ Ca 0 . 2 pM ln toad vesicles and 0. 4 pM in pig vesicles. These
2+ 
values are well within the physiological range of Ca repor e 
resting smooth muscle and are comparable to values reported for the
smooth muscle plasmalemma1 Ca2+ ATPase (Matlib et a1., 1979; Grover et
al., 1980; Wibo et al. , 1981; Raeymakers et al., 1983).
These data 1 ed us to conc 1 ude that most of the Ca transport
appeared to p 1 a sma 1 emma 1 origin. Further support for this
contention was provided by studies examining the sensitivity of the
transport system calmodulin. Calmodulin has been reported
stimulate the ATP-dependent transport plasma membrane
fracti ons from pi g antra smooth musc 1 e (Wuytack et a 1 ., 1981), canine
gastric smooth muscle (Grover et a1. , 1983) and intestinal smooth muscle
(Wi bo et a 1 ., 1981). It is generally considered that the binding of2+ Ca-Calmodu1in to the pump 1n uces a conformational change in the
enzyme (see Figure 13) removing a 4-kDa inhibitory sequence from the
region of the active site (Carafoli, 1988).
+ Ca and
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Figure 13. , A scheme of the architecture of the plasma membrane Ca
pump as derived fom studies oJ , limited proteolysis. The 9-kDa
calmodulin -- interacting domain is visualized to contain a 4-kDa
ca 1modul i n bi ndi ng sequence, and a 5-kDa sequence that is necessary for
activation by calmodulin, i. e., for the removal of the 4-kDa
inhibitory " sequence from the active site. (from Carafoli, 1988).
Sensitivity to calmodulin was tested in two ways: by examining the
effects of exogenous calmodulin addition and the effects of calmodulin
antagonists on ATP-dependent Ca2+ uptake. The addition of exogenous
CaM produced a 1. fold stimulation of ATP-dependent 
uptake by pig and toad plasmalemmal vesicles increasing both the
affinity for Ca2+ and the maximum velocity. These modest effects of
calmodulin are probably an underestimate since the membrane preparation
was not depleted of endogenous calmodulin. This conclusion is supported
by results from Enyedi et a1. (1988), who studied the effects of
calmodulin on plasmalemmal Ca2+ ATPase in rat myometrium. Their data
indicated that exogenous calmodulin caused only a 20% increase in Ca
transport in untreated membranes , but a 4- fo 1 d i nc rease if the membranes
were first depleted of endogenous calmodulin (Enyedi et al., 1988). The
depletion of endogenous calmodulin was not attempted in the present
studies since we felt that the rather drastic procedures necessary for
calmodulin extraction (including hypotonic and hypertonic washes with
EGTA) would compromise the integrity of the plasmalemmal vesicles.
Instead, we sought evidence for the calmodulin dependence of
ATP-dependent Ca transport us i ng ca lmodu 1 i n antagoni sts. A vari ety
of chemically unrelated substances have been shown to antagonize the
effects c a 1 mod u 1 enzymes in vitro These i nc 1 udetarget
phenoth i azi nes TFP) . naptha 1 ene sulfonamides (eg. W7) and(eg.
calmidazolium, a complex imidazolium compound. Despite their variable
structures, most if not all of these compounds are cationic amphiphiles
and exhibit structural regions complementary to calmodulin. It has been
proposed that these agents bind to the hydrophobic regions on calmodulin
that are exposed upon its binding to Ca , competitively blocking the
interaction of calmodulin with target enzymes (Gietzen, 1982). Most of
the antagonists have other actions apart from blocking the effect of
ca lmodu 1 in, however. Some exert di rect effects on the target enzyme,
producing, for example, an inhibition of the purified C/+ ATPase and
an attenuation of the effects of other activators of the pump (acidic
lipids and limited proteolysis; Adunyah et a 1. , 1982) . Therefore,
extreme caution must be exercised if inhibition of 45Ca uptake by
calmodulin antagoni sts taken reliable evidence for
regulation by calmodulin.
In the present studies we were able to define conditions under which
we cou1 d demonstrate a ca lmodul in-dependent i nhi bi tion of ATP-dependent
Ca uptake in gastric smooth muscle by both TFP and CMZ. These
conditions involved brief exposure of the membranes to relatively low
concentrat ions the antagoni sts and produced inhibition
calmodulin-stimulated , ATP-dependent uptake that could not be explained
nonspeci fi c changes membrane permeabi ity. higher
concentrations of TFP and CMZ (100 pM and 10 , respectively) or at
longer exposure times (greater than 1 min), we could not demonstrate
selective effects of these drugs on Ca transport. The increase in
membrane Ca2+ permeability could account for essentially all the
observed ecrease 1n accumu a 10n. Therefore , any decrease in
ATP-dependent upatke observed at these moderate concentrations would be
compos ite of two simultaneous events: a dec rease in ATP-dependent
uptake theseand increase eakage. Note that
concentrations and exposure times have been extensively used in previous
studies to test the role of a calmodulin-sensitive Ca2+ pump in smooth
muscle Ca2+ homeostasis with no recognition of these secondary
prob 1 ems.
The C/+ canprofound effects andTFP effl uxCMZ
explained in several ways. Due to the highly lipophilic nature of these
compounds , it is possible that the changes in 45Ca could result from a
nonspecific effect membrane i ntegri ty. Anderson al.(1984)
reported that binding 1-10 calmidazolium sa rcop 1 asmi c
reticulum membranes produced morphological changes including membrane
thickening and loss of resolution of the surface detail. However, the
results may be artifacts due to the high concentration of DMSO (the
solvent for CMZ) that was added to the membranes. In fact , other
reports demonstrated that neither TFP or CMZ, in concentrations as high
100 produced effects on the membrane permeabi ity pM, any
sarcoplasmic reti cul um vesicles (Tuana and MacLennon, 1984) . This
evidence along with the clear dose-dependency of the effects on ca
permeability in our own system makes this explanation less likely.
Alternatively, the increased loss of 45Ca from vesicles in the
presence of calmodulin antagonists could result from an interaction of
these agents with a ca2+ release channel located within the plasma
membrane and/or Wlt ln t pump. Support for this possibility
has al so been provi ded from studies us i ng sarcoplasmic reti cu lum
membranes. Although camodulin regulation is not a property of the
sarcoplasmic ret1cu um Ca pump per se, CMZ has been shown to inhibit
2+ uptake by skeletal muscle sarcoplasmic reticulum fractions2+ 
without affecting Ca ATPase actlv1 y (Tuana and MacLennon, 1984).
This effect was attributed to interaction with a Ca release channel
some other ca 1modul in-dependent translocation site. The
latter speculation is of particular interest since it has been 
suggested
that under certain conditions the sarcoplasmic retlcu um Ca pump can
function as a ca
2+ pore or channel. McWhirter et al. (1981) were able
to observe a fast Ca
2+ effl ux from reconstituted phospho 1 i pid vesi c 1 es
containing the sarcop asm1C ret1cu um Ca ATPase as the sole protein.
The results from these studies have also provided some insight into
the interaction of CMZ or TFP with calmodulin. As expected. we found
that the add i t i on of exogenous
effects of TFP on Ca uptake.
c a 1 mod u 1 i n reversed inhibitorythe
This is consistent with observations
from many studies suggesting a competitive interaction between TFP and
the Ca
2+ pump (i. e. the target enzyme) for the hydrophobic binding
region on calmodulin (for a review see Garrahan, 1986). However, the
inhibitory action of CMZ on ATP-dependent 45Ca uptake was enhanced in
the presence of added calmodulin. This result suggests that CMZ binds
to the calmodulin-
2+ pump 
complex and may indicate an interaction of
CMZ wi th an all osteri site on the Ca pump that is exposed upon
calmodulin binding. Support for thi s mechani sm can be inferred from
studies demonstrating that CMZ attenuates the effects of treatments that
enhance Ca
2+ ATPase activity by mimicking calmodulin actions
(exposure to. acidic phospholipids or mild proteolytic digestion; Adunyah
et a 1 ., 1982).
It was concluded from the results described above that essentially
all of the observed Ca uptake could be attributed to the presence of
plasma 1 emma 1 Ca ATPase. We were then able to determine that the
plasmalemma1 Ca ATPase is capable of maintaining steady-state levels of
2+ in 
smooth muscle. More specifically we were able to show that:
gastri c smooth musc 1 e 
intracellular Ca levels in toad
1) the K for Ca 2+ of the toad
pM, similar to the resting
pump was
stomach smooth musc 1 e measured with Qui n (Wi 11 ims and Fay,
with an intracellular Ca2+ electrode (Yamaguchi, 1986); 
exposed to 250 nM 
1986).
vesicles
were capable of generating at least a 10, 000
fold gradient for ca
gradi ent for ca2+ that is
similar to the physiological transmembrane
thought to exist across most cell membranes;
3) two independent assessments indicate that the transport capacity of
the plasmalemma1 Ca+ pump is at least 3-fo1d higher than that required
2+ 
to offset the inward 1 eak of Ca measure 1 n smooth musc 1 e at rest.
These results indicate that operation of the plasma 1 emma 1 
pump mu s c 1 e rol e ma i ntai ni ng lowsmooth plays a dominant
Ca 2+ 1 eve 1 s .steady-state cytosol i c
the pump for ci+
In addition since the K 
the prevailing resting ci+close
concentration, it is likely that this enzyme can buffer any small
changes in cytoso1ic Ca2+ resulting from increased Ca2+ entry.
Moreover, from the point of view of cellular Ca2+ homeostasis, the
i nterre1 ati onshi between cytosol i c Ca2+ concentrati ons ca 1modu1 in
and the activity of the plasmalemma1 pump provides an elegant
autoregu 1 atory system for the contro 1 0 cytoso 1 c Ca 1 eve 1 s. For
example, an abrupt rise in the Ca2+ concentration inside the cell
would activate calmodulin , which in turn would increase the activity of2+ the Ca pump to lower the Ca back to resting levels.
The values measured for the transport capacity of the plasmalemmal
Ca pump predi ct that the operati on of thi s transport system a lone
would not be able to remove completely the rise in free cytoplasmic
Ca produced in response to contractile agents.
the free cytoplasmic ca2+ in smooth muscle
During contraction,
ri se 1 eve 1 smay
approachi ng pM (Wi 11 iams and Fay, Yamaguchi 1986). Under1986 ;
these conditions restoration of Ca2+ back to resting levels would
additional extrusion mechansism, such as Na /Canecessitate
exchange, or sequestration into internal stores.
The relative contribution of each Ca2+ transport
(Na /ca2+ exchange and the p1asma1emmal and sarcoplasmic
2+ pumps) under these condition remains unknown.
system
reticulum
However
procedures similar to those used in these studies could be applied to
determine transport capacity of the p1asma1emma1 Na +/ca2+ exchange
2+ 
system. The way in which' intracellular omeostas1S 1S achieved
may vary in di fferent types of smooth musc 1 e. For example, many
invest i gators have argued that the sarcoplasmic reticulum may
relatively more important in vascular smooth muscle than in visceral.
Thi s hypothes is in agreement with morphological data showi ng 
well-developed (up to 7. 5% of cell volume) sarcoplasmic reticulum occurs
in vascular smooth muscle whereas this organelle comprises only 2% 
the cell volume in visceral smooth muscle (Eggermont et al., 1988a).
Another i nteresti di fference found between vascular and vi scera 1
smooth muscle is that the Na -ATPase activity is higher and the
(ca2+ + Mg ) ATPase activity is lower in pulmonary arteries than 
gastric smooth muscle (Eggermont, et al., 1988b). Since the activity of
the Na ATPase sets the upper limit to ca
2+ efflux that can 
mediated by the Na /ca2+ exchanger the conditions present 
vascular smooth muscle may allow the Na /ca2+ exchanger to play
more important role in ca
2+ extrusion.
The relative contribution of each Ca transport system to the
restorati on resti ng 1 eve 1 s after contraction may also
determined by the relative levels of other intracellular mediators (cAMP
and diac1glycerol). Scheid and Fay (1984b) observed a 13-fold increase
Ca efflux from toad gastric smooth muscle cells in response to
the beta- adrenergic agonist isoproterenol. From the observations that
the effects of isoproterenol were mimicked by dibutyryl cAMP and blocked
by 13 receptor, anyagonists and by ouabain (an inhibitor of the Na
+ '
ATPase), they were able to conclude that the 1ncrease ln Ca efflux
reflected an indirect activation of Na /Ca exchange secondary to
+ +
13 adrenergic stimulation of Na , pump activity.
Other i nvesti gators
Ca transport and the
have suggested that both the ATP-dependent
(ca2+ + Mg
) -
dependent ATPase acti vity 
the pump are stimulated by cAMP or by the catalytic subunit of cAMP
dependent protein kinase (Bhalla et al., 1978; Hisayama and Takayanagi
1983; Katternburg and Daniel, 1984). Others, however, found no effect
of either compound on the activity of the plasma1emmal enzyme (Sands et
al., 1977). The reasons for these inconsistent findings is not clear
but may depend on the experimental conditons used, since the most
cons i stent effects of cAMP were found in stud i es where the membranes
were fi rst pretreated with phosphatase to remove any nati ve
phosphorylation of the Ca
2+ pump. In our own studies, the effects of
cAMP and the kinase were inconclusive perhaps because we did not
attempt to dephosphorylate the membranes. Other studies demonstrated
that activation of protein kinase C by phorbo1 esters or l-oleoyl-
2-acety1g1ycero1 stimulated the plasmalemma1 Ca pump in vascular
smooth musc 1 e cell s (Furukawa, 1989).
The above discussion indicates that many factors may dictate the
relative contribution of each transport system to the removal of the
increased cytosolic Ca
2+ levels that are observed in response to
contractil e stimul i. These factors may i nc 1 ude the abundance of each
transport system, their affinity for Ca , the maximal translocation
velocity, their stoichiometry of Ca transport, and their regulation
by second messengers. Thus, the precise role of the smooth muscle
which Ca2+ levels are elevated plasma 1 emma 1 c/+ pump under
contractile agents remains to be resolved.
In summary, the results from this portion of my thesis research
provide the first quantitative measurement of the transport capacity of
the smooth muscle plasmalemmal Ca ATPase and demonstrated that this
en zyme was capab 1 c omp 1 ete 1 y offsetting the i nwa rd leak
observed in intact smooth muscle cells. The methodologies developed
could be applied to future studies of the transport capacity of the
Na +/Ca2+ exchanger and/or to studies of the regulation of each
transport system by i ntrace 11 u 1 ar second messengers. Thi s methodo logy
could also be used to study the mechanisms that underlie alterations 
cellular Ca
2+ handling that are observed certain disease states
such as hypertension. In addition, these studies provided the first
demonstration of the profound effects of the calmodulin inhibitors TFP
and CMZ on the permeabi 1 i ty of the plasma membrane to Ca 2+ and
seriously questioned the use of these agents to examine the calmodulin
regulation of plasmalemmal Ca
2+ transport.
Chapter V.
Introduction to Muscarinic Receptors
The study of the mechanisms by which the parasympathetic nervous
system regulates smooth muscle contraction has long been an important
aspect of smooth muscle physiology and pharmacology. It is generally
accepted that acetylcholine is the major excitatory neurotransmitter
that regu ates the contractility of smooth musc 1 e in the airways, the
gastroi ntesti na tract and the urogenital Evidence for thetract.
postsynaptic localization of muscarinic receptors is well established
having been provided by a variety of functional and binding studies.
binding studies, Burgen et a1. (1974), using the muscarinic antagonist
propyl benzi 1 y1 cho 1 i ne mustard, were among the fi rst to demonstrate
saturable binding to specific muscarinic acetyl cho 1 i ne receptors 
longitudinal muscle of the guinea pig ileum. In functional studies , it
was demonstrated that the addition acetylcholineexogenous
carbachol caused contraction of bronchial or gastri c smooth musc 1 e
(Yamamura and Snyder, 1974). The contracti 1 e response was medi ated by
muscarinic receptors since it was antagonized by low concentrations of
the musca ri n i c-se 1 ect i ve antagoni st atropi ne re view see(for
Mitchelson, 1988).
The first radioligand binding studies of muscarinic receptors were
performed by Paton and Rang (1965) who demonstrated that the bi ndi ng of
H)-atrop1ne could be used to identify receptors in guinea pig
ntesti na 1 smooth musc 1 e. The development of radioligands with higher
specific activity (and, thus a greater signal to noise ratio) allowed for
a more detailed identification of smooth muscle muscarinic receptors.
The H)-dexetimide wasantagoni st used 1 abe 1 receptors
homogenates of bovine tracheal smooth muscle (Be1d and Ariens , 1974) and
the high affinity antagonist ( H)-quinuclidinyl benzilate (QNB) was
used to identify receptors in gui nea pi g il eum (Yamamura and Snyder
1974) . The excellent agreement between the values of the affinity
constants determi ned by bi ndi ng measurements and by antagoni sm of smooth
muscle contraction indicated that the sites labelled by the muscarinic
antagonists represent functionally active receptors.
The interaction of muscarinic agonists with smooth muscle muscarinic
receptors was determined by competition with labeled antagonists for the
binding sites. In contrast to the apparent homogeneity of antagoni st
binding, agonist binding was complex and deviated significantly from
that expected for a simple bimolecular reaction of the ligand with one
population of receptors (Nathanson , 1987). Stud i es of the bi nd i ng 
radio labelled agonists to intestinal smooth muscle indicated that the
observed heterogeneity in agonist binding could be explained by the
presence of both high and low affinity sites (Roeske , et al. , 1983).
Moreover, other evidence indicated that conversions between the high and
low agonist affinity sites could be induced by guanine nucleotides,
suggesti ng that smooth musc 1 e muscari ni c receptors were coupled to
GTP-binding regulatory (G) proteins.
Whi le the results from these early binding studies demonstrated the
di stri buti on muscarinic receptors within smooth muscle and their
affinities for agoni sts and antagoni sts the relationship between
receptor occupancy and contraction induced by muscari ni c agoni sts was
poorly understood. generally thatnow acceptedHowever,
activation of smooth muscle muscarinic receptors leads to contraction by
increasing availability cytosolic Ca2+ to the
of intracellular Ca levels and
the contracti le
machi nery. Cho 1 i nergi c contro 1
hence the contractile state of smooth muscle , is now thought to result
from the actions of cholinergic agonists on a number of cellular
processes. . Many studies have indicated that muscarinic receptors in
smooth muscle and other excitable tissues modulate ion channel activity,
intracellular ca
2+ release; 2+ an Ca extruslon; an these actions of
cho 1 i nergi c mediated generat i on secondtheagents may
messengers via phosphoinositide and adeny1yl cyc 1 ase pathways.the
However, the detail ed mechani sms by whi ch muscari ni c receptors regu1 ate
these diverse biochemical responses in smooth muscle is unclear.
In other systems , the effects of muscarinic agents on both second
messenger systems are thought to be mediated by receptors coupled to
guani ne-nuc 1 eotide binding protei ns. examp 1 eregu 1 atory ( G) For
muscarinic receptors in brain (Nathanson 1987) and exocrine tissues
(Merritt et al., 1986) are thought to regulate phospholipase C activity
Phospho 1 i pase hyd ro 1 yzesGTP-dependent manner.
phosphat idyl i nos i to 1 bisphosphate (PIP
)' 
generating two second
trisphosphate (IP which mobilizes Ca
stores, and 1, diacylglycerol which activates
messengers: i nos ito 1
from i ntracell u1ar
protein kinase C (Berridge, 1987). There appea rs to be more than one
type of 6 protein (termed Gp) that couples muscarinic receptors to
phospho1 ipase the muscari ni c phosphoinositidestimul ati on
hydrolysis is blocked by pertussis toxin in some, but not in other cell
types (Ashkenazi et al., 1989). Thus, at east two types of Gp-coup 1 ed
muscarinic be distinguished their sensitivity toreceptors can
ADP-ribosylation catalyzed by pertussis toxin.
Muscarinic agents in airway smooth muscle (Takuwa et al. , 1986) have
been shown to regulate polyphosphoinositide metabolism , indicating that
and diacylglycerol can be generated in response to receptor
activation. IP3 in turn can mo 1 lZe a from storage sites within
the sarcoplasmic reticulum, as is evident by its ability to release Ca
from permeabi 1 i zed musc 1 e (Somlyo a 1. , from1985 )smooth
mi c ros omes from uterine sarcoplasmic reticulum (Carsten andderi ved
Miller, In addition, Salmon and Honeyman (1979) demonstrated1985) .
that carbacho 1 stimulated formati on phosphatidic acicthe
metabolite of diacylglycerol) in toad gastic smooth muscle cells; and
diacylglycerol has been shown to regulate a vo tage-sensltlve a
channel in the same preparation, presumably via activation of protein
kinase C (Vivaudou et a1., 1988). The involVement of G protei ns in the
muscarinic-induced changes in phospholipid metabolism has not yet been
demonstrated in smooth musc 1 e.
Muscarinic regulation of levels of the second messenger cAMP is also
mediated by coupling to G proteins. Muscari ni c in manyreceptors
ti ssues i nhi bit adenyly1 cyclase acti vity through i nteracti on with the
pertussis-sensitive G protein, G.. Studies in tracheal smooth muscle
i ndi cated that muscari nic agoni sts can inhi bit cAMP production induced
B-adrenergi c i soprotereno 1 was nota 1 thoughagoni stthe
determi ned intracellular duecAMP wasthe decrease
inhibition cyclase or stimulation cAMP-dependentof aadenyly1
phosphodi esterase (Torphy, a 1. , 1985) . The fi rst direct
demonstration of muscari ni c inhibition of adenylyl cyclase in smooth
muscle was provided by the studies of Jones et al. (1987) in which
muscarinic agonists were shown to decrease cAMP levels in the presence
of added phosphod i esterase i nhi bitors. Aga in the i nvo 1 vement of G
proteins in mediating the cholinergic effects on cAMP levels has not yet
been demonstrated in smooth musc 1 e.
Given these diverse mechanisms of signal transduction mediated by
muscarinic receptors in smooth muscle , a major question in the study 
cho 1 i nergi c contro 1 smooth musc 1 e contract il ity re 1 ates to the
mo 1 ec u 1 a r mechani sms that underlie the biological diversity
muscarinic activity. One proposed exp 1 anat ion for thi s tremendous
diversity is the of multiple receptor subtypes, with eachpresence
receptor subtype mediating a distinct biochemical response. On the
other hand this heterogeneity may reflect diversity in G proteins that
transduce muscarinic receptor occupancy to the activation of specific
biochemical responses. (i. e. a single class of receptor may couple to
di fferent effector systems).
The exi stence di fferent muscari ni c subtypesreceptor was
initially inferred from studies which showed that selective muscarinic
antagonists exhi bit different affi niti es for receptors va ri ous
tissues. Hammer et a 1. (1980) were the fi rst to demonstrate that the
1 i gand binding propert i es muscarinic cou 1 receptors
differentiated by the antagoni st pi renzepi ne. contrast to the
homogeneous binding seen for classical muscarinic antagonists such as
atropine, competition curves for pirenzepine indicated the presence of
multiple affinity states. Cardiac and smooth muscle had a single class
of low affinity binding sites while glands and neural tissues possessed
varying proportions of an additional site with approximately a 50-fold
higher affinity. Receptors with high affinity were termed Ml while
thos e wi th lower affi ni ty were termed M In genera 1, functional
studies examining inhibition agoni st- i nducedthe responses
pi renzepi ne supported distribution muscari ni c receptorthi s
subtypes. examp 1 e, pi renzepi ne cou 1 inhibitlow dosesFor
cholinergic stimulation of gastric secretion from glandular tissue but
much higher doses were needed to inhibit contraction of cardiac muscle
and of smooth muscle lining the stomach wall (Hammer and Giachetti,
1982) . It was later found that pirenzepine inhibited gastric secretion
indirectly. by antagonizing the release of excitatory neurotransmitters
from enteric nerve within the stomach tissue (Nathanson, 1987).
Further studi es indicated that the receptor population
consisted of a mixed population of In functional testsreceptors.
compari ng receptors on atrial versus ileal tissue, for example, the
compound d i pheny 1 acetoxy- methyl pi peridi ne ( 4-DAMP) proved more
potent for the muscarinic receptors on ileal smooth musc 1 e than 
card i a c tis s ue ( Dood s a 1 . , 1987) . the bi ndi ngMoreover,
characteri stics and hexyhyd ro-s i 1 ad if en i do 1 di ffered4-DAMP
cardiac versus glandular or smooth muscle tissue. Thus it was suggested
that a thi rd subtype of muscari ni c receptors may exi st.
The development of the compound AF-DX 116, a muscar; ni c antagoni st
structurally related to pirenzepine, provided more conclusive evidence
of an additional class of muscarinic receptor. AF-DX 116 bound wi th
high affinity to M receptors in the heart but with an approximately
30-fold lower affinity to M receptors in exocrine glands (Giachetti
et al., 1986; Micheletti et al., 1986). In pharmacological tests, AF-DX
116 also displayed a 10-fold higher potency for antagonism of muscarinic
agonist-induced decrease in heart rate than for antagonism of salivary
secretion (Giraldo et a1. 1987). Based on both the functional and
binding data, Doods et al. (1987) have suggested that cardiac muscarinic
receptors with affi nity c 1 ass if i ed
low
for AF- 116high
receptors and glandular muscari ni c wh i c h havereceptorsthat
affinity for AF-DX 116 and high affinity for 4-DAMP be classified as
3 receptors.
Evidence mu lt i p 1 e receptor subtypesthe exi stencefor
functional and binding studies has been verified in genetic studies by
the isolation and cloning of multiple genes encoding for different
muscari ni c subtypes. Muscari ni c have beenreceptorreceptor genes
cloned and sequenced from porc i ne brai n and heart cDNA 1 i brari es as well
as from human genomic libraries (see Kerlavage et al., 1987). The ami 
acid compositions of the purified porcine brain (M ) and heart (M
receptors suggested differences primary sequences. Thesethei r
di fferences have been confi rmed by the ana lysi s of the primary sequence
of each receptor based on thei r respecti ve cDNA I Recent studies have
identified at least five distinct but highly homologous genes encoding
for muscarinic receptors (Bonner et al, 1988; Peralta et al., 1988).
The amino acid sequence of each subtype reflects a structure consisting
of seven highly conserved transmembrane sequences , a structure common to
all protei n-coup1 ed intracellular regionand 1 a rg ereceptors,
between the fifth and sixth transmembrane loops that is unique to each
subtype and may constitute the effector-coupling domain (Ashkenazi et
a 1 ., 1989). Thus , both pharmacological and genetic evidence support the
existence of multiple receptor subtypes.
Muscari ni c heterogeneity smooth beenmusc 1 e hasreceptor
studies. competition experiments againstindicated by several
HJ-N-methyl scopo lami ne heterogeneousrecogn i zedAF - 116
receptor population in membranes prepared from both longitudinal and
ci rcular smooth muscle of the guinea pig ileum (Giraldo et al. , 1987).
The maj ority 80%) identifi edthe receptors were
receptors (KD = 100 nM characteristic
while the remainder were classified
cardiac M receptors)
1-3 pM,
characteri sti c glandular M receptors) . Simi lar findings have
also been reported for membranes from rat urinary bladder smooth muscle
(Ladinsky et al. , 1988) and bovine tracheal smooth muscle (Roffel et
a 1. , addition Collins and Crankshaw (1986 )1988) .1987,
demonstrated recogni zed popu 1 at ionthat heterogeneousDAMP
muscari ni c smooth mu s c 1 e ce 11 s isolated from cani nereceptors
stomach. Further evidence for muscarinic receptor heterogeneity in
smooth muscle has been gained from the determination of the tissue
distribution of the mRNA' s encoding for each receptor subtype by blot
hybridization analysis with subtype-specific mRNA probes (Maeda et al.,
1988) . Thi s study indicated that smooth muscle from the trachea
intestine and urinary bladder contained both M
2 and M3 mRNA'
The data summari zed above support the poss i bil ity that di fferent
receptor subtypes may mediate each of the biochemical pathways involved
in muscarinic actions on smooth muscle contractility. Further support
for this notion has been provided by studies correlating the occupancy
of a particular subtype by agonist with the preferential activation of a
specific cellular effector. Initial studies with pirenzepine suggested
the preferential coupling of rat brain M receptors to the activation
of phosphoinositide hydrolysis and rat cardiac M receptors to the
inhibition of adeny1y1 cyclase (Peralta et a1. , 1988). More direct
information concerning the selective coupling of receptor subtypes to
cellular responses has been revealed from experiments in which the DNA
for each i ndi vidua 1 subtype was transfected and expressed in di fferent
cell The results indicate that the transfected M and M
strongly coupled to phosphoinositide hydrolysis in CHO
1 i nes .
receptor are
cells , Xeno us oocytes and NG108-l5 neuroblastoma x glioma cells , and
receptors are preferentially coupled to adenylyl cyclase (Peralta
et al., 1988); Ashkenazi et a1., 1987). Other cDNA expression studies
us i ng Xeno us oocytes i nd i cated that Ml receptor occupancy induced an
activation of Ca -dependent current, whereas receptor
1 n occupancy evoked an activation of and K currents
independent a 1 . , Finally, and1988) .( Fukudama n n e r
receptors expressed ce 11 s efficiently stimulated
a -
NGl 08-1 5
phosphoinositide metabolism,
dependent K current and an
eliciting activation
inhibition of the M-current (Fukuda et
al., 1988).
These observations different muscarinic receptori nd i cate that
subtypes have the capabil ity of preferentia 11 y coup 1 i ng to different
bi ochemi ca thi s coup 1 i ngeffector may notHoweversystems.
exclusive. For example, M receptors expressed in CHO cells were not
only coupled to the inhibition of adenylyl cyclase through a pertussis
sensitive protei n, but al so coup 1 ed phosphoi nos i tidewere
hydrolysis though a pertussis insensitive G protein if the receptor
number was increased to x 10 sites/cell (Ashkenazi et a 1 . ,
1987) . Therefore, a single muscarinic receptor subtype may be coupled
to multiple biochemical effector systems by interacting with different G
protei ns. Thi s content ion has been conf i rmed reconst i tut ion
experiments using purified G proteins and purified brai n muscari ni c
receptors. Studies by Florio and Sternweiss (1985) indicated that a
single receptor subtype was capable of coupling to both G and G 
as measured by agonist stimulated GTP-binding to reconstitiuted vesicles
and by GTP- i nduced shifts in agoni st bi ndi ng. These results raise the
possibility that the complex actions of cholinergic agonists in smooth
musc 1 e cou 1 mediated by sing 1 muscarinc receptor subtype
interacting with several G proteins, each coupling to distinct cellular
responses.
The maj or goa 1 for this portion of my thesis research was to
determi ne whether the diverse bi ochemi ca observed uponresponses
cholinergic activation of smooth muscle were due to a heterogeneity in
muscarinic receptor subtypes and/or different stimulus-effector 
coupling
mechani sms. The specific aims were to: 1) . define the muscarinic
receptor subtype(s) in smooth muscle and 2). determi ne whether or not
these receptors coup 1 ed protei ns. These studies werewere
undertaken in both toad gastri c smooth musc 1 e and bovi ne tracheal smooth
muscle since both preparations exhibit multiple cellular 
responses to
cholinergic agents. In toad gastric smooth muscle, cholinergic stimuli
evoke changes in phospho 1 i pi d metabo 1 i sm (Salmon and Honeyman , 1979),
activate a vo tage-sens1tlve Ca channel (Vivaudou et a1., 1988) and
suppress a time- and voltage- dependent K current termed the
current (Sims et al., 1985). In tracheal smooth muscle , cholinergic
acti vati on cyclase andadenyly1 acti vityleads changes
phospholipid metabolism (Jones et a1. , 1987; Takuwa et al., 1986). The
parallel studies on both smooth muscle types enabled us to determine if
each smooth muscle used the same muscarinic receptor subtypes and G
proteins to regulate the biochemical effector systems that ultimately
lead to the same biological endpoint , contraction.
Chapter VI
Interaction of Agonists and Selective Antagonists with Gastric
Smooth Muscle Muscarinic Receptors
SUMMARY
The interaction of cholinergic agonists and antagonists with smooth
musc 1 e muscari ni c receptors has been investigated by measurement of
displacement muscari ni c antagoni st HJQNB (quinuclidinyl
The binding of
the
benzi late)
H)QNB was
in membranes prepared from toad stomach.
saturable revers i b 1 e and of high affinity (KD = 423
pM) . The muscarinic receptor subtypes present in gastric smooth muscle
were classified by determining the relative affinities for the selective
antagonists pirenzepine (M )' AF-DX 116 (M and 4-DAMP (M
)' 
The
results from these studies indicate the presence of a heterogeneous
population of muscarinic subtypes, with majority ( 87%)receptor
exhi biti ng characteri st i and much sma 11 erreceptors
population ( 13%) exhibiting characteri stics Thereceptors.
binding curve for the displacemnt of ( HJQNB binding by the agonist
oxotremori ne was comp 1 ex and was cons i stent with presence of two
affinity states: 24% of the receptors had a high affinity (KD = 4.
nM) for oxotremorine and 76% displayed nearly a 1000-fold lower affinity
D = 4. pM). When oxotremorine displacement of ( H)QNB binding
was determi ned high affinity binding wasGTPyS,the presence
abolished, indicating that high affinity agonist binding may represent
receptors coupled to G proteins. Moreover, pertuss is toxi n pretreatment
of membranes also abolished high affinity agonist binding, indicating
that the muscarinic receptors are coupled to pertussis toxin - sensitive
G proteins. Reaction of smooth muscle membranes with pertussis toxin in32 32the presence ( PJNAD caused the ( P)-labell1ng of a 40 kD protein
that may represent the a subunit(s) of G proteins that are known to be
NAD-ri bosyl ated the conc 1 ude that both andtox in.
receptors may be coupled to G proteins in a pertussis-sensitive manner.
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I NTRODUCTI ON
There now considerable experimental evidence suggesting that
there are multiple types of muscarinic cholinergic receptors. These
subtypes have been di sti ngui shed pharmaco ogica lly based on differences
in the ability of various muscarinic cholinergic antagonists to bind to
muscari ni c receptors and/or on differences in thei r abil ity to block
muscari ni c actions ( see Mitchelson 1988 and Nathanson, 1987 for
revi ews) . In addition , receptor subtypes have been defined genetically
from the identification of discrete (albeit closely related) cDNA and
mRNA species Ker1avage a 1 . , for revi ew) .( see 1987 recent
Initially, muscarinic receptors were divided into two classes based on
the relative affinities the for the antagoni streceptors
pi renzepi ne. Receptors which exhibited high affinity for pirenzepine
were localized predominantly in the brain and termed M Receptors
which exhibited low affinity for pirenzepine were localized in heart,
smooth muscle and glandular tissue and termed M2 (Hammer et al.
, 1980;
Hammer and Giachetti, '982). Subsequent studies using the newly
deve loped muscarinic antagoni sts AF-DX 116 and 4-DAMP have suggested
that the initially des i gnated al so represent
116
receptors
highershowedheterogeneous population AF -DXreceptors.
affinity for receptors in the heart than for those in exocrine glands
(Giachetti et al., 1986; Hammer et al., 1986; Micheletti et al. , 1986),
while 4-DAMP showed a higher affinity for receptors in exocrine glands
(de Jonge et al., 1986; Doods et al., 1987). Tissues such as smooth
muscle on the other hand appeared to possess a mixed population of
receptors (Giraldo a 1., 1987 ; Gi ra 1 do a 1. 1988; Ladi nsky
a 1 ., 1988). Because these recent findings, Dood s et a 1 . (1987)
proposed classification scheme wh i c h muscari ni c receptors were
subdivided into three subtypes, M and M based 
relative binding affinities of pirenzepine, AF-DX 116 and 4-DAMP.
the
receptors were defined as those exhibiting high affinity for pirenzepine
and 4-DAMP (KD = 1-20 nM) and intermediate affinity for AF-DX 116
D = 700-800 nM). M receptors were defi ned as those receptors
exhibiting high affinity for AF-DX 116 (KD = 50-100 nM) and low
affi nity for pi renzepi ne and 4-DAMP (KD = 200-600 nM). M receptors
were defined as those exhibiting high affinity for 4-DAMP (KD = 1-10
nM) and low affi nity for pi renzepi ne and AF-DX 116 (KD = 3-5 pM). A
similar classification scheme has also been proposed by de Jonge et al.,
(1986) and reviewed by Mitchelson (1988).
In addition to the diversity in receptor subtypes that recognize
muscarinic cho 1 i nergi c considerablethere appea rsagents,
diversity in the biological to - these agents. Muscari ni cresponses
stimuli have been shown to regulate adenyl ate cyclase, phosphoinositide
phospho 1 i pase and membrane ion conductances various ti ssues
(Ashkenazi et al. , 1987; Christie and North 1988; Mitchelson 1988).
addition, these agents appear capable of producing multiple responses
withi n si ngl e ti ssue type. In smooth muscle for example, in which
muscari ni c acti vati on el icits contraction , muscari ni c agoni sts produce
changes in diacylglycerol, inositol phosphate and cyclic AMP metabolism
a s we 11 changes in specific ion conductances in the membrane
(Nathanson, 1987; Takuwa et al., 1986; Akhtar et al., 1987; Benham, et
al., 1985). The manner by which muscarinic agents elicit such diverse
responses in smooth muscle is as yet unknown. This diversity could
reflect a heterogeneity in receptor subtypes since recentmusca ri ni c
reports (Giraldo et al., 1987; Giraldo et a1. , 1988; Ladinsky et al.
1988 ) indicate that smooth mu s c 1 e from the gastroi ntest i na 1 tract
possesses both M and M receptors (using the classification scheme
for receptor subtypes described above). It is also possible that the
diversity biological musc 1 e to muscarinicresponses smooth
agoni sts reflects diversity in stimulus-effector coupling mechanisms.
In other tissues, the coupling of muscarinic receptors to biological
responses seems to involve more of the family of guani neone or
nucleotide binding proteins termed G proteins (Merritt et al. , 1986;
Nathanson, 1987), and indirect evidence suggests that different subtypes
of muscari ni c receptors may preferentia 11 y interact with different G
protei ns and regulate different biochemi ca 1 processes.
The present studies were designed to examine the biological basis
for the heterogeneity of muscari ni c responses in smooth musc 1 e. These
studies employed toad gastric smooth musc 1 e preparation in which
muscarinic agonists have been shown to elicit changes in phospholipid
metabolism (Salmon and Honeyman, 1980), in the ion conductance of the
plasma membrane (Sims et a1. 1986;
intracellular Ca
2+ levels (Williams
Vivaudou et a1., 1988 ) and in
a 1 . , 1987) . Us i ng thi s
preparation we looked for possible heterogeneity in muscarinic receptor
subtype( s) on the smooth muscle membranes by examining the relative
affinities of the receptors for the muscarinic antagonists pirenzepine,
AF-DX 116 and 4-DAMP. We examined the involvement of GTP binding
protei ns in muscari ni c actions by assessing the effects of guanine
nucleotides and pert u s s i s toxi n on agoni st These studi esbinding.
indi cate that at east two types of muscari ni c receptors are present in
toad gastric smooth muscle and that both subtypes may be coupled to G
proteins in a manner sensitive to pertussis toxin.
METHODS
Membrane Pre arati on.
Smooth muscle plasma membranes were prepared from the stomach of the
toad (Bufo marinus) as previously described (Lucchesi et al. , 1988).
Briefly, the muscle layer was dissected free of mucosa and homogenized
wi th The ti ssue homogenate was furtherU1traturrax Ti ssuemi zer.
disrupted by nitrogen cavitation and membrane fractions were collected
by centrifugation. Crude membrane fractions were then extracted with
6 M NaC1 to remove contracti le proteins and further puri fi ed 
flotation on discontinuous sucrose gradients. The plasmalemmal vesicles
were then resuspended by sonication in storage buffer consisting of 250
mM sucrose , 40 mM MOPS ((N-morpho1ino)- propane sulfonic acid , pH 7. 1),
1 mM DTT (dithiothreitol) and 10 pg/ml of leupeptin), rapidly frozen
in liquid nitrogen , and stored at -80 Protei n content was measured
with the bicinochoninic acid (SCA) protein assay reagent described by
Redinbaugh and Turley (1986). The purified membranes were enriched
15-20 fold for the membrane markers 5 nucleotidase and K -stimulated
ni trophenyl-phosphatase contained minimal contaminationand
mitochondria or sarcoplasmic reticulum (Lucchesi et al., 1988).
Muscari ni c cho 1 i ner i c rece tor assa
All binding assays were carried out in a final volume of 2 ml in a
buffer containing 50 mM MOPS, pH 7. 1, 10 mM MgC1 2' 50 mM NaCl and 2 mM
EDTA. For saturation binding experiments , 0. 01 to 30 nM ( H)QNB
(quinuclidinyl benzilate) was added. Nonspecific binding was defined as
the amount of ( H )QNB bound in the presence of 100 pM atropi ne.
For displacement experiments, membranes were incubated in the presence
of 1 nM ( H)QNB and varying concentrations of unlabe11ed ligands. All
binding reactions were initiated by the addition of 50 pg of membranes
and were allowed to incubate for 60 min at Bound ( H)QNB was
separated from free by fi ltration through Whatman GF/F fi 1ters that were
presoaked in 0.1 % BSA. The fi lters were washed 5 times with 3 
aliquots of ice-cold buffer containing 50 mM MOPS, pH 7. , 25 mM NaC1,
and mM M9C1 The filters were then placed in vials containing
scintillation fluid (Optiflour, Hewlett-Packard) and H was determined
by liquid scintillation counting at 40-47% efficiency.
ADP-Ribos lation of Membranes b Pertussis Toxin.
32 PJADP usingperformedreactionsri bosyl ati on were
modification of the method described by Ribiero-Neto et al., (1987).
Incubations were carried out for 60 min at 30 C in a final volume of 60
pl containing 35 
pg 
of membranes, pg/ml BSA 10 pM ( p)NAD
(- 5 x 10 cpm/assay) , 10 mM thymidine , 20 mM Tris-Hcl , pH 7. 5, 1 mM
ATP, 1. 5 mM DTT, in the presence or absence of 10 p1 of 100 pg/ml
pertussis toxin. Pertussis toxin was preactivated by incubation with 20
mM DTT for 10 min at 30 C. NADP (0. 5 mM) was included in the reaction
mixture to decrease the hydrolysis of PJNAD by glycohydro1ases.
Reactions were initiated by the addition of ( P)NAD and stopped by
the addition of 500 pl of ice-cold 0. 1 mM NAD. The samp 1 es were then
centrifuged 7 min at 14, 000 rpm in an Eppendorf microfuge. The pellets
were resuspended in 120 p 1 of Laemml i I S sample buffer and the protei 
were separated sodi um dodecy1 sul phate-po 1 yac ryl ami de gel
e 1 ectrophores i (SDS- PAGE) in 10% polyacrylamide gel slabs (Laemml i
1980) . After electrophoresis, the gel slabs were dried under vacuum and
subjected to autoradiography at -80 C for 24 hrs using Kodak XR-5
fi 1m.
For experiments measuring the effects of pertussis toxin on agonist
binding, membranes were incubated in a reaction mixture consisting of 20
mM glycine-phosphate, pH 7. 5, 1 mM NAD, 1 mM ATP, 2 ffg/ml ovalbumin , 2.
mM DTT, and 1 mM EDTA, in the presence or absence of 3 pg/ml of
preactivated pertussis toxin. After incubation for 30 min at 30 , the
reaction stopped the addition vo 1 umes ice-coldwas
gl yc i ne-phosphate buffer and the membranes co 11 ectedwere
centrifugation in a Ti50 rotor at 4 C for 90 min at 40, 000 rpm. The
membranes were then resuspended in the buffer used for ( H)QNB bi ndi ng.
Data Anal sis
Data from all binding experiments were analyzed using a weighted,
nonlinear fitting LIGAND (Munson andeast squares curve program,
Rodbard, 1980). For analysis of displacement curves, data were also
analyzed using the ALLFIT program (De Lean et' a1. , 1978), an analysis
using a four-parameter logistics equation, in order to obtain estimates
of the IC50 (the concentration of ligand required to inhibit 50% of
HJQNB binding) and the slope factor (pseudo-Hill coefficient, a
parameter that indicates the complexity of the interaction(s) between
ligands and receptors). Ki neti c values are presented as Mean :t SE.
However, these errors are only approximations and are not useful for
traditional statistical analysis. A two-site binding model was chosen
over a one-site binding model when a significant reduction in the
residual sum of squares was obtained (F-test, P 05 or lower).
MATERIALS
( HJQNB p)NAD wereCi/mmol)(800
MA) .
( 35- Ci/mmol) and
AF-DX 116 (11-purchased from New England Nuclear (Boston,
(( di ethyl ami no)-
6H-pyri doe 2, 3-
methyl) -l-pi peri d i nyl) acetyl) -5, ll-di hydro-
pi renzepi neandbenzodi azepi ne-6-one) were
gene rous gi fts from Karl Thomae supplied through Boehri ngerDr.
Ingelheim (Ridgefield , CT). 4-DAMP (4-d i phenyl acetoxy-N-methyl-
piperidine methobromi de) purchased from Research Biochemicalswas
(Nati ck MA) . Pertussis toxi n was purchased from List Biologicals
( Campbell , CA) . GTPyS (guanos i ne 5 I -0-( 3-thi otri phosphate) was
purchased from either Boehri nger-Mannheim (Indianapo 1 is IN) or Sigma
Chemicals (St. Louis , MO). Oxotremorine , leupeptin and DTT were from
Sigma. Atropi ne was purchased from Ma 11 i nckrodt (Swedesboro NJ). All
other chemi ca 1 s were of reagent grade. The LIGAND program was obtained
from the National Institutes of Health (Bethesda, MD) and was modified
for use with an IBM PC by P. J. Munson and M. Beveridge.
RESULTS .
studies of the binding of ( H)QNB to toad gastric smooth muscle
membranes indicated that the binding of this nonselective antagonist was
specific and saturable (panel A of Figure 14). Nonspecific binding,
which constituted only 2-3 % of total binding at the equilibrium
di ssociati constant for H )QNB was nonsaturab 1 e and
increased 1 i nearly with increasing concentrations H)QNB.
Simultaneous ana 1 ys is the data obta i ned from five separate
experiments with the LIGAND program indicated that the binding of QNB
could best be described by its interaction with a single population of
receptors with :t 63 and 941
max
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fmo l/mg rote in. A Scatchard representation of the data is shown in
panel B of Figure 14. There was no evidence for a second class 
saturable sites with lower affinity for QNB.
Muscarinic receptor density in these membrane fractions was
estimated to be 1. 10 x 109 sites/cm ba5 on the observed Bmax
and previ ous estimates membrane surface area/vesicle ( seeour
Lucchesi et al., 1988 for details of the estimation of surface area).
For comparison, we also determined the density of muscarinic receptors
on isolated smooth muscle cells prepared by enzymatic dispersion of toad
stomach muscle. Saturation binding studies of ( H)QNB to suspensions
of smooth muscle cells revealed that the density of muscarinic receptors
on the isolated cells averaged 1. 18 x 10 sites/cell (mean of 
experiments) or 3. 77 x 109 sites/cm (assuming a cell surface area
of 3. 13 X 10 cm /cell, see Lucchesi et al., 1988). The close
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ure 14. Concentration dependence of (3H)QNB binding to Toad
Gastri c Smooth Musc 1 e Membranes.
Panel A: representative experiment in which varying amounts of
(3HJQNB were incubated with 45 ).g of toad membranes for 60 min atC. Specific binding of (3HJQNB (s uares) was defined as the
difference between total binding (circles) and binding observed in the
presence of 100 pM atropine (X' s). Nonspecific binding (Xi s) was
linear and represented less than 2-3% of total binding at concentrations
equal to the dissociation constant (KD)' Panel B: Scatchard
transformation of the data in panel A. Analysis of the data with the
LIGAND program indicated a KD of 557 pM and a Bmax of 1. 08 pmo1/mg
protein for this experiment. Similar data were obtained in 4 additional
experiments.
agreement between the receptor density calculated for membrane vesicles
and for isolated cells suggests that the binding characteri sti cs
observed membranes deri ved from intact ti ssue 1 a rg e 1 ymay
attributable to the smooth muscle cells within the tissue.
To characteri ze muscari ni c receptor subtypes in these membranes , we
exami ned H)QNB presence severa 1 muscarinicthebinding
antagoni sts including non-se 1 ecti ve antagoni st atropi ne, thethe
-selective antagonist pirenzepine, the M selective antagonist
AF-DX 116 and the M -se1ective antagonist 4-DAMP. Specific QNB
binding was inhibited in a concentration- dependent manner by all
antagon i sts tested ( Fi g . 15). Analysis of the atropine displacement
curve indicated that this antagonist interacted with a single class of
binding sites (pseudo-Hill coefficient of 1.04 :: 0. 13) with a KD of
31 :: 0.43 nM. Analysis of the displacement curve for the
se1ective antagonist pirenzepine indicated interaction with 
single class of sites (pseudo-Hill coefficient of - 93) with a KD of
267 :: 32 nM. The displacement curveS for AF-DX 116 and 4-DAMP
however, indicated that these antagoni sts exhibited comp 1 ex
interaction with the muscarinic receptors. The binding isotherms for
both AF-DX 116 and 4-DAMP both had pseudo-Hill coefficients less than 
suggesting that these agents may interact with heterogeneous
population receptors (coeff i c i ents were and 0 . 73 ,
respectively) . Analysis of these data with the LIGAND program indicated
that the binding of AF-DX 116 could best. be fitted by assuming two
populations of receptors; 13% having a high affinity, KD = 7. 37 
and 87% havi ng low affinity K 50 :: 0. pM.
Analysis of the data obtained with 4-DAMP indicated that the curve was
best fit to a two-site model with 88% of the receptors having a high
affinity (KD = 7. 00 :: 1. nM) and 12% of the receptors displaying a
low affinity (K 600 :: 332 nM) (see Table 5). Since all of the
antagonists that we employed displaced QNB to the same extent, 
appeared that all of the ligands were interacting with the same total
population of receptors, but that at least two subtypes of receptors
100 100
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ure 15. Displacement of (3HJQNB binding by selective muscarinic
antagonists in toad gastric smooth muscle.
Representative binding curves for the displacement of 1 nM (3HJQNBby selective antagonists. Panel A. uares: Displacement curve for the
nonselective antagonist atropine. Atropine interacted with a single
class of high affinity receptors (KD = 4. 48 nM, pseudo-Hill slope =
-1. 04; n=2). Circles: Displacement curve for the Ml-se1ective
antagonist pirenzepine. Pirenzepine interacted with a single class of
low affinity receptors (KD = 330 nM pseudo-Hill slope = - 0. 95;
n=3). Panel . S uares: Displacement curve for the M3-selective
antagonist 4-DAMP. 4-DAMP binding was best described by an interaction
with a mixed population of receptors: 83% of the receptors displayed a
high affinity (KD = 4. 92 nM) and 17% of the receptors had a low
affinity (KD = 204 nM) for the antagonist (pseudo-Hill slope = - 0. 58;
n=3). Circles: Displacement curve for the M2-selective antagonist
AF-DX 116. AF-DX 116 interacted with two classes of receptors, a smallpopulation (20%) that bound with a high affinity (KD = 3. nM) and alarger population (80%) that bound with low affinity (4. 41 pMpseudo-Hill slope = - 0. 45; n=3).
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Table 5. Binding Characteristics of Selective Muscarinic Receptor
Antagoni sts.
Pi renze i ne AF-DX 116 4-DAMP
(n = 3) (n = 3) (n = 3)
IC50 (nM) 769 :! 327
- 0. 93 :! 0.
4250 :! 2340
- 0. 46:! 0. 08*
27. + 4. 6 nM
Slope - 0. 73 :! 0. 06*
KH (nM)
KL (nM)
37:! 9. 21** 7 . 00 + 1. 4 **
267 :! 3500:! 350 600 + 332
13%
87%
88%
12%100%
Values are the Mean :! SE for the number of experiments indicated inparentheses. IC50 and slope values were obtained by individual
analysis of each curve using the ALLFIT curve fitting program. KH,
RH; KL, RL: dissociation constants and percentage of receptors inthe high and low affinity states respectively, determined by 
non- l i near east squares curve fitti ng program, LIGAND.
* Statistically significant difference from unity (P 
05).
** A two-state model was accepted only if it significantly improved the
fit over a one-state model using the F-test (P 001).
were present. The majority of receptors exhibited high affinity for
4-DAMP and low affinity for both AF-DX 116 and pirenzepine and thus were
classified as M The remaining small population of receptors
exhibited high affinity for AF-DX 116 and low affinity for both 4-DAMP
and pirenzepine and thus were classified as
To examine the coupling of muscarinic receptors to G proteins, the
binding of the muscarinic agonist oxotremorine was determined in the
absence and presence of the non-hydrolyzable GTP analog, GTPyS (Figure
16) . In the absence of guanine nucleotide, the oxotremorine displacement
2000
1500
1000
500
- -. -.--- -- - .. - - - --..
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Fi ure 16. Oxotremori ne Di sp 1 acment of (3H )QNB in the Presence or
Absence of GTPyS.
Plasma membranes from toad stomach muscle were incubated for 60 min
at C in the presence of 1 nM 3H-QNB and the indicated concentrations
of oxotremorine. Representative experiment illustrating oxotremorine
displacement curves in the absence (squares) and presence (X' s) of 100
pM GTPyS. In the absence of GTPyS, the oxotremorine displacement
curve could best be described by assuming the agonist 
interacted with two
species of muscarinic receptors, a small population (29%) of high
affinity receptors (KD = 11. 7 pM), and a larger population (71%) of low
affinity receptors (KD = 3. 42 pM, pseudo-Hill slope = - 0.44). 
the presence of GTPyS, essentially all of the receptors were converted
to the low affinity state (KD= 3. 67 pM, pseudo-Hill slope = - 0. 86.
Similar results were obtained in 5 additional experiments.
curves exhibited a pseudo-Hill coefficient of - 0.49 while in the
presence of GTPyS the coefficient was not different from unity (Table
6) . Analysis of the binding isotherms with the LIGAND program indicated
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Table 6. Effects of Guanine Nuc1eotides and Pertussis Toxin on
Oxotremorine Binding.
Oxotremorine
(n = 6)
+ GTPyS
(n = 5)
+ Pertussi s Toxi 
(n = 4)
12. 25 + 0.IC50 (pM) 47 + 2. 32 .: 1.
- 0. 86 .: O. - 0. 93 + 0.Slope - 0. 49 + 0. 03*
KL (pM)
.: 4. 11 nM**
.: 0. 01 + 0. 93 .: 0.
24%
76% 100% 100%
Values represent Mean .: SE for the number of experiments indicated 
parentheses. See the legend to Table 1 for explanation of the terms and
details of the analysis.
* Statistically significant difference from unity (P 05).
** A two-site model was accepted only if it significantly improved the
fit over a one-site model , using the F-test (P 001).
that the binding of oxotremorine in the absence of GTPyS could best be
described by the interaction with two populations of receptors: 24%
exhibiting a high affinity, KD = 4. :! 4.'11 nM and 76% exhibiting a
low affinity, K = 4. :! 0. 66 pM. In the presence of GTPyS,
oxotremori ne binding could be best described by interaction with a
single class of receptors with low affinity (KD = 3. 01 :! 0. 27pM).
Since the nucleotide had no effect on the affinity of QNB or on the
tota 1 number of bi nd i ng sites (data not shown), the GTP-dependent loss
of high affinity agonist binding may reflect the conversion of a high
affinity receptor state to a low affinity state. This sort of shift in
receptor affinity is a hallmark for receptors coupled to G proteins.
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The coupling of gastric smooth muscle muscarinic receptors to G
protei ns al so i nvesti gated exami nati on effectsthewas
pertussis toxin on agonist binding. As shown in Figure 17A, pertussis
toxin pretreatment of the membranes caused the ( p)NAD ribosylation
of a single, 37-41 kD protein band detected by one-dimensional SDS-gel
e 1 ectrophores is membrane protei ns exami ne the effects
pertussis toxin on agonist binding, membranes were incubated with NAD in
the absence and presence of the toxi n. In control membranes, the
oxotremorine displacement curve had a pseudo-Hill coefficient of less
than 1 and could best be described by interaction with high and low
affinity receptors (Figure 17 and Table 6). Conversely, the binding of
oxotemori ne to membranes reacted with pertuss is toxi n was best descri bed
as an interaction with one, low affinity site (Figure 17 and Table 6).
Since the toxin did not alter the total number of binding sites , these
results indicate that the toxin like GTP , may shift the state of
receptors from high to low affinity.
DISCUSSION
The present studies descri be the characteri sti cs muscarinic
receptors and thei coup 1 i ng to G protei ns in toad gastri smooth
muscle. Nearly all of the binding of the nonselective muscarinic
antagonist ( HJQNB could be displaced by atropine and was therefore
termed specific. The binding of ( HJQNB was best described by 
interaction with homogeneous populati on receptors with
dissociation constant of 423 pM. Thi s estimate for the K value
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ure 17. Effects of Pertussis Toxin on Gastric Smooth Muscle
Muscarinic Receptors.
Membranes were pretreated with pertussi s as descri bed in Methods. Panel
8.. Autoradiograph of smooth muscle membranes reacted with 
(32p)NAD in
the absence (Lane 1) and presence (Lane 2) of pertussis toxin for 60 min
at 30 C. Labelled proteins were separated by SDS-PAGE on a 10% gel.
Molecular weight markers: 35 kD - porcine stomach pepsin; 45 kD - egg
albumin. Pertussis toxin catalyzed the ribosylation of singledistinct band with molecular weight of 37-41 kD. Panel 
Oxotremorine displacement of (3H)QNB binding in control (squares) and
pertussi s-treated (ci rc 1 es) membranes. In untreated membranes
oxotremorine recognized two classes of receptors: a small population
(19%) with a high affinity (3. 22 nM) and a larger population (81%) with
a low affinity (3. 62 pM) for the agonist (pseudo-Hill slope = - 54).
Pertussis toxin pretreatment converted all of the receptors to the low
affinity state (KD = 3. 66 pM, pseudo-Hill slope = - 1.08). Similar
results were obtained in four additional experiments.
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agreed well with those reported previously for smooth muscle and other
tissues, as did our estimate for receptor density (Akhtar et al. , 1987;
Rinner et al. , 1988). The displacement of specific ( HJQNB binding by
the selective muscarinic receptor antagonists pirenzepine , AF-DX 116 and
DAMP was used to characterize further the binding properties of
muscarinic receptors in gastric smooth muscle. Pirenzepine , which binds
with high affinity to M receptors but with low affinity to M
2 and
receptors, interacted with a single population of receptors with
low affinity (KD = 267 nM, Figure 15 and Table 5). The lack of high
affinity pirenzepine binding indicates that the receptors are either
The conclusion that smooth mu s c 1 e conta ins few
receptors is in agreement wi th the resu ts obtained wi th porc i ne gastri c
smooth muscle (Herawi et al. , 1988), rabbit iris smooth muscle (Akhtar
et al. 1987), and with the IC50 values reported
inhibition of acetylcholine-induced contraction
for pi renzepi ne I s
gui nea pig
longitudinal smooth muscle (Grider et al., 1987).
Displacement of ( HJQNB binding with the M selective antagonist
AF-DX 116 and the M selective antagonist 4-DAMP demonstrated the
presence of a heterogeneous population of receptors. The majority of
receptors displayed a low affinity for AF-DX 116 and a high affinity for
4-DAMP, and on this basis could be classified as M receptors (see
Doods et al., 1987). The remaining receptors (11-12 %) displayed high
affinity for AF-DX 116 and low affinity for 4-DAMP and could therefore
be classified as M receptors (Figure 15 and Table 5). It 
noteworthy that both 4-DAMP and AF-DX 116 detected a nearly identical
proportion of M
3 and M2 receptors.
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While a heterogeneous population of muscarinic receptors has been
reported for guinea pig ileum (Giraldo et al., 1987; Giraldo et al.
1988; Ladinsky et al., 1988;), rat urinary bladder (Ladinsky et al.
1988) and pig coronary smooth muscle (Rinner et al., 1988 ), these
tissues exhibit a much higher proportion of M receptors than M
receptors. The explanation for this difference in receptor distribution
is unknown but may reflect differences amongst species or tissue types.
It would be of interest to establish whether significant differences 
physiological are mani fest cell types with differentresponses
subtypes of receptors.
Clearly, most of the muscarinic receptors in toad stomach muscle are
subtype. The ocati on of the sma 11 populationthe
receptors is not well defi ned. These receptors may exist in low numbers
on all smooth muscle cells; they may occur in relatively high numbers on
small subpopulation of smooth muscle cells (eg. pacemaker cells); or
they may be localized on nonmuscle cellular elements within the tissue
(eg. presynapt i c nerve end i ngs , Ki lbinger . and Nafziger, 1985). The
latter possibility seems unlikely for several reasons. For one , a
heterogeneous population (70% M and 30% M ) of muscarinic receptors
was also observed in binding studies using homogeneous suspensions of
di spersed canine gastri c smooth musc 1 e ce 11 s (Collins and Cranshaw
1986) . Second 1 y, receptors constitute the majority of receptors
present in a number of other smooth musc 1 e types.
A heterogeneity in agonist as well as antagonist binding was also
observed stomach musc 1 e finding that 1 i ke 1 ymembranes,toad
refl ects the interaction receptors with endogenousstate 
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protei ns. In other ti ssues receptors coupled to G proteins exhibit
high affi nity for agoni st wh i 1 e uncoup 1 receptors exhi bit low
affi nity. The addition of GTP or its analogs leads to the dissociation
of receptors from G proteins, thereby shifting those receptors to the
low affinity state. This GTP-dependent shift in agonist affinity has
been demonstrated for virtually all types of receptors coupled to G
protei ns, including muscarinic receptors in rat forebrain and ileum
(Birdsall et al., 1978), and rat heart (McMahon and Hosey, 1985).
simi lar GTP-dependent shift in agonist affinity was observed in the
present studies using toad gastric smooth muscle. In the absence of
added guanine nucleotide, approximately 25% of the receptors exhibited
high affinity for the agonist oxotremorine (Fig. 16, Table 6). ' The
addition of GTPyS abolished all high affinity binding and produced a
proportional increase in the number of receptors with low affinity. 
Studies using pertussis toxin provided additional evidence for the
existence of G proteins coupled to muscarinic receptors in toad gastric
smooth musc 1 e. In other cell types, pertussis toxin has been shown to
ADP-ri bosyl ate the s ubuni ts of severa 1 G protei ns, including 
and G (Nathanson, 1987).
of receptors wi th the G protei ns and therefore shi fts these receptors to
This ribosylation prevents the interaction
the low affinity state for agonist. In toad gastri smooth musc 1 e
membranes, incubation of membranes with pertussis toxin and ( p)NAD
led to the ribosylation of a protein band with a molecular weight
similar to the subunits of 6. anf G (see Figure 17). Moreover,
this treatment shifted receptors with high affinity to low affinity
( Fi 9 . 17). Si nce pertussi s toxi n and GTPyS treatment produced similar
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effects on the affinity of muscarinic receptors , it appears likely that
(a) GTP binding protein(s) couple(s) to muscarinic receptors in toad
gastri c smooth musc 1 e.
The identity of the G protein(s) coupled to muscarinicexact
receptors in these membranes is as yet unknown, but it ; s i nteresti ng to
note that all of the receptors were shifted to the low affinity state by
these treatments. Thi s suggests that M and M receptors may both
be coupled to G protein(s) in a pertussi s sens iti ve manner, although
some uncertainty remains as to the coupling state of the M2 receptors
which constitute only 12% of the total receptor population. In any
case the data provi de the most convi nc i ng evi dence to date for the
coupling of M to G protei ns. (Note however, that onereceptors
previous report by Merritt et al. , 1986 , did demonstrate the coupling of
prate; ns muscarinic that has subsequentlybeenreceptor
identified as an M3 receptor).
The conclusion that toad smooth muscle contains two subtypes of
muscarinic receptors both of which appear to be coupled to G proteins in
a pertussis-sensitive manner leaves unresolved the biological basis for
the di versi ty of responses to muscari ni c agoni sts. As ment i oned above
muscarinic activation of toad gastric smooth muscle elicits changes 
both phospholipid metabolism (Salmon and Honeyman, 1980) and in membrane
permeability to K and ca2+ (Sims et a1. 1986; Vivaudou et al.
1988) ; and available data the literature have not resolved the
selectivity receptors for these physiologicalversus
responses. Changes in phospholipid metabolism were reportedly mediated
by M
2 receptors in 
rabbit iris smooth muscle (Akhtar et al., 1987) and
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rat parietal cells (Pfeiffer et al., 1988) but appeared to be mediated
by M receptors in neurob 1 astoma ce 11 s (Fi sher and Heacock 1988).
There also remains some question as to the involvement of G proteins in
mediating all of the observed physiological responses to muscarinic
agents. Data obtained in cardiac tissue suggested that free (uncoupled)
receptors mediate the observed activation of phospholipase C by
muscari ni c ( McMahon and 1985) . There a1 so someagents Hosey,
questi on whether the muscari ni c- i nduced ionchanges
permeabil ity di rect secondary changes phospho 1 i pi dare
metabolism since diacylglycerol mimicks the effects of acetylcholine on
the Ca current in toad gastric smooth muscle cells (Vivaudou et al.,
1988) . Whi le questions such as these remain , the present study provides
the information necessary for designi ng experiments to deli neate the
receptor subtypes and G proteins that are responsible for each of the
known physiological responses to muscarinic stimuli.
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Chapter VI I
Muscarinic Receptor Subtypes and G Protein Coupling
in Airway Smooth Muscle
I NTRODUCTI ON
It has long been recogni zed that the acti vation of muscari nic
cholinergic receptors in smooth muscle, including airway smooth muscle
(Nadel, 1984), leads to contraction, presumably y 1ncreaslng a
availability the contracti 1e machi nery. Thi s increase
intracellular Ca results f rom a concerted action cholinergic
agoni sts number biochemical and physiological processes
including inositol phospholipid and cyclic AMP metabolism, ion channel
conductance i ntrace 11 u1ar ca2+ release and ca2+ transport (see
Nathanson, 1987 for a revi ew) .
The by whi ch c h 0 1 i n e rg i c s t i mu 1 i produce such di versema n n e r
physiological and bi ochemi ca 1 rema ins unclear. Severa 1responses
possibilities have been suggested. Multiple subtypes of the muscarinic
receptor have been described in many tissues including airway and other
types of smooth muscle (Mitchelson, 1988). It is possible that these
distinct subtypes regulate different bi ochemi ca and physiological
signalling pathways (Ashkenazi et al. , 1987 , 1989; Peralta et a1., 1987;
Fukuda et al., 1988). Thus, the diversity of response in smooth muscle
may reflect the presence of multiple receptor subtypes. Alternatively,
since muscarinic exert effects through number ofreceptors can
different GTP binding proteins (G proteins), it is possible that the
diversity of response in smooth muscle reflects the interaction of the
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muscarinic receptor with more than one type of G protein.
The present studi es initiated define thesomewere
characteristics of the muscarinic receptors in airway smooth muscle and
their coupling to G proteins. Previous studies studies have suggested
that more than one subtype of muscari ni c receptor may be present in
trachea (Roffe1, et al., 1987, 1988), but because the studies utilized
membranes prepared from tissues , the exact cellular distribution of
these receptors (eg. on smooth muscle cells and/or on other cellular
elements within the tissue) was not clear. Furthermore, the extent and
nature of the coupling of receptors to G proteins in airway smooth
muscle has not been defined. Thus, the present studi es exami ned the
subtypes of muscarinic receptors and their coupling to G proteins in
membranes and isolated cells prepared from bovine trachea. The results
of these studies indicate that at least two subtypes of muscarinic
receptor are present and that these receptors may interact with more
than one type of G-protei n.
Preliminary reports of some of these results have been presented
(Lucchesi, et al., 1989). In addition, this work has been submitted for
publication to the American Journal of Physiology.
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METHODS
Fresh bovi ne trachea were obtained f rom a 1 oca 1 abattoi r and
transported to the laboratory in ice cold mammal ian Krebs-Ringer (MKR)
containing 118 mM NaC1, 4. 6 mM KC1, 24 mM NaHC03' 1. 21 mM 
16 mM MgS04' 2. 5 mM CaC1
and 11 mM glucose. The smooth muscle
layer was dissected from the cartilage, trimmed of mucosa, connective
tissue and fat and minced with scissors in ice cold homogenization
buffer containing 50 mM 3-(N-morpholino)propane-sulf ic acid (MOPS), pH
1, 150 mM NaCl, 5 mM EDTA, 1 mM dithiothreitol (DTT), 17 pg/ml of
pheny1methy1sulfonyl fluoride and 10 pg/ml soybean trypsin inhibitor.
All subsequent procedures were performed at 4 o The ti ssue was then
homogenized in 20 volumes of buffer in a Waring blender (2 x 30 sec at
low speed) and further d is rupted with an Ultraturrax t i ssuemi zer (an
initial 25 sec burst with a SDT-182EN probe followed by a 25 sec burst
with a SDT-100EN probe). The crude homogenate was filtered through gauze
and disrupted twice cavitation (20 min at 1400 psi).by nitrogen
Cellular debri s and mitochondria were removed by two, low speed
centrifugation steps: 20 min at 5000 x g followed by 10 min at 10, 000 x
The supernatant from this spin was centrifuged at 30, 000 x g for 90
min. The resultant microsomal pellet was resuspended in homogenization
buffer containing 0. 6 M NaC1 (to solubilize and effectively remove
contaminating contractile proteins, see Lucchesi et al , 1988) and the
membranes again harvested by centrifugation at 30, 000 x g for 90 min.
The membrane pe 11 et was then resuspended in storage buffer (250 mM
sucrose, 40 mM MOPS, pH 7. 1, 1 mM DTT and 10 pg/m1 1eupeptin), rapidly
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frozen in liquid nitrogen, and stored at -80 Protei n content was
measured the bicinochoninic acid ( BCA) protei n reagentassay
described by Redinbaugh and Turley (1986).
Cell Pre aration.
Suspensions of isolated tracheal smooth muscle cells were prepared
modification procedures previously described (Yamaguchi and
Grayce, 1989) . Briefly, the smooth muscle layer of the trachea was
dissected free of cartilage, mucosa, connective tissue and fat , and cut
into sma 11 segments wi scissors. Thi s mi nce was then incubated at
0 C for 60 min in MKR with ci+ reduced to 0. 625 mM at a ratio of
1 g mince / 5 ml buffer. The buffer contained collagenase (1. 6 mg/ml,
Boehringer Mannheim, Type D or Sigma Chemical, Type V), elastase (0.
mg/ml, Sigma Chemical, Type II), and hyaluronidase (1. 5 mg/ml, Sigma
Chemical). The partial digest was collected by filtration on a 1 mm
mesh Teflon filter, rinsed with reduced Ca -MKR containing 0.
albumin and suspended in reduced Ci+-MKR containing 0. mg/m1 ATP at
a ratio of 5 ml buffer/g of original mince. After incubation at 32
0 C
for 15 min, the isolated smooth muscle cells were harvested by 
filtering
the digest through a 1 mm Teflon filter. This procedure yielded a
suspension of approximately 2 X 10 cells/ml.
were long and thin and appeared to be relaxed.
About 75% of the cells
Preparations in which
less than 50% of the cells were relaxed were discarded.
descri bed deta i elsewhere (Yamaguchi, 1988) , isolated
trachea 1 smooth muscle cells reversibly contracted in response to
agonists, histamine or elevated extracellular (K
). 
The
resting membrane potential and intracellular (c ) similar
muscari ni c
cells had
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to values determined in intact strips of muscle.
Muscari ni c Chol i ner ic Rece tor Assa
Muscarinic cholinergic binding was determined from the binding of a
non-selective antagonist, ( H)quinuclidinyl benzilate (QNB) to cells
and described previously for gastric smooth mu s c 1 emembranes
(Lucchesi et al, 1989). The apparent affinity for QNB was calculated
from curves relating the amount of ( H)QNB bound as a function of QNB
concentration (over a range from 0. 01 to 7. 0 nM). Nonspeci fi c bi ndi ng
was defi ned as the amount of ( H)QNB bound in the presence of 100 pM
atropine and generally represented less that 5% of total binding.
The binding constants for unlabelled ligands were estimated from
curves relating di sp 1 acement H)QNB increasingthe
concentrati ons the ligands. For these studies QNB was added
concentrat ion near the estimated (0. nM). Binding assays
membranes were carried out fi na 1 vo 1 ume buffer
consisting of 50 mM MOPS, pH 7. 1, 10 mM MgC1 2' 50 mM NaCl and 2 mM
EDTA. Binding reactions were initiated by adding 15 
pg 
membrane
protein and were terminated after incubating for 60 min at 31 C. For
cells, the binding reactions were carried out in a total volume of 3 ml
in MKR supplemented with 25 mM HEPES, pH 7.4. These reactions were
initiated by the addition of 2-3 x 104 cells and were terminated after
30 min incubation at 20-22 o These conditions were chosen to
minimize the amount of cell associated ( H)QNB that could come about
as a consequence of receptor internalization. In both membrane and cell
experiments, bound HJQNB was separated from free fi ltration
through Whatman GF/F filters presoaked in 0. 1% BSA. The filters were
1) 6
then washed four times with 3 ml aliquots of ice-cold HEPES-buffered MKR
(cells) or ice-cold buffer containing 50 mM MOPS, pH 7. , 5 mM MgC1
or 25 mM NaCl (membranes). The filters were placed in vials containing
5 mls of scintillation fluid (Optifluor, Packard Instrument Co. ) and the
radioactivity was quantitated by liquid scintillation counting at 45%
efficiency.
ADP-Ri bos ati on b Pertussi s Toxin.
p)NAD ribosylation of membranes catalyzed by pertussis toxin
was determi ned modification the procedure descri bed
Ri bi ero-Neto li. (1987). Incubations were carried out for 60 min at
C in final volume of 60 p containing 35 pg protein 20 mM
Tris, pH 7. 5, 10 mM thymidine, 1 mM EDTA, 30 pg/ml BSA, 1. 75 mM DTT, 2
mM ATP, and 10 pM ( pJNAD (5 x 10 cpm/assay) in the absence and
presence of 1 pg pertussis toxin. NADP (0. 5 mM) was included in the
reaction decrease the nonspecific hydrolysis pJNAD
glycohydro1ases. Pertussis toxin was preactivated by incubation at a
concentration of 10 pg/ml for 20 min at 32 C in the presence of 25 mM
DTT. Reactions were initiated by the addition of ( p)NAD and were
stopped by the addition of 500 pl of ice-cold 0. 2 mM NAD. Membranes
were harvested by centrifugation for 10 min at 14,000 rpm in 
Eppendorf microfuge, dissolved in 100 p1 of Laemlli' sample buffer
and separated by one dimensional sodium dodecy1 sulphate polyacrylamide
gel electrophoresis (SDS-PAGE) in 10% gel slabs. The gel slabs were
stained with 0. 2% Coomassie blue, dried under vacuum and the 32
labelled proteins were detected by autoradiography (24-48 hours using
Kodak XR-S fi 1m) 
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To determine the effects of pertussis toxin pretreatment on agonist
binding, membranes were incubated for 2 hr at 32 0 C in reaction
mixture containing 20 mM Tris, pH 7. 5, 1.2 mM thymidine, 1 mM ATP , 16
pg/ml BSA, 2. 5 mM DTT, 1 mM EDTA, and 1 mM NAD in the absence or
presence acti vated pertussis toxin ( 20 pg/mg protein) . The
reaction was stopped by addition of 10 volumes of ice-cold buffer (250
mM sucrose, 40 mM MOPS, pH 7. 1), and the membranes were collected by
centrifugation in a Ti60 rotor at 40 000 rpm for 90 min at 4 C and
resuspended in the buffer for binding studies as described above.
Data Ana s is.
Data from binding experiments were analyzed using the LIGAND program
(Munson and Rodbard, 1980) , an analysis that employs an iterative
nonlinear least approach for curve fitting, and the ALLFITsquares
program (De Lean et al. 1978), an analysis that uses a four-parameter
logistics equation to obtain estimates of the IC 50 and the 
pseudo-Hill
coefficient (n
)' 
If binding curves had pseudo-Hill coefficients
significantly less than unity (p" 0. 05 one-tailed Student1 s t-test), it
was assumed to reflect interaction of the ligand with more than one
class of binding sites. Evidence for the interaction of the ligand with
more than one class of binding sites was also obtained by analyzing the
data with the LIGAND program. From this analysis, a two-site binding
model was selected over a one-site model when a significant reduction in
the residual sum of squares (F test , p " 0. 05 ) was obtained. This
analysis also provided estimates for binding constants and proportions
of each receptor class which best fit the observed binding curves.
Estimates for K and proportion of each class of binding site are
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presented as means 1: SEM but, because both the binding affinity and
the relative proportion of receptor classes are highly interdependent
and log norma 11 y d i stri buted, calculated onlythese errors are
approximations and are not useful for traditional statistical analysis.
Materi a 1 s
H)QNB (45 Ci/mmol) and (
p)-
NAD (800 Ci/mmol) were purchased
from New England Nuclear.
ami no-methyl) - pi peri d i nyl 
Pirenzepine and AF-DX 116 ((l1-((diethyl-
acetyl - ll-dihydro-6H- pyrido(2, 6)-
(1, 4 benzodiazepine-6- one) were generous gifts of Dr. Karl Thomae,
GmBH, supplied through Boehri nger Ingelheim. DAMP (4-diphenyl-
acetoxy-N-methyl-pi peri di ne methobromi de) was purchased from Research
Bi ochemi ca 1 s. Pertussis toxin was obta i ned from Lis t Biologicals.
GTPyS (guanosine- -0-(3-thiotriphosphate)) was purchased from either
Boehringer-Mannheim or Sigma Chemical. Oxotremori ne, eupepti n and DTT
we re from Sigma. Atropi ne was purchased from Mall i nckrodt. A 11 other
chemicals were of reagent grade. We obtained a version of the LIGAND
program compatible with an IBM PC from P. J. Munson and M. Beveridge.
RESUL TS
The binding of ( H)QNB to membranes and isolated cells prepared
from tracheal smooth muscle are shown in Fig. 18 and Fig. 19. In both
cells and membranes, the saturation isotherms were best described by an
interaction of ( H)QNB with a single class of binding sites.
119
.15
0 10 20 30 40 50 60
BOUND
1000 2000 3000 4000 5000 6000
TOT AL QNB (pM)
Figure 18. (3HJQNB binding to membranes prepared from tracheal smooth
muscle.
Representati ve experiment in whi ch vari ous concentrati ons of (3H )QNB
were incubated with 15 pg of membrane protei for 60 mi n at 31 o
Specific binding (squares) was defined as the difference between total
binding (circles) and nonspecific binding (Xi s) observed in the presence
of 100 pM atropine. Nonspecific binding varied as a direct function
of the concentration of QNB , and represented less than 2-3% of total
binding at QNB concentrations equal to the equilibrium dissociation
constant (KO)' Inset: Scatchard transformation of the specific
binding. Analysis of the data with the LIGANO program indicated that
QNB binding could be described by interaction with a single class of
binding sites with a KD of 232 pM and a Bmax of 2. 86 pmol/mgprotein. Similar data were obtained from three additional experiments.
membranes the average equi 1 i bri um di ssociati on bi ndi ng constant (K
was 176 :t 33 pM and the number of binding sites (B ) was 4. 31 :t
max
pmol/mg (n=4). In isolated cells, the KD averaged 234 :t 42 pM
and the density of sites was 2. 61 :t 0. 65 x 10 sites/cell (n=4).
Nonspecific binding represented 2-3% of the total binding at the KD in
both cells and membranes.
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Figure 19. (3HJQNB binding to isolated smooth muscle cells prepared
from bovi ne trachea.
Representati ve experiment in whi ch vari ous concentrat ons of (3H )QNB
were incubated wi th 26, 000 cell for 30 mi n at room temperature.
Specific binding (squares) was defined as the difference between total
binding (circles) and nonspecific binding (Xi s) observed in the presence
of 100 pM atropine. Nonspecific binding varied as a direct function
of the concentration of QNB and represented - 2% of total binding at
QNB concentrations equal to the KD' Inset : Scatchard transformation
of the specific binding. Analysis of the data with the LIGAND program
indicated that QNB binding could be described by interaction with a
single class of binding sites with a KD of 175 pM and a Bmax of 1.
106 sites/cell. Similar data were obtained in three additional
experiments.
To characteri ze muscari ni c subtypes in tracheal smoothreceptor
musc 1 e exami ned the displacement H)QNB binding the
non-selective muscari ni c antagonist atropine and the selective
antagon i sts, pi renzepi ne, AF-DX 116 and 4-DAMP. These se 1 ecti ve
antagoni sts have been used characteri ze the subtypes the
muscarinic receptor in previous functional and receptor binding studies
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(Hammer et a1. 1980; Hammer and Gi achett i , 1982; Giachetti et al.,
1986) . For example Dood s (1987) and others (1986 ) haveet a 1 .
classified muscarinic receptors as Ml' M and M based on studies
with the selective antagonists , pirenzepine , AF-DX 116 and 4-DAMP. M
receptors, characteristic of muscarinic in brain, have areceptors
higher affinity for pirenzepine (KD of 1-20 nMolar) than for AF-DX 116
of 700-800 nM). M receptors, characteristic of muscarinic
receptors in cardiac tissue , have a higher affinity for AF-DX 116 (K
of 50-100 nM) and 4-DAMP (KD of 20 nM) than for pirenzepine (KO of 
pM) . M
3 receptors
characteri stic of muscari nic receptors in
glandular tissues, have a higher affinity for 4-DAMP (KO of 1-2 nM)
than for AF-DX 116 (KD of 2- pM) or pirenzepine (K of 0. 7-1
pM). Thus pirenzepine exhibits a 50 fold selectivity for M over
and M receptors. AF-DX 116 exhibits a 30 selectivity for M
over M and M receptors and 4-DAMP exhibits a 10 fold selectivity
for M over M receptors. Representati ve di sp lacement curves for
atropine, pirenzepine, AF-DX 116 and 4-DAMP in membranes are found in
Fi gure 20. The estimates of the binding constants and pseudo-Hill
coefficients obtained from composite analysis of 3-6 such experiments
are presented in Table Analysis of the composite displacement curve
for atropi ne indicated a pseudo-Hi 11 coefficient not significantly
different from 1. 0 (nH = - 99), thus indicating an interaction with a
single class of binding sites. When analysed with the LIGAND program,
the atropine displacement curve was best described by an interaction
with a single class of sites with an apparent KD of 3. 8 ! 0. 3 nM.
15 
15 
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Figure 20. Displacement of (3H)QNB binding by muscarinic antagonists
in tracheal smooth muscle membranes.
anel. Circles: Representative displacement curve for the
nonselective antagonist atropine. The atropine displacement curve had a
pseudo-Hill coefficient near unity (nH = - 98) and was best decribed
by an interaction with a single class of binding sites with a KD 36 nM. uares: Representative displacement curve for the
M1-se1ective antagonist, pirenzepine. The displacement curve for
pirenzepine had a nH = - 94 and was best described by an interaction
with a single class of binding sites with a KD of 1. 17 pM. Bottom
panel Circles: Displacement curve for the M3-selective antagonist
4-DAMP. The displacement curve for 4-DAMP had a nH of - 95 and was
best described by an interaction with a single class of binding sites
with KD of 14. nM. uares: Displacement curve for the
M2-selective antagonist , AF-DX 116. The displacement curve for AF-
116 had a nH significantly less than 1 (- 74) and could best be
described by an interaction with two classes of binding sites , with 76%
of the total binding having high affinity (KD = 113 nM) and 24% having
low affinity (KD = 1. 02 pM). The data are representative of 3-
experiments for each antagoni st.
1 ,
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Table 7. Bi ndi ng characteri sti cs of muscari ni c receptor antagoni sts
to tracheal smooth muscle membranes.
Atropi ne
( n=3 )
Pi renzepi ne
(n=3 )
AF-DX 116
(n=6 )
4-DAMP
(n=3 )
IC50 (nM) 10. 1 :! 0. 2970 :! 400 563 :! 64 43. 4 :! 3
Slope 99 :! 0. 88 :! 0.
1 , 11 0 :! 60
0 . 7 7 :! O. 05* -0. 9 5 :! O. 1
KH (nM) 8 :! 0. 129 :! 35** 16. 4 :! 3
100% 100% 85% 100%
KL (pM) :! 1.5
15%
Values are the Mean :! SEM for the number of experiments indicated 
parentheses. IC50 and slope values were obtained by simultaneous
analysis of each curve using the ALLFIT program. KH, RH, KL,
RL: dissociation constants and percentage of receptors in the high and
low affinity sites , respectively, determined by composite analyses using
the nonlinear least square curve fitting program, LIGAND.Statistically significant difference from unity 
(p 
05) using
one-tai 1 ed Student 1 t test.
** 
A two site model was accepted only if it significantly improved the
fit over a one site model using the F test (p 
001).
The displacement curves for the M selective antagonist
pirenzepine were also best described as an interaction with a single
class of binding sites (n = - 88 ) and the composite curve could be
fit to a single site model with an apparent KD = 1. 11 :! 0. 06 pM.
Simi larly, the di splacement curves for the M se 1 ecti ve antagoni st
DAMP were consistent with an interaction with a single class of sites
H = - 95 ) and the composite curve could be fit to a 
single site
model with an apparent KD of 16.
4 :! 3 nM.
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The shape of displacement curves obtained with the M -selective
antagoni st AF-DX 116 suggested the presence of more than one c lass of
binding sites for this antagonist. A curve representative of 4 of 
experiments is presented in Figure 20 (lower panel). Thi s curve has a
H significantly less than 1.0 (- 74) indicating that the ligand may
interact with more than a single class of binding sites. The AF-OX 116
displacement curve was best fit by assuming interaction with two sites;
76% of the sites with a KD of 113 nM and the 
rema i nder with a KO of
1 . 02 pM. In the remaining two experiments the displacement curves
could be fit to a model assuming a single calss of binding sites. When
the data from all 6 experiments were ana1ysed, the nH was sign:f)cantly
less than unity (Table 7) and the composite curve could best 
described by interaction of the ligand with two classes of binding
sites, 84% having high affinity (KO = 129 :t 35 nM) and the remainder
having lower affinity (KD = 2. :t 1. 5 pM).
In intact cells, the displacement curves for ( H)QNB by 4-DAMP and
AF-DX 116 were similar in character to those observed in membranes.
Representati ve curves for 1 ndi vidua 1 experiments are presented in Figure
21 and estimates of binding parameters calculated from composites of all
experiments are presented in Table The binding of 4-DAMP to intact
cells could be explained by interaction with a single class of receptors
H = - 88 ) with an apparent KD similar to that observed for
interaction with tracheal membranes (20 nM vs 16 nM). As was the case
for membranes, the displacement curves for AF-DX 116 binding to cells
could not always be fit by assuming interaction with a single class of
binding sites. In three of six experiments conducted with isolated
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Figure 21. Displacement of (3H)QNB binding by the muscarinic
antagonist , 4-DAMP and AF-DX 116 in isolated tracheal
smooth muscle cells.Circles: Representative displacement curve for the M3-s lective
antagonist 4-DAMP. The displacement curve for 4-DAMP had a nH not
different from 1 (- 88) and was best described by an interaction with a
single class of receptors with KO of 21. nM. uares:
Representati ve di splacement curve for the M2-se 1 ecti ve antagoni st
AF-DX 116 that was best fit to a one-site model. The displacement curve
had a nH not different from 1 (- 03) and was best described by an
interaction with a single class of binding sites with a KD of 89 nM.
Trian les: Representative displacement curve for AF-DX 116 that wasbest f to a two-site model. The displacement curve had a 
significantly less than 1 (- 66) and was best described by 
interaction with two classes of binding sites; a large population (80%)
having a KO of 54 nM and a small population (20%) having a KD of 1.
pM.
cells, the AF-DX 116 displacement curves had pseudo-Hi 11 coeffi c i ents
significantly less than 1. 0 and these curves were best fit as the sum of
binding to a large number of high affinity sites and a small number of
low affinity sites. In the remaining experiments, nH values were less
,- k' "
. ""., ;;. - -
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Table 8. Binding characteristics of selective muscarinic
antagonists to tracheal smooth muscle cells.
receptor
AF-DX 116
( n=6 )
4-DAMP
(n=3 )
IC50 (nM) 197 :t 45. 1 :t 
Slope
KH (nM)
84 :t 0. 04* 88 :t O. 1
93. 6:t l' nM**
KL (nM)
97%
290 :t 2, 040 19. 11.
100%
Values represent mean 1 SEM for the number of experiments indicated in
parentheses. See the legend to Table 1. For explanation of the terms
and details of the analyses.Statistically significant difference from unity 
(p 
05) using
one-ta i 1 ed Student 1 t test.
** The curve obtained from composite analysis is best fit to a 2 site
model (p 00' , F test). Curves from individual experiments were best
fit to a l-site model (3 of 6 experiments) or a 2-site model with 10-20%
of the sites having low affinity for agonist.
than unity but not significantly so and the displacement curves could be
fit to a single site model. Examples of each type of result are
presented in Fi g. 21. When data from all experiments were analysed , the
composite nH value was significantly less than 1. 0 (- 84), and the
composite curve was best fit as a sum of binding to a large number of
sites with a K of 94 nM and a small number of sites with a K 
pM. As shown in Figure 21, since the second class of binding
sites represents only a small fraction of the total , their contribution
to the overall binding curve is corresponding small. Furthermore , the
ability to detect such sites will be variable and estimates as to their
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number and affinity wi 11 be imprecise because of the large signal to
noise ratio inherent in measurements of specific ( H)QNB binding at
the pM concentrati ons of AF-DX 116 necessary to interact with the low
affinity sites.
In order to determine the interaction of receptors to G proteins, we
examined the effects of guanine nuc1eotides on the
muscarinic agonist , oxotremorine, to displace ( H)QNB.
abi 1 ity 
Representat i ve
curves obtained from individual experiments are shown as Fig. 22 and
analyses of composite data are shown in Table Compos i te ana 1 ys is of
the data indicates that in the absence of GTPyS , the displacement
curve had a n
H significantly less than 1.
0 and could best be described
as a sum of binding to two sites: 34% having high affinity (KD = 3.
nM ) and the remainder having low affinity (KD = 2. 21 pM). Although
the total number of binding sites was not changed by incubation with 100
GTPyS, the cou 1 d desc ri bed i nteracti curve
oxotremorine with a single class of low affinity binding sites with a
D of Since the total number of binding sites
was not53 pM.
altered by the nucleotide , the GTP-dependent loss of high affinity
agonist binding may be explained as a shift of the high affinity agonist
binding sites to the low affinity form. Thi s sort of GTP-dependent
shift is a hallmark of receptor coupling to G proteins.
In order to determine the type(s) of G protein(s) coupled to the
muscarinic receptor, we examined the effects of pertussi s toxi n 
agoni st binding affinities. other cell pertussi s toxintypes
cata 1 yzes the incorporation of ADP-ri bose from NAD into certain G
protei ns, notab 1 those te rmed and, Thi s cova 1 entG .
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Figure 22. Effects of GTPyS agonist binding to 
tracheal smooth muscle
membranes.
Representati ve experiment in which membranes were 
incubated for 60 mi 
at C with 0. 2 nM (3HJQNB and the indicated concentrations of the
muscarinic agonist oxotremorine in the absence (circles) or 
presence
(squares) of 100 pM GTPyS. In the absence of GTPyS, the
oxotremorine displacement curve had a nH significantly less than 
31) and was best described by an interaction with two classes 
binding sites; a large population (63%) having low affinity (KD of 1.
pM) and a smaller population (37%) with high affinity (KD = 0.
nM). In the presence of GTPyS, the oxotremorine displacement curve
had a nH not different from 1 (- 93) and was best described by an
interaction with a single c lass of binding 
sites with low affinity (KO
2. 'pM). The effects of the nucleotide can be described as
converting high affinity binding sites to low affinity binding 
sites.
modification disrupts the interaction of the G 
proteins with receptors
and reduces the number of receptors exhibiting high affinity for
agoni st. s h own i n Fig. 23, reaction of tracheal membranes with
pertussis toxin and 32 P)NAO generated a 
( p)-
labelled protein 
40 kO. This is the same molecular weight noted for the a. subunits of
and/or G . determi ne when . the all available sites
were
, " .. '.- ,..:": . :",,!: ,!:-~~~
. i,c:",:'
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Table 9. Effects of guanine nucleotides and pertussis toxin on agonist
binding to tracheal membranes.
GTPyS + GTPyS - toxi n + toxi n
( n=6) (n=5) (n=5) (n=5)
IC50 (nM) 1880 1: 620 5550 1: 500 1170 1: 200 1880 1: 400
Slope 1: 0. 04* 0 . 89 1: O. 1 0 . 43 1: O. 02 0 . 47 1: 0.
(nM) 3 . 74 1: 2. 4 ** 12. 1: 9. 6** 04 1: 1 0*
34% 40% 31%
KL (nM) 22101:0. 2530 1: 200 2880 1: 800 2300 1: 600
66% 100% 60% 69%
Va 1 ues represent Mean 1: SEM for the number of experiments i ndi cated. See
the Legend to Table 1 for explanation of terms and details of the 
analyses.
Statistically significant difference from unity 
(p .( .
05) using
one- ta i 1 ed Student 1 t test.
** A two site model was accepted only if it significantly improved the fit
over a one site model using the F test (p .( 0. 005).
reacted with the toxin and NAD, membranes were incubated with toxin and
unlabelled NAD for one or two hours then reacted again with fresh toxin
and p)NAD. in thi sAlthough reacting the vesicles with toxin
manner produced almost complete ribosylation
1ncorpora 10n 0 Urlng
(as indicated by the
re lati ve lack the subsequent toxi 
reaction) the toxin had only a slight effect on high affinity agonist
binding. In the experiment presented as Fi g. 23, the displacement
curves for membranes incubated with NAD in the absence of toxi n had a
H of -
43 and were best fit by assuming interaction with two classes
of receptors, with 39% having a high affinity. The displacement curve
for membranes treated with NAD and pertussis toxin had a nH of -
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Figure 23. Effects of pertussis toxin treatment on tracheal smooth
muscle membranes.
Panel A. Autoradiograph of 32P-labelled proteins produced by reaction
of membranes with (32p)NAD and pertussis toxin as indicated below.
Equal amounts of protein (35 pg) were applied to all lanes. Lane 1:
Membranes were incubated for 60 min at C with (32p)NAD in the
absence of pertussis toxin. Lane 2: Membranes were incubated for 60 min
at C with (32p)NAD in the presence of pertussis toxin (13 pg/ml).
Lane 3: Membranes reacted for 60 min with pertussis toxin and unlabe11ed
NAD folJowed by reaction (32p)NAD and toxin as in Lane 2. Lane 4:
Membranes reacted for 120 min with pertussis toxin and unlabelled NAD
followed by reaction with (32p)NAD as in Lane 1. The slight degree of
labelling may be due to incomplete removal of pertussis toxin. Lane 5:
Membranes reacted for 120 min with pertussis toxin and unlabelled NAD
followed by reaction with (32p)NAD and toxin as in Lane 2. Panel 
Representative experiments for oxotremorine displacement of H)QNB
binding in control (circles) and pertussis-treated (squares) membranes.In untreated membranes, the oxotremorine displacement curve had a 
significantly less than (nH = - 34)and was best described by 
interaction with two classes of binding sites: a large population (61%) 
having low affinity (KD of 1. 56 pM) and a smaller population (39%)
with high affinity (KD = 3. nM). In pertussis-treated membranes, the
oxotremorine displacement curve had a nH significantly less than 
(nH = - 49) and was best described by an interaction with two classes
of binding sites: a large class (76%) having low affinity (KD of 2.
pM) and a smaller class (24%) with high affinity (KD = 1. 6 nM).
of.
" . "' ,. -",_
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and only a slightly smaller percentage of receptors with high affinity
(24% vs 39% ). The KO va 1 ues for contro 1 and toxi n-treated groups
were similar and the addition of guanine nucleotide abolished high
affinity binding in both preparations. When data from separate
experiments were analyzed, the slight decrease in high affinity agonist
binding produced by reaction with pertussis toxin was not statistically
significant (Table 9). Thus, although the membranes contain a substrate
for pertuss is-dependent ADP ribosylation, conditions which produced
nearly complete ribosylation of the substrate proteins produced only a
minor effect on high affinity agonist binding. These results suggest
that the G protein ' which confers the high affinity state of the
receptor(s) for agonist is not affected by pertussis toxin-catalysed
ribosylation.
DISCUSSION
The present studies have defined a number of characteristics of
muscari ni c receptors in ai rway smooth muscle. The binding to the
antagonist QNB in both membranes and cells prepared from bovine trachea
was highly specifi c (nonspecific atropi ne- i nsens i ti ve binding
constituted less than 5% of tota 1 binding) and was descri bed
interaction with a single binding site. The apparent K for QNB
determined for muscarinicbinding (- 200 nM) is similar to values
receptors in a number of other tissues and cell types. Because QNB
binding could for the first time be assessed in isolated smooth muscle
cells of airway origin, the receptor density could also be calculated.
, - , ",,. ". , ' " ':. '' ; . . , , . ," ".,' '" ,.,, . ". " . . " '
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The density of muscarinic receptors (1-2 X 10
6 sites/cell) is at least
10 fold higher than the values we observed in gastric smooth muscle
cells (see Chapter VI).
Informati on deri ved the displacement H)QNB thefrom
selective antagonists pirenzepine, AF-DX 116 and 4-DAMP indicates that
the predomi nant subtype of muscari ni c receptor in tracheal smooth musc 1 e
has the pharmacological characteri sti cs the subtype.
Furthermore, in agreement with previous studies (Roffel et al., 1987,
1988) tracheal smooth muscle may also contain an additional population
of M subtype receptors. This conclusion is based on the following
observati ons. Pirenzipine interacted with sing 1 population
receptors and exhi bited a KD very much lower than that reported for
interaction with M receptors but near that reported for 
interaction
with M and/or M subtypes. The displacement curves for AF-DX 116
and 4-DAMP indicate that the majority of receptors can be classified as
the M subtype since the KD calculated for 4-DAMP (- 20 nM)
for the majority of sites interacting with AF-DX 116 (- 100 nM)
and
are
near values determined for the interaction with classical M2 receptors
(e. g. cardiac muscle). The conclusion that tracheal smooth muscle lacks
receptors and contains M receptors is in agreement with previ ous
studies in airway smooth muscle (Roffel et al., 1988).
The composite displacement curves for AF-DX 116 in both membranes
and isolated cells had nH significantly less than 
The observati 
that the binding AF- 116 cannot described simple
bimolecular interaction in agreement with previ ous stud i es wi th
membranes and extend s the observati on isolated ce 11 s. The
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displacement curves for AF-OX 116 can be exp 1 a i ned if the 1 i gand
interacted with more than one population of receptors or if the ligand
bound allosterically in a negatively cooperative manner. The former
exp 1 anat ion the more 1 i ke 1 y since we found evidenceseems
allosteric interaction in the binding of other antagonists. It follows
that the best explanation for the binding curves is that AF-DX 116
interacted with binding sites di fferi ng affi nities.two
membranes, the composite AF-DX 116 displacement curve was best fit by
the sum of binding to a population of two receptors: 85% having a K
of 129 nMolar (a value near that demonstrated in cell types containing
receptors) and the remainder having pMo 1 
value near that demonstrated in cell types containing M receptors).
Thus the tracheal membranes contain a high proportion of M versus
3 receptors.
The composite AF-DX 116 displacement curve from experiments with
isolated cells, like that for studies with membranes, exhibited a n
significantly less than 1; and the curve was best fit as the sum 
binding to a relatively large number of sites with an estimated Ko of
93 nMolar (i . e. M subtype) and a small population of sites with an
estimated KD of 3. pMolar (i. e. M subtype). Since the composite
analysis indicates that the binding of AF-DX 116 could not be explained
by interaction with a single class of binding sites, the isolated smooth
muscle cells also contain a mixed population of muscarinic receptor
subtypes.
The conclusion that airway smooth muscle contains both M2 and M
receptors is in agreement with the studies of Maeda et al. (1988) from
- , , - :!;' "'" 
'i" I.;
;-:
,,:r
'!y,,
Y:: :i:-
;:: - :::'-""\' :,' :,::
r;,
\--- ..-. -:.
.'.f-
' ;..
134
analysis of mRNA species encoding for muscarinic receptor subtypes).
The presence of both subtypes in smooth muscle is in agreement with our
findings in gastric smooth muscle which, interestingly, contains a
predomi nance of M receptors rather than M receptors.
The proporti on of M receptors estimated from
isolated cells was less than that estimated from studies
studies with
with isolated
membranes. Although the membranes were prepared from muscle strips that
were carefully dissected free of mucosal and epithelial layers (limiting
the contamination of these cell types), it is possible that some of the
receptors detected in membrane preparati ons contri butedare
nonmuscle cells or elements embedded within the muscle layer. For
example , Gabella (1987) observed that there were approximately 20 nerve
terminals present for each 100 muscle cells. Receptors present in the
nerve terminals could thus contribute to the receptor population in the
membrane vesicle preparation. However, since the density of receptors
is far greater on the muscle cells than on the mucosal or 
epithelial
cells (50 times fewer in mucosa (Madison et al., 1987); and 10 times
fewer in epithelia (Scott and McMahon, 1988)), the membrane preparation
would have to be very heavily contaminated to account for the 
findings.
Furthermore neura 1 ce 11 s have preponderance receptors
(Kilbinger and Nafziger, 1985) and would not contribute substantially to
the observed M population.
the relative numbers of M
Most likely the apparent difference 
versus receptors calculated for
membranes and isolated cells reflects only the imprecision inherent in
estimating the relative number of the two classes of binding sites from
curve fitting routines.
,; j::" 
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The binding of 4-DAMP could be explained by interaction with a
single site although this antagonist binds to M3 receptors with higher
affinity than to M receptors. The finding that 4-DAMP apparently
interacts with a single site while AF-DX 116 interacts with at least two
sites agrees with previous studies (Ladinsky et a1. , 1988; Roffe1 et
al., 1988), but would seem to be inconsistent with the conclusion that
two subtypes of muscarinic receptors are present. However, the abi 1 i 
to resolve classes of binding sites with selective ligands is dependent
on both the ratio of the KD values for the 
different sites (i . e. the
selectivity of the ligand) and the relative proportions of the different
classes of binding sites (De Lean et al., 1981). The selectivity of
DAMP for M3 and M
receptors calculated from binding to other cell
types whi ch contai n a predomi nance of each of these subtypes of receptor
(Doods et al, 1987) is approximately 5 to 15 fold. Gi ven the low
selectivity of this ligand, it would be impossible to resolve binding to
receptors in the presence of a arge number of M receptors, and
therefore the di splacement curve would be readi ly described by 
interaction with a single class of binding sites.
The displacement curves for the agonist oxotremorine were complex
and could best be explained by assuming interaction with low and high
affi nity binding sites. Based information deri ved from . other
systems, it reasonab 1 to assume that the high affinity state
corresponds to receptors coupled to G proteins (-35% of the total
repceptor pool) and the low affinity state corresponds to uncoupled
(free) receptors. Consistent with this interpretation, we found that
the add it i on of the GTP ana 1 ogue GTPyS had no effect on the the tota 
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number of binding sites but rather abolished the high affinity binding,
e. the nucleotide shifted high affinity receptors to a low affinity
form. Thi s GTP-dependent shi ft in agoni st affi nity is characteri sti c of
receptors that interact wi th G protei ns.
As shown in Fig. 23 , tracheal membranes contain protein(s) which
serve as substrates for ADP ribosy1ation catalysed by pertussis toxin.
The molecular weight of the protein (- 41 kD) is near that of the
subunits of the G protei ns G. and G whi ch have been shown to
be ribosy1ated in other cell types. However, reaction of the membranes
with the toxin affected high affinity agonist binding only slightly,
indicating that the muscarinic receptors in the trachea are not coupled
in a pertussi s-sens iti Wh i 1 e possible that somemanner.
receptors do interact with pertussis-sensitive G proteins, (e. g. it may
be that the M subtype interacts with a toxin-sensitive G protein as
was noted in gastric smooth muscle), this small population was not
consistently detected.
In other cell types, notably cardiac muscle, the M subtype is
coupled to the toxin-sensitive G protein , G. (McMahon and Hosey, 1985;
Ladinsky et a1., 1988). Since trachea contains both a large number of
receptors and a protein ribosylated by pertussis toxin, it was
surprising to find that the receptors are not coupled in a pertussis-
s ens i t i ve ma n n e r . It follows that neither the receptor subtype nor the
G protein complement of a cell is necessarily predictive of their
interaction. In this regard, the results of transfection studies using
cloned M receptors are of interest (Ashkenazi et a 1 . , 1987) . When
2 receptors were 
expressed in CHO cells at low receptor density, they
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appeared to be coupled exclusively to pertussis-sensitive G proteins.
However, when expressed to a higher receptor density (- 1. x 10
sites/cell ), the receptors appeared to couple to pertussis- insensitive
G protei ns. It is perhaps significant then that tracheal smooth muscle
cells have a density of receptors greater than that needed for toxin
insensitive coupling (2. 61 x 106 sites/cell).
The present results indicate that the major receptor subtype present
is M that thi c lass is coupled to Greceptorstrachea
proteins but in a largely pertussis toxin-insensitive manner. However
the trachea also contains M receptors and proteins similar in size to
the a subunits of pertussis-sensitive G proteins. Thus the trachea
conta ins at east 2 subtypes of muscari ni c receptors and at east 2
classes of G proteins (pertussis-sensitive and insensitive). It fo 11 ows
that the variety of cholinergic actions on smooth muscle (i. e. changes
inositol phospho 1 i pi d metabo 1 ism activationcyc 1 i c AMP
inhibition of membrane channels or ion transporters) may be controlled
by selective interaction between receptor subtypes and species of G
protei n. results from the study provide i nformat ionpresentThe
essential for defi ni ng conditions for the selective occupation
receptor subtypes and inactivation of pertussis-sensitive G proteins and
establ i sh bas is for studies correlating specific receptor
transduction mechanisms with specific cholinergic responses.
, " *.' ,- .
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Chapter VI 
Discussion of Smooth Muscle Muscarinic Receptors
The foregoing studies were undertaken as an initial step towards
understand i ng cellular mechani sms that regu 1 ate the di versethe
physiological responses of smooth muscle to muscarinic stimulation.
performed experiments in both bovine tracheal and toad gastric smooth
muscle in order to determine the extent to which they share common
biochemical signalling systems to control contractility. These studi es
reveal a heretofore unappreciated degree of complexity in muscarinic
regulation of contractility in different smooth muscle tissues. The two
types smooth musc 1 e differed thei r dens i ty muscarinic
receptors as we as in the proportion of M2 and M3 receptors , and
Each of these aspects wi'l be described below.G protein coupling.
both smooth mu s c 1 e preparati ons ana 1 ys is the saturation
binding isotherms for H)QNB withinteractionindicated
homogeneous population of receptors, as is expected for a nonselective
antagon i st. - The pM for ( H)QNB exhibited by trachea'175
smooth muscle muscarinic receptors agrees well with values reported for
other preparations (Yang et a1., 1986; Akhtar et al., 1987; Giraldo et
al., 1988; Rinner et al., 1988). However , the affinity of the amphibian
gastric receptors for QNB, although somewhat lower than the average
va 1 ues reported for mammalian ti ssues, was in agreement with the K
values reported for QNB in canine gastric smooth muscle cells. Thus , a
lower affinity for QNB may be a general property of gastric smooth
mu s c 1 e cell s An alternative, intriguing possibility is that the lower
. ", ' . . ,. , !
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affinity for QNB in toad gastric smooth muscle is attributable to the
preva 1 ence of M receptors, since comparison of antagoni st bi ndi ng
properties of cloned receptors expressed in cell lines indicated that
receptors displayed a 3-5 fold lower affinity for QNB than other
subtypes (Peralta et al., 1987).
The muscarinic receptor density in each smooth muscle type was
The density of binding sites for ( H)QNB to toadmarkedly different.
smooth muscle averaged 940 pmo1/mg protein for purified membranes or
x 10 sites/cell for suspensions of enzymatically dispersed
cells. These values are very similar to those reported for membranes
prepared from ileum (Yamamura and Snyder, 1974), coronary smooth musc 1 e
(Rinner et al., 1988) and for suspensions of canine gastric smooth
muscle cells (Collins and Crankshaw , 1986). The receptor density in
tracheal smooth muscle was significantly higher averaging 4. pmol/mg
protein for crude membranes or 2.6 x 10 sites/cell for suspensions of
enzymatically dispersed cells. The density in tracheal membranes 
quite similar to values reported by others for bovine (Madison et a1.
1987); Cheng and Townley, 1982), porcine (Yang et al., 1986) and canine
trachea (Murlas et al., 1982).
The functional significance of the nearly 10-fo1d higher receptor
density in tracheal smooth muscle cells is unknown. Murlas et al.
(1982) have speculated that the high density of muscarinic receptors
reflects the important role played by the parasympathetic nervous system
in regulating airway smooth muscle. On the other hand , the high density
of receptors could also represent a spare receptor capacity that would
allow the cell to respond rapidly but transiently to the low levels of
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acetylcholine released from parasympathetic nerves. This would occur
because the large receptor pool would provide a mechanism for 
obtaining
a response at low concentrations of an agonist even when the affinity 
the receptor for this agonist was low. The low affinity, in 
turn, would
ensure a rapid dissociation of the agoni st from the receptor and
termi nati on of the response. Support for this possibility is provided
from studies by De 1 haye et a 1 . , (1984 ) who demonstrated that the
concentration of acetylcholine needed to fully inhibit adenyl 
ate cyclase
in the heart requi red occupancy of only a few percent of the total
muscari ni c receptors. Alternatively, the occurrence of a large receptor
pool may allow for the preferential coup 1 i ng between particular
receptor subtype and a specific effector system, as was shown for
phospholipid coupling in transfection experiments (Ashkenazi et
al., 1987). Ashkenazi and colleagues demonstrated that M receptors
coupled to a pertussis-sensitive G protein when 
expressed in CHO cells
low dens i ty 100, 000 sites ce 11 ) , but that theseper
receptors could also couple to a pertussis-insensiti G protein when
expressed at a 10-fold higher density.
Information deri ved from binding profi 1 the selective
antagoni sts pi renzepi ne, AF - 116 and 4-DAMP indicated that
heterogeneous popu at i on of M2 and M receptors were present in 
both
toad gastric and bovine tracheal smooth muscle. However, the 
relative
proportion of each of these subtypes was completely opposite (see Table
10) . In toad gastri c smooth musc 1 e, 85-90% of the receptors were M
and the rema i nder were M in tracheal smooth muscle 85-90% of the
receptors were M and the remainder were M It is interesting to
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Tab 1 e 10. Compari son of tracheal and gastri c smooth musc 1 e muscari n; c
receptors and G protein coupling.
Receptor Subtypes
Trachea Gastri c
Smooth Musc 1 e Smooth Musc 1 e
M2 85-90% M2 12%
M3 10-1 5% M3 88%
Yes Yes
Yes Yes
Yes
Interaction with
G Protei n
Presence of Pertuss i s
Toxi n Substrate
Pertussis Sensitivity
of Agoni st Bi ndi ng
note that the sma 11 fracti on of M receptors in trachea, whi ch has a
higher receptor density, constitutes nearly the same total number of
receptors as were found in gastri c smooth musc 1 e. Therefore , M
receptors may have equally important physiological roles in both tissues.
Whereas Roffe 1 et a 1. (1987) conc 1 uded that the M3 receptors found
in tracheal membranes were localized on contaminating submucosal gland
membranes, we concluded that this possibility was unlikely for 
several
reasons. For one , based on published reports of the muscarinic receptor
density in tracheal submucosal glands (Yang et al., 1986; Scott and
MacMahon , 1988), our preparation of membranes from tracheal tissue would
have to consist entirely of glandular membranes in order to account for
the population receptors. Moreover, studies us i ngour
suspens ions enzymatically di spersed cells confi rmed that
receptors are indeed located on the smooth muscle cells. However, it is
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possible that estimates the proporti on versusour
receptors wi change slightly as more selective antagonists become
a va i 1 ab 1 e. One such agent that appears promising in this regard is the
antagoni st methoctrami ne, compound that exhi bits 50- fold
selectivity for M
and Whiting, 1988).
receptors and receptors (Michelversus
We were initially surprised at our findings that both AF-DX 116 and
DAMP provided better resol uti on of M versus M
toad gastric smooth muscle than in tracheal smooth muscle.
receptors
In trachea,
displacement curves for 4-DAMP could only be fit to a one site model
( n 1 ) whi ch the bi ndi ng site exhibited affi nity
characteristic of M receptors. However in retrospect, we realized
that the i nabil ity to resolve 4-DAMP bi rid i ng to M3 receptors was due
to a combination of factors: the limited 5-10 fold selectivity of this
agent toward M receptors and the fact' that M receptors represented
only a minor component of the to.tal receptor population. Similar
difficulties in resolving mixed receptor pools were reported by Roffel
(1988) in studies on the trachea and by Ladinsky et al. (1988) for the
80% M/20% M3 mixture of receptors in 
ileal smooth muscle. Despite
these difficulties, however, the results from composite analysis of the
data in trachea for AF-DX 116, 4-DAMP and pirenzepine strongly suggested
that both M
2 and M3 receptors were present in thi s ti ssue.
In toad gastric smooth muscle the majority of receptors exhibited
affinities for the selective antagonists that are characteristic of M
receptors while the remaining receptors exhibited a binding profile that
resembled M receptors. However, the absolute K values for binding
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to AF-DX 116 (10 nM) and 4-DAMP (700 nM) for the latter 
pool were quite
different from the affinities expected for 
classical M2 receptors (100
nM for AF-DX 116, 20 nM for DAMP). These findings suggest that the
M II receptors in toad gastric smooth muscle may be 
subtly different
from mammalian M receptors, or may be a completely different 
subtype
of muscari ni c receptor. To obtain a more rigorous identification 
this subtype would require analysis of the mRNAs encoding for muscarinic
receptors in toad gastri c smooth muscle with subtype-specifi
mRNA
probes.
smooth musc 1 e a 1 so
Studi es of toad gastri c and bovi ne tracheal
revea 1 ed heterogenei ty
the binding agoni st membrane
fractions. However, thi s heterogeneity in 
agonist binding reflects
heterogeneity in coup 1 i ng of a 11 receptors to G 
protei ns (see fi gure
24) . It is generally considered that receptors can exist in two
states: free receptors with low affinity for agonist and 
receptors
coupled to G proteins with high affinity for agonist; see 
Fig. 24a).
Agonist binding to a receptor induces a conformat i ona 
change that
increases the affinity of the receptor for G 
protein bound to GDP and
causes the format ion ternary complex consisting
agoni st-
receptor- protei n. The agoni st-receptor comp 1 ex
acti vates the
protein by promoting the exchange of GDP for GTP.
Binding of GTP 
turn promotes the dissociation of the ternary complex and causes the
dissociation the G protei into its BY and 
subunits (Fig.
24b) . Both the ex subuni t bound to GTP and BY 
subuni ts may then
interact with target sites.
The conclusion that muscarinic 
receptors were coupled to G proteins
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GDP
+Mg
GTP
Fi ure 24. Scheme for receptor-G protei n si gna 1 transducti on. From the
unliganded state (a) receptor binds agonist (A) which produces a change
(b) in receptor-G protein interaction, allowing GTP, in the presence ofto replace GDP on the e subunit. The activated e-GTP
subunit and the By subunits dissociate and one or both interact with
effectors. Alternatively, free By may bind other e subunits. The
intrinsic GTPase activity of the e subunit hydrolyses GTP to GDP , and
GDP recombines with By (c), ending the activation cycle. (from
Neer and Clapham, 1988).
in both airway and gastric smooth muscle was based on two lines 
evidence. The fi rst is that in the absence of guani ne nuc eoti des, the
agonist oxotremorine interacted with both high and low affinity states
of the receptors, with 24% of the gastri c and 35% of the trachea 
receptors displaying high agonist affinity characteristic of G protein-
coup 1 ed
additi on
receptors (see Figs. 16 and 22). The second is that the
GTPYS, nonhyd ro yzab 1 ana log GTP, compl ete ly
abolished all high affinity agonist binding without affecting the total
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number of receptors. The GTP-dependent shift in agonist binding is
characteri sti c of a 11 receptors coupled to G protei ns.
Although we did not obtain direct evidence that both M and M
receptors were coupled to G proteins, the data were consistent with this
possibility. The number of high affinity agonist binding sites in the
trachea (35% of the tota 1 receptor pool) was too 1 a rge to be accounted
for by the small (10%) population of M3 receptors. Moreover, there 
reason to expect that high affinity agonist binding was not due soley to
the coup 1 i ng of M receptors to G protei ns. Data from transfection
studies (Peralta et al., 1987) demonstrating that both cloned M2 and
receptors were capable of interacting with G proteins, as well as
our own data in toad gastric muscle , support this contention.
Moreover studi es us i ng pertussis toxi n provi ded unanticipated
results. other systems pertussis tox in has been shown
ADP-ri bosy1 ate the subunits and prevent i ng thei r
coupling receptors and abolishing high affinity agonist binding.
our studies, incubation of both toad gastric and bovine tracheal smooth
muscle membranes with toxin and ( p)NAD led to the ribosylation of a
single protein with a molecular weight of kD on SDS-PAGE, a
finding consistent with the ribosylation of both of the G proteins
menti oned above. However, pretreatment of membranes wi th pertuss is
toxin under conditions that caused a nearly complete ribosylation of all
of the available - kD substrate (see Fi g. 23), abolished high
affinity agonist binding in toad gastric smooth muscle membranes but
produced only a slight reduction in high affinity agonist binding
trachea.
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These results were surpri sing in several respects. First , in other
ti ssues, most notably the heart, receptors a re coup 1 ed to the
pertussis-sensitive G protein G..
of receptors in trachea smooth
However , even though the maj ori ty
and pertussis-are M
itt 1 e
musc 1 e
or effect sensitive substrate there waspresent
pertussis toxin on agonist binding. Therefore in trachea , most if not
all of the M receptors are coupled to a pertussis-insensitive G
In this regard, the results of transfection studies usingprotei n.
Whencloned M receptors are of interest (Ashkenazi et al. 1987).
receptors were expressed in CHO cells at low density they coupled
exclusively to pertussis-sensitive G proteins. However , when expressed
at a hi gher receptor dens i ty 1. 5 x 10 ites/ce 11) the receptors
appeared to be coupled to pertussis- insensitive G proteins. Thus the
hi gh receptor dens ity in tracheal smooth musc 1 e may somehow fac il itate
the interaction of M2 receptors with toxin-
insensitive G proteins.
The finding that the M receptors in toad gastric smooth muscle
are coupled to a pertussis substrate was also unexpected since the
coupling of transfected M receptors to G proteins in both NG108-15
cells were insensitive to toxin treatmentce 11 s and RAT
(Pi nkas-Kramarski et a 1 . , 1988) . The physiologic relevance of the
results from transfecti on experiments may be questi onab 1 e, however , in
that the cell lines used may have differing amounts and/or types of G
protei ns that cou 1 d influence the the coupling thenature
expressed muscarinic receptors. For example, although M receptors
were coupled to a pertussis- insensitive G protein in CHO cells, the
receptors, when expressed at an identical density in a human embryonic
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cell line were coupled to pertussis-sensitive G 
proteins (Ashkenazi et
al., 1987; Peralta et al., 1989).
Our results both smooth musc 1 e types support the
notion
originally set forth by Ashkenazi et al. (1987) that the ability of an
individual receptor subtype to recognize and interact with various G
proteins is differential rather than exclusive and may be determined by
the cellular context in which it evoked. Thus, the nature of
coupling of muscarinic receptors to G 
proteins in a given tissue may
depend on such factors as receptor density, the type and amount of G
proteins, the affi nity of these two components for one another, and
their physical arrangement within the cell membrane (Neer and Clapham,
1988) .
Comparison of the results obtained in toad gastric smooth muscle
with those in bovine tracheal smooth muscle indicate that their common
biological responses upon cholinergic activation may be mediated by very
di fferent receptor-G protei n i nteracti ons. Based on our own results, as
well as on evidence obtai ned in other systems, we propose the 
foll owi ng
models to explain the mechanisms that 
control the diverse effects of
cholinergic agents in each smooth muscle 
type. In toad gastri c smooth
muscle (Fig. 25) we hypothesize that M receptors are coupled to a
pertussis-sensitive G protein that in turn 
stimulates phosphoinositid
hydrolysis via activation of phospholipase 
The breakdown products of
PIP2' IP
and diacylglycerol, in turn act at several effector sites
to promote the increase in intracellular Ca
contraction. IP stimulates Ca release from intracellular stores
within the sarcoplasmic reticulum (Carsten, et al., 1985; Suematsu et
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al., 1985). Diacylglycerol directly activates voltage-sensitive ca
channels (Vivaudou et al., 1988) and suppresses a potassium current
termed the M current, (an effect which causes membrane depolarization
and consequent openi ng voltage sensitive Ca channels). This
latter portion of this proposed pathway has been demonstrated for M
receptors expressed in NG108-l5 neuroblastoma x glioma cells (Fukuda et
a 1., 1988) except that i ri thi s system the M3 receptors were coupled to
pertussis-sensitive G proteins
The M receptors in toad gastric smooth muscle could be coupled
through the pertussis-sensitive
cyclase.
to an inhibition of adenylyl
It is generally considered that the BY subunits from G
mediate the inhibition adenylyl cycl ase bY bi ndi ng free 
subunits from G (Weiss, et al., 1988; Gilman, 1987). Alternatively,
the cr. subuni t from G may directly inhibit the cyclase enzyme.
The function of this muscarinic pathway may be to inhibit cAMP-
dependent
processes that normally produce smooth muscle relaxation such as the
lowering of cytosolic Ca
2+ levels through the activation 
/Ca2+ exchange (an effect that is secondary to an increase in
Na+ , K+ - ATPase activity, Scheid et al., 1979; Scheid and Fay, 1984) or
the Ca ATPase ( Kattenburg '984 ) changesDaniel,and
myosin-ATPase activity secondary to a decrease ili myosin light chain
kinase activity (Conti and Adelstein, 1981; Aksoy et al., 1983).
and theThe preferential coupling of receptors to 
inhibition of adenylyl cyclase has been well established in a number of
sysytems. Studies in cardiac tissue using pirenzepine and AF-DX 116
indicated that AF-DX 116 was much more potent in blocking the muscarinic
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agoni st- i nduced inhibition adenylyl cyclase, suggesting that
receptors in the heart are coupled to this enzyme. Moreover, Capon I s
laboratory demonstrated that receptors cloned into CHO ce 11 s
(Ashkenazi et al., 1987) or into human embryonic kidney cells (Peralta
et al., 1988) were efficiently coupled to adeny1yl cyclase inhibition by
a pertussis-sensitive G protein.
The results observed in tracheal smooth muscle have led us to
suggest that the cholinergic control of the contractile state of this
ti ssue occurs by slightly di fferent mechani sms than those that may occur
in toad stomach (Figure 26). As in gastri c muscle, we assume that
muscari ni c receptors modulate both the phosphoi nos itide 
and the cAMP
second messenger pathways in airway smooth muscle. This assumption is
supported by studies using intact tracheal tissue, in which 
muscarinic
agonists were shown to inhibit cAMP production (Madison et a1., 1987)
and stimulate phosphoi nos i ti de metabo 1 i ( Takuwa a 1. , 1986) .
However, we are postulating that different G proteins are involved in
mediating each signa 11 i pathway in the trachea. Specfically,
propose that the hi gh dens ity muscari ni c receptors allows the
trachea 1 receptors couple PIP 2 breakdown through
pertuss i s- i nsens i ti ve protei n Gp. The receptors may also
inhibit adenyly1 cyclase activity stimulated ei ther B-adrenergi c
histamine H2 or VIP receptor that are coupled to G
Thi s can occur
two the subuni ts could donated from theways:
pertuss i s- i nsens i t i ve thereby removi ng itsto bind a
stimulatory effect on cyclase; alternatively, a small percentage of the
receptors cou 1 coupled the pertus s is -sens i t i ve
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inhibit cyclase by a manner analagous to that described for toad 
gastric
smooth musc 1 e. The fact that we 
were occasionally able to observe
pertussis-toxin effects on agonist binding lends support to this latter
possi bil ity. We are also postulati ng that the 
small percentage of M
receptors are coupled to phosphoinositide metabolism by a 
pertussis-
insensitive G protein. Such a coupling has been proposed for pancreati
acinar ce 11 s' wh i c h the muscari ni c-
i nduced increases PIP 2
hydrolysis were found sens iti ve
GTP but insensitive
Again this coupling may be physiologically 
important
pertussis toxin.
200, OOO/cell)
since the number of receptors trachea
identical to the total number of 
muscarinic receptors on other 
smooth
muscle types (Collins and Crankshaw, 1986 ; Chapter VI.
Once the
effector pathways have been act i vated, we assume
that the second
messengers elicit similar changes ln 
handling in the trachea as
were described for the toad stomach muscle.
To test the models described above, it would first be 
necessary to
demonstrate that each subtype of 
receptor was capable of interacting
with a G protein. This could be achieved by repeating the 
agonist
displacement experiments in each tissue using AF-
DX 116 or 4-DAMP as the
radio ligand. Then using our estimates of 
the binding constants for
antagoni sts and agoni sts and the proporti 
ons of each receptor speci es,
we could define conditions for the selective activation of a 
given
receptor speci es. This would allow us to 
correlate the activation of a
specific receptor species with a particular 
biochemical response. Thus,
for example, in toad gastric smooth muscle, in order to 
show that M
receptors are coup 1 ed pertus s is -sens i t i ve
protei ns and
'''''::'::ii
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phosphoinositide metabolism we would 
first need to demonstrate that
phosphoinositid hydrolysis can be activated by muscarinic agonists at a
concentrati on near the KD value for G 
protei n coupled receptors. To
show that M receptors mediate this 
response we would need to
demonstrate that this 
activation could be blocked by concentrations of
DAMP near its K value for M
concentrations of AF-DX 116 .,
that
receptors, but be unaffected by
selectively interact with
receptors. The participation of a 
pertussis-senstive G protein could
then be determi ned from the effects of toxi n treatment 
on both the
activation of phospholipase C and the 
suppressio of the M current
induced by muscarinic agonists.
Lastly, we would need to test whether
PIP (IP and diacylglycerol)
can mimic the effects of muscarinic agonists on the M 
current. Simi lareither of the breakdown products of
strategies could be employed to test each of the other proposed 
pathways
for regulating bovine tracheal and gastric smooth muscle contractility.
The models proposed above also predict that each subtype of receptor
regulates different transduction 
pathways within the cell. Thi s may
allow for an amplification of the 
response to acetylcholi , i. e.,
max; ma 1 changes in ; ntrac ell u 1 a r c
.z+ could be obtained if both see and
messenger pathways were modulated simultaneously.
Alternatively, each
signa 11; ng pathway could be 
used separatelY to respond to different
extracellular signa 1 s . For examp 1 e ,
muscari ni c regu 1 at ion
the
used to modulate responses to B
adeny1yl cyclase system could 
activation the
adrenergi c stimul i . Conversely,
the muscar; ni c
phas pha; nos it ide system may serve as a 
direct eXC i tatary pathway
; n
response to acetylcholine release from 
parasympathetic nerve 
endings.
- "-
f:-
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Thus, the M receptor-mediated phospho 
1 i pi d pathway in toad ga stri c
smooth muscle could be used as a 
direct excitatory pathway whereas the
adenylyl cyclase pathway could be 
used to integrate incoming 
signals
from the parasympatheti c and sympathet i c
nervous systems. In th i s
regard, the adenylyl cyclase signalling system would represent a balance
point between imputs from the autonomic nervous 
system.
These studies allowed us to 
compare the subtypes and patterns of G
protei n coup 1 i ng between gastri c 
and airwaY' smooth muscle. Si nce data
from the iterature have demonstrated
muscari ni c receptor mediated
phospholipid metabolism in both tissues,
our data Suggest that the
muscarinic receptors can be coupled to 
this pathway by different G
and
protei ns: pertuss i s- i nsens i t i ve
protei n trachea
It may be
pertussis-sensiti G protein in toad 
gastric smooth muscle.
that the apparent differences in coupling of 
muscarinic receptors to
phosphoinositide hydrolysis within the different 
tissues may depend on
the di fferent stoi chi ometri c relationshiPs
between the receptors,
protei ns and phospho 1 i pase
a 1 ternat i possibility that
muscari ni c receptors in di fferent 
smooth muscle ti ssues may be 
inked to
different routes of metabolism of phosphatidylinositides (phospholipase
C versus phospholipase A
' Peralta et al., 1989).
In summary, the results of these 
studies have provided an initial
identification of the receptor 
subtypes and G proteins that may mediate
the diverse responses of smooth muscle to 
cholinergic stimuli. Perhaps
even more significant are our findings that 
different smooth muscle
receptor subtypes and G proteins to
types use di fferent muscari ni c
Thus, it may be that
regulate the same biochemical signalling 
systems.
- .
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the nature of a smooth muscle cell' s response to 
acetylcholine will be
dictated by its endowment of receptors, G proteins, and 
effectors, as
well as by the relative concentrations and affinities of all of these
compounds.
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Chapter IX
ANALYSIS OF DISPLACEMENT CURVES
The general approach to the identifi cati on of muscari ni c receptor
subtypes present in toad gastri c and bovi ne tracheal smooth musc le was
to evaluate the ability of unlabeled antagonists , which exhibit varying
degrees of selectivity for muscarinic receptor 
subtypes, to displace the
binding of the nonselective antagonist ( HJQNB. Similar displacement
."'
experiments for the agoni st oxotremori ne were used to demonstrate the
presence of multiple agonist affinity states.
The mathemati cal model s that descri be these i nteracti ons is based on
the law of mass action which dictates that drugs combine with their
receptors by a simple bimolecular reaction at a 
rate dependent upon the
concentration of drug (D) and receptor (R) and that the resulting drug
receptor (DR) complex breaks down at a rate proportional to the number
of complexes' formed:
o + R k, R. D and (9.
the equilibrium dissociation constant (K ) equals
KO = l r
(DRJ
= K2 (9.
Si nce the total receptor concentrati ons must be a sum of the free and
bound concentrations:
TOTJ = (R) + (DR)
(9.
combining the last two equations to solve for 
(D-RJ gives
-=-
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(D-R) = rDl (RTOTl
KO + (D)
(9. 4 )
which describes the law of mass action and which yields a hyperbolic
displacement curve. The mass action model also dictates that for more
than one population of receptor sites , the observed binding curve would
reflect the II S urn hyberbolas ll for each drug- receptor interaction.
Thi s assumes that the igand interacts independently wi th each receptor
class aDd that the affinity remains unchanged with increasing occupancy.
Whether or not a displacing ligand interacts with the receptors via
simple mass action law (reflecting one hyberbola) or via greater
complexity (reflective of multiple hyperbolas) can be determined by
examining the overall II shape ll of the displacement curve in a plot of %
Bound versus the log of the concentration of the displacing ligand.
When the radioligand and the displacing compound interact revers i bil y
with the receptor via a simple bimolecular reaction , the competition
curve for the displacing compound will proceed for 10% to 90% over an
81-fold concentration of the displacing compound. This generalization
was fi rst made Kosh1and (1970) for displayingenzymes
Mi c hae 1 is-Menton k i net i c s . Curves that exhibit this displacement are of
norma 1 steepness and have characteri stic slope or pseudo-Hi 11
coeffi c i ent equa 1 1.0. proceed i ng from 10% 90%C u rv e s
displacement over a greater than 81-fold range of displacing ligand
concentration are frequently referred to as II sha110w
ll and possess a
pseudo-Hill coefficient less than 1. A Hill coefficient 1.0 for
such curves is generally assumed to reflect the sum of binding to two
sites, but may also reflect negativ cooperativity between binding sites
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such that the overall affinity of the receptor population decreases as
its fractional occupancy by the ligand increases.
The analysis of displacement curves can be modeled by severa 
equations and most curve fitting programs fit the data nonlinear least
squares regression. Linear regression unsuitable for fitting
displacement since the 1 oga ri thmi c functions.curves curves are
Nonlinear determi nes va 1 ues pa rameters relativeregresson
number and proportion of binding sites, etc. ) that minimize the sum of
the squares of the distances of the data points from the curve generated
by the equati ons used to describe the binding reactions (Motulsky,
1987) . Two nonlinear least squares regression programs were used for
curve fitting in our studies: ALLFIT developed by De Lean (1978) and
LIGAND developed by Munson and Rodbard (1980).
The ALLFIT program is a four parameter logistics equation that is
mathematically analagous to the Hill equation:
1 +( X/C) 
(9.
where Y= concentration of the radio ligand bound
x= concentration of displacing ligand bound
c= IC
50 of displacing ligand
b= steepness factor or pseudo-Hi 11 coeffi ci ent
a= extrapolated upper limit for Y (total binding)
d= etrapolated lower limits for Y (nonspecific binding)
The primary advantage of the ALLFIT program is that it allows for a
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constrained, simultaneous fit to several curves, forcing them to share
certain parameters in common. In our case, the constrained fit to the
curves forced them to share either C (IC ) or B (the slope factor or
pseudo-Hill coefficient). For analysis of individual curves, the
standard errors and the confidence limits of the parameter estimates in
nonlinear regression are only approximate since they are logarithmically
distibuted rather than normally distributed; therefore , any conclusions
regardi ng the equal i ty of correspondi ng parameters are a 1 so approxi mate
(De Lean, 1978). In contrast, simultaneous constrained curve fitting
permits testi ng the equality pa ramete rs i nspecti the
consequences of forc i ng them to be equa 
The ALLFIT program was thus used to provide the value of the
pseudo-Hi 11 coeffi c i ent for the agonist and antagonist displacement
experiments. Thi s program, however , is unable to resolve the complex
bi ndi ng curves further. Therefore, if the pseudo-Hi 11 coeffi ci ent was
significantly different from 1. 0, the data were then analyzed with the
LIGAND program to obtain estimates of the KD values and proportion of
the different binding sites. Implicit in this statement is the
assumption that the binding reactions between ( H)QNB , the displacing
1igands and the receptors follow the mass action model assumed for the
LIGAND program (as opposed to refl ecti ng negati ve cooperati vity between
binding sites, Limbird, 1986).
The mathematical model of the LIGAND program is analagous to a "
sum
of hyperbolas " description for complex binding similar to equation 9.
The algebraic descriptions below are from (1983).
For a single ligand binding to a single class of binding sites:
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B= (KR/(l + KF)+N)F (9.
T= B + F
where T= concentration of total ligand added
B= concentration of bound ligand
F= concentration of free ligand
R= receptor density
N= ratio of nonspecifically bound ligand to free ligand
K= equilibrium association constant in units M
2 ) For two ligands binding to a single class of receptors as occur in
displacement experiments, the mathematical model becomes
B = (K R/l +K F + K F )+N )F1 1 1 2
= (K R/(1+K l + K )+N
T 1 = B
1 + F 
T 2= B
2 + F 
(9.
(9" 8)
Where the subscripts refer to ligands L or L The value K
for
the radio1igand, ( H)QNB , is determined in independent experiments by
Scatchard analyses of QNB binding data. These equati ons take into
account the fraction of the receptor population that wi 11 be occupied by
each ligand.
For a ligand binding to 2 classes of receptors, a double subscript
is used in the LIGAND program to describe the affinity constant K 
= (K /(1 + K 1 + K
) +
/(1 + K F + F )+N )F2 1 22 2 
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= (K /(1 + K
1 + K
) +
/(1 + K l + K
)+N
where x = L iagnad 1 or 2 and y = receptor 1 or The program a 1 so
introduces correct ion factor that adj usts for varyi ng receptor
concentrat ions between experiments and thus permi ts simultaneous
analysis and comparison of the data from several experiments.
The LIGAND program has severa 1 features that demonstrate the
advantages of computer-assi sted ana lysi s for the estimation of bi ndi ng
pa ramete rs . First, the computations are done using the concentration of
the ligand added to the reaction, which can be precisely determined.
Therefore most of the measurement error confi ned to a sing 1 
variable, the concentrat ion bound radio ligand. contrast
Scatchard analysis introduces error in both the Bound and the Bound/Free
axes. Secondly, the program weights the data based on the reciprocal
of their variance so that the analysis is most significantly influenced
the most rel i ab 1 data. Without , thi s procedure the nonlinear
regression program would tend to emphasize points with a large variance
from the predi cted curve. Thi rd, the curve-fitti ng program provides a
variety of statistical methods to determine lithe goodness of fit" for a
given model (one-site versus a two-site model, etc., see below).
ana 1 yze the results from the displacement experiments the
following data are entered in the ligand program: the specific activity
of ( H)QNB, the total cpm added to each tube, and the cpm bound at
each concentration of displacing ligand. The data is first fit to the
simpler one site model; since a nonlinear equation cannot be resolved in
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single step, initial estimates of each parameter are supplied. The
nonl i near regressi on procedure then adj usts these val ues to im rove the
fit of the curve to the data. The initial values of the affinity for
H)QNB are obtained from previous saturation binding experiments, the
estimates of R and K (affinity for the displacing ligand) are based
on the raw data. For example, a suitable initial estimate for the
affinity of the disp1acer would be the concentration of the drug that
caused a 50% reducti on in total cpm bound.
The data are then fit to the more complex two-site model. Initial
estimates are also provided for this fit. The program then compares the
two models to determine if the more complex model resulted in a better
fit to the data. The comparison of two models with a different number
of parameters is not straightforward because an increased number 
parameters gives more flexibility to the curve fitting procedure and
almost always leads to a curve that is close to the points (remember
that a nonlinear least squares program iterates until the average sums
of squares of the di stance between the data poi nts and the curve are
mi nimi zed) . The question is whether the improved fit is worth the loss
of degrees of freedom (number of data poi nts mi nus the number of
parameters) . This question can be answered statistically by performing
the F test.
F = SS -SS /(df - df 
SS/df 2
where SS and SS equal the total sums of squares for the one site
and two site models respectively, and df refers to the number of
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degrees of freedom. value is then obtained by the program by
comparing this calculated value with tabulated values for (df
and df degrees of freedom. A ' P value -( 0. 05 indicates that
the more complex model fits the data significantly better than a
one-s ite mode 1.
A problem with LIGAND program that was identified in these studies
is the manner in which it defines nonspecific binding (N). In analysis
of individual curves , N is defined as a function of the total counts
added (T) (i. e. nonspecifi c binding the limiting rati 0
bound/total as T approaches infinity However, in composite analysis,
as described above , a correction factor (C) is introduced to account for
differences in receptor concentrations between experiments; this factor
is also used to scale the nonspecific binding value. Therefore, in
composite analysis , N is defined as a function of receptor concentration
(i e. amount bound" The scaling of N may lead to an overestimate of
the contribution of nonspecific binding to the composite curves and may
obscure the detection of a small population of receptors with low
affinity for the ligand. This problem was recognized in the composite
analysis of AF-DX 116 displacement curves in tracheal smooth muscle in
which the low affinity binding site represented "" 10% of the total
number of sites. To adj ust for thi s prob 1 em, corrected each
individual curve for non-specific binding and held N constsant at zero
for the composite analysis. After thi s correcti on was performed, the
composite analysis was able to resolve the second low affinity site for
AF-DX binding.
'r--
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DeLean and associates (1981) provided an empirical test of this
computer modeling method by analyzing radioligand bi ndi ng data for
mixtures of receptor subtypes and helped determine the limits of the
analysis. They utilized LIGAND to analyze complex binding data which
resulted from mixing known proportions of 13 adrenergic receptor subtypes
in radioligand binding reactions. Such mixtures of receptor subtypes
were created comb i n i n g vari ous proportions previously
c ha racteri zed pure 13 and 13 receptors populations from turkey and
frog erythrocyte membranes (DeLean et a 1., 1981). It was determi ned
that accurate resolution of the two subtypes could be obtained using an
agent with only a 5 to 8 fold selectivity for a particular receptor
subtypes when the receptors were present in a 50/50 mi However, the
practical limit of the program s ability to statistically resolve two
receptor populations from one another was reached with a 90%/10% mix of
receptors. In this case , the displacing ligand needed at least a 30 to
1 OO-f old selectivity for receptor subtype o rd e r for theone
statistics in the computer modeling program to favor a two-site model
over a one-s i te mode 1 .
These results may explain our inability to discriminate 4-DAMP
binding to the - 85% M2 / 15% M receptor mixture in tracheal
smooth muscle. 4-DAMP based on the ratio of its affinity for M
receptors in exocrine glands and M receptors in cardiac membranes,
has only a 10-fold selectivity towards M3 receptors. Therefore
, given
the mixture of receptor subtypes in trachea, it is unlikely that both
sites would be resolved. On the other hand , it was curious that both
and M receptors were resolved in toad gastric membranes given
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the 87% Ml13% M
in th is
mi xture receptors. Although the
receptors ti ssue s ha red the same relative binding
pi ren zepi ne, AF- 116 and DAMP as classical receptors, the
abso 1 ute bi ndi ng constant for AF-DX 116 and 4-DAMP were di fferent than
those expected for classical M receptors (i. e. 100 nM for AF-DX 116,
20 nM for 4-DAMP). Analysis of the data indicated that this M
receptor exhibited 10 nM affinity for AF- DX 116 and 700 nM affinity
for 4-DAMP. Therefore , the apparent selectivity of 4-DAMP was 100-fold
for the M receptor, based on the rati 0 of the K values for the 
receptor subtypes. These results suggest that the c lass of receptors
defined as M2 in the 
toad stomach muscle may be subtly different than
subtype.
receptors or may actua 11 y represent a nove 1 receptor
Alternatively, the phospholipid environment of the membrane
mamma 1 i 
surrounding the receptor may be somewhat different in the amphibian
tissue, forcing the M receptor into a slightly altered conformation
that would affect binding to AF-DX 116 and 4-DAMP.
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